6-K - MFC - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of November, 2022

Commission File Number: 1-14942

MANULIFE FINANCIAL CORPORATION

(Translation of registrant's name into English)

200 Bloor Street East

North Tower 10

Toronto, Ontario, Canada M4W 1E5

(416) 926‑3000

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F	☐	Form 40-F	☑

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

The registrant’s Management’s Discussion and Analysis and Unaudited Interim Consolidated Financial Statements for the quarter ended September 30, 2022 included on pages 5 to 66 and 67 to 107, respectively, of the registrant’s 2022 Third Quarter Report to Shareholders filed with this Form 6-K as Exhibit 99.1, are incorporated by reference in the registration statements filed with the Securities and Exchange Commission by the registrant on Form S-8 (Registration Nos. 333-12610, 333-13072, 333-114951, 333-129430, 333‑157326, and 333-211366), on Form F‑3 (Registration No. 333-159176) and on Form F-10 (Registration No. 333-259543). Except for the foregoing, no other document or portion of a document filed with this Form 6-K is incorporated by reference in the above registration statements.

DOCUMENTS FILED AS PART OF THIS FORM 6-K

The following documents, filed as exhibits to this Form 6-K, are incorporated by reference as part of this Form 6-K:

Exhibit	Description of Exhibit
99.1	Third Quarter Report to Shareholders
99.2	Certification Chief Executive Officer
99.3	Certification Chief Financial Officer

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MANULIFE FINANCIAL CORPORATION
	By: /s/ James D. Gallagher
	Name: James D. Gallagher
	Title: General<br> Counsel
Date: November 9, 2022

EXHIBIT INDEX

Exhibit	Description of Exhibit
99.1	Third Quarter Report to Shareholders
99.2	Certification Chief Executive Officer
99.3	Certification Chief Financial Officer

Manulife reports 3Q22 net income of $1.3 billion, core earnings of $1.3 billion, APE sales of $1.3 billion, and Global Wealth and Asset Management net inflows of $3.0 billion

Today, Manulife announced its third quarter of 2022 (“3Q22”) results. Key highlights include:

◾	Net income attributed to shareholders of $1.3 billion in 3Q22, down $0.2 billion from the third quarter of 2021 (“3Q21”)
◾	Core earnings^1^ of $1.3 billion in 3Q22, down 14% on a constant exchange rate basis from<br> 3Q21^2^. 3Q22 core earnings include a $256 million charge in our Property and Casualty (“P&C”) reinsurance business related to<br> Hurricane Ian.
---	---
◾	LICAT ratio^3^ of 136%
---	---
◾	Core ROE^4^ of 10.3% and ROE of 10.5% in 3Q22
---	---
◾	NBV^5^ of $514 million in 3Q22, down 6%^5^ from 3Q21
---	---
◾	APE sales^5^ of $1.3 billion in 3Q22, down 6% from 3Q21
---	---
◾	Global Wealth and Asset Management (“Global WAM”) net inflows^5^ of $3.0 billion in 3Q22, compared with net inflows of<br> $9.8 billion in 3Q21
---	---
◾	The impact to net income attributed to shareholders of our annual review of actuarial methods and assumptions was a modest net gain of $36 million in total, and approximately net neutral for<br> long-term care (“LTC”)
---	---
◾	Purchased for cancellation approximately 23 million common shares in 3Q22 for $0.5 billion
---	---

“We delivered resilient operating results in the third quarter amidst a challenging market and operating environment,” said Manulife President & Chief Executive Officer Roy Gori. “We continued to deliver solid results in our Asia business and delivered in-force business growth of 8% and 12% in the third quarter and year-to-date, respectively. And, in Global WAM, we generated net inflows of $3.0 billion and our core EBITDA margin^4^ was 32.7% in 3Q22, a very strong achievement given the market volatility.”

“We are focused on driving resilience for our people, customers and communities. Through our behavioural insurance offerings, we are committed to helping our customers lead longer, healthier, better lives, and we are rewarding them for making healthy lifestyle choices. We are expanding our Manulife Vitality offerings in Canada across our core product suite. In the U.S., we have made a multi-cancer, early detection test available to a pilot group of existing customers through John Hancock Vitality, enabling customers to make more informed choices about their health. And, in Asia, we continue to roll out servicing features in our ManulifeMOVE app, furthering its position as a one-stop health and servicing gateway for our customers,” added Mr. Gori.

“Our diverse business and strong capital levels position us well to navigate an uncertain market environment. Our LICAT ratio of 136% provides significant flexibility, and we have repurchased approximately 3.1% of our common shares for $1.4 billion so far this year^6^ as we remain committed to delivering value to shareholders,” said Phil Witherington, Chief Financial Officer.

“Expense efficiency continues to be a key strategic priority and important lever in the current operating environment. Our third quarter general expenses were held in line with the prior year, providing an offset to topline pressure,” Mr. Witherington continued.

^1^	Core earnings is a non-GAAP financial measure. For more information on non-GAAP and other financial measures, see “Non-GAAP and other financial measures” in our Third Quarter 2022<br> Management’s Discussion and Analysis (“3Q22 MD&A”) for additional information.
^2^	Percentage growth / declines in core earnings stated on a constant exchange rate basis is a non-GAAP ratio.
---	---
^3^	Life Insurance Capital Adequacy Test (“LICAT”) ratio of The Manufacturers Life Insurance Company (“MLI”). LICAT ratio is disclosed under the Office of the Superintendent of<br> Financial Institutions Canada’s (“OSFI’s”) Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline.
---	---
^4^	Core return on common shareholders’ equity (“Core ROE”) and core EBITDA margin are non-GAAP ratios.
---	---
^5^	For more information on new business value (“NBV”), annualized premium equivalent (“APE”) sales and net flows, see “Non-GAAP and other financial measures” in our 3Q22 MD&A. In<br> this news release, percentage growth / declines in NBV and APE sales are stated on a constant exchange rate basis.
---	---
^6^	As of October 31, 2022 the Company has purchased for cancellation approximately 60 million common shares for $1.4 billion.
---	---

Manulife Financial Corporation – Third Quarter 2022

BUSINESS HIGHLIGHTS:

In Asia, we accelerated the utilization of ManuAcademy, our regional digital learning platform rolled out to Vietnam last quarter. Since the roll-out, the platform has enabled the onboarding of over 11,000 newly-recruited insurance agents, and delivered over 150,000 training hours to approximately 45,000 insurance agents. Our new training series, Manulife MasterClass, captures best practices from our Million Dollar Round Table agents and shares them across all agents through the platform. In Canada, we announced an expansion of the Manulife Vitality program, making it available to new term and universal life insurance policyholders effective November 2022. In the U.S., we continue to innovate our wellness offerings and announced a partnership with GRAIL, a healthcare company, offering access to Galleri®, their leading edge, multi-cancer early detection test to a pilot group of customers through John Hancock Vitality. As the first life insurance carrier to make GRAIL’s Galleri® test available, we are enabling eligible customers to take proactive steps to better understand and make more informed choices about their health. In Global WAM, we expanded our Environmental, Social and Governance investment offerings with the launch of the Global Climate Action strategy in Europe to meet increasing demand for sustainable investment solutions.

In addition, we continued to make progress on our digital journey in 3Q22. In Asia, we continued to drive the adoption of ePOS, our proprietary digital onboarding app, to enhance the distributor experience and enable faster, error-free new business application submissions with case adoption at 90%, an increase of 9 percentage points compared with 3Q21. In the U.S., we reduced the amount of time to onboard producers within our traditional brokerage channel by 92% by automating the background check process. In Global WAM, we made a number of enhancements to our digital platform in Retirement including rolling out functionality that enables members in Canada to book one-on-one meetings with a Manulife PlanRight financial advisor directly in the mobile app, which generated successful engagement, and resulted in approximately 1,400 advisor meeting requests in 3Q22. In addition, we recently enhanced digital service features which enable members in the U.S. to self-serve to a greater extent, resulting in a reduction of approximately 10,000 calls to the call centre this quarter.

Manulife Financial Corporation – Third Quarter 2022

FINANCIAL HIGHLIGHTS:

						YTD Results
( millions, unless otherwise stated)	3Q22			3Q21			2022			2021
Profitability:
Net income attributed to shareholders	1,347		$	1,592		$	5,403		$	5,021
Core earnings	1,322		$	1,517		$	4,436		$	4,828
Diluted earnings per common share ()	0.68		$	0.80		$	2.72		$	2.51
Diluted core earnings per common share (“Core EPS”) ()(1)	0.67		$	0.76		$	2.22		$	2.41
Return on common shareholders’ equity (“ROE”)	10.5	%		12.6	%		14.0	%		13.7	%
Core ROE	10.3	%		12.0	%		11.4	%		13.2	%
Expense efficiency ratio(1)	53.9	%		51.3	%		51.0	%		48.9	%
General expenses	1,900		$	1,904		$	5,641		$	5,828
Business Performance:
Asia new business value	333		$	399		$	1,010		$	1,275
Canada new business value	89		$	71		$	275		$	225
U.S. new business value	92		$	69		$	253		$	188
Total new business value	514		$	539		$	1,538		$	1,688
Asia APE sales	854		$	930		$	2,740		$	3,160
Canada APE sales	285		$	303		$	1,009		$	932
U.S. APE sales	207		$	203		$	615		$	544
Total APE sales	1,346		$	1,436		$	4,364		$	4,636
Global WAM net flows ( billions)	3.0		$	9.8		$	11.6		$	19.8
Global WAM gross flows ( billions)(2)	32.0		$	35.2		$	104.1		$	108.7
Global WAM assets under management and administration ( billions)(3)	748.8		$	823.6		$	748.8		$	823.6
Global WAM total invested assets ( billions)	3.7		$	4.3		$	3.7		$	4.3
Global WAM net segregated funds net assets ( billions)	214.5		$	244.6		$	214.5		$	244.6
Financial Strength:
MLI’s LICAT ratio	136	%		138	%		136	%		138	%
Financial leverage ratio	28.8	%		25.5	%		28.8	%		25.5	%
Book value per common share ()	26.17		$	25.78		$	26.17		$	25.78
Book value per common share excluding AOCI ()	25.88		$	23.41		$	25.88		$	23.41

All values are in US Dollars.

^(1)^	This item is a non-GAAP ratio.
^(2)^	For more information on gross flows, see “Non-GAAP and other financial measures” in our 3Q22 MD&A for additional information.
---	---
^(3)^	This item is a non-GAAP financial measure.
---	---

PROFITABILITY:

Reported net income attributed to shareholders of $1.3 billion in 3Q22, down $0.2 billion from 3Q21

The decrease in net income attributed to shareholders was primarily driven by lower gains from investment-related experience and lower core earnings, partially offset by a smaller charge from the direct impact of markets. The direct impact of markets in 3Q21 included a $0.5 billion charge related to the impact of updated Ultimate Reinvestment Rate assumptions issued by the Canadian Actuarial Standards Board. Investment-related experience in 3Q22 reflected the favourable impact of fixed income reinvestment activities and favourable credit experience, partially offset by lower-than-expected returns (including fair value changes) on alternative long-duration assets primarily related to real estate. The charge from the direct impact of markets in 3Q22 was primarily driven by the impact of unfavourable equity market performance, losses from the sale of available-for-sale (“AFS”) bonds and swap spread movements, partially offset by gains due to rising interest rates in the U.S., a flattening of the yield curve in Canada, and widening corporate spreads in the U.S.

Delivered core earnings of $1.3 billion in 3Q22, a decrease of 14% compared with 3Q21

The decrease in core earnings was driven by a $256 million charge in our P&C Reinsurance business for estimated losses related to Hurricane Ian (compared with a $152 million charge in the prior year quarter for estimated losses related to Hurricane Ida and the European floods), lower net gains on sales of AFS equities and the unfavourable impact of markets on seed money investments in new and segregated mutual funds in Corporate and Other, lower new business gains in Asia and the U.S., lower U.S. Annuities in-force earnings due to the variable annuity reinsurance transaction that closed in the first quarter of 2022, and a higher charge from net

Manulife Financial Corporation – Third Quarter 2022

unfavourable U.S. policyholder experience. These items were partially offset by higher yields on fixed income investments and lower expenses in Corporate and Other, and in-force business growth in Asia and Canada. Lower expenses in Corporate and Other reflect lower supplemental pension expense primarily due to market impacts and lower variable incentive compensation.

ANNUAL REVIEW OF ACTUARIAL METHODS AND ASSUMPTIONS:

We completed our annual review of actuarial methods and assumptions, which resulted in a modest net gain of $36 million post-tax to net income attributed to shareholders in total and approximately net neutral impact for LTC. The review included a comprehensive study of our U.S. LTC experience, including all aspects of claims assumptions and future premium rate increases. Other assumptions reviewed included mortality and certain lapse assumptions for Canada’s life insurance business, as well as lapse and mortality assumptions for certain Asia markets.

BUSINESS PERFORMANCE:

New business value (“NBV”) of $514 million in 3Q22, a decrease of 6% compared with 3Q21

In Asia, NBV decreased 17% from 3Q21 reflecting lower sales in Hong Kong and changes in product mix in Asia Other^1^, partially offset by higher individual protection and other wealth sales in Japan. In Canada, NBV increased 25% from 3Q21, driven by higher margins in our insurance businesses, partially offset by lower volumes in Annuities. In the U.S., NBV increased 27% from 3Q21, driven by improved margins due to pricing actions, higher interest rates and changes in product mix.

Annualized premium equivalent (“APE”) sales of $1.3 billion in 3Q22, a decrease of 6% compared with 3Q21

In Asia, APE sales decreased 7%, reflecting lower sales in Hong Kong, partially offset by higher sales in Japan and Asia Other. In Hong Kong, APE sales decreased 40% driven by the impact of weaker customer sentiment on financial planning decisions and tighter COVID-19 containment measures in Macau during the quarter. In Japan, APE sales increased 22% as a result of higher individual protection and other wealth sales. Asia Other APE sales increased 6%, reflecting higher bancassurance sales in mainland China, Vietnam and Singapore, partially offset by lower agency sales in Singapore and mainland China. In Canada, APE sales decreased 6%, primarily driven by lower segregated fund sales and the non-recurrence of a large affinity markets sale in 3Q21, partially offset by normal variability of large-case group insurance sales. In the U.S., APE sales decreased 1%, primarily due to lower sales of domestic life insurance products, partially offset by an increase in international sales, which are reported as part of U.S. segment results. APE sales of products with the John Hancock Vitality PLUS feature increased 12% compared with 3Q21, reflecting the increasing attractiveness of the Vitality feature as an option for health-focused life insurance consumers.

Reported Global Wealth and Asset Management net inflows of $3.0 billion in 3Q22, compared with 3Q21 net inflows of $9.8 billion

Net inflows in Retirement were $1.4 billion in 3Q22 compared with net inflows of $0.6 billion in 3Q21, driven by growth in member contributions and lower plan redemptions. Net inflows in Retail were $1.0 billion in 3Q22 compared with net inflows of $7.9 billion in 3Q21, reflecting lower gross flows and higher mutual fund redemption rates due to decreased investor demand amid equity market declines and higher interest rates. Net inflows in Institutional Asset Management were $0.6 billion in 3Q22 compared with net inflows of $1.3 billion in 3Q21, driven by higher redemptions, partially offset by higher sales of equity and fixed income mandates.

^1^	Asia Other excludes Hong Kong and Japan.

Manulife Financial Corporation – Third Quarter 2022

MANAGEMENT’S DISCUSSION AND ANALYSIS

This Management’s Discussion and Analysis (“MD&A”) is current as of November 9, 2022, unless otherwise noted. This MD&A should be read in conjunction with our unaudited Interim Consolidated Financial Statements for the three and nine months ended September 30, 2022 and the MD&A and audited Consolidated Financial Statements contained in our 2021 Annual Report.

For further information relating to our risk management practices and risk factors affecting the Company, see “Risk Management and Risk Factors” and “Critical Actuarial and Accounting Policies” in the MD&A in our 2021 Annual Report and the “Risk Management” note to the Consolidated Financial Statements in our most recent annual and interim reports.

In this MD&A, the terms “Company”, “Manulife”, “we” and “our” mean Manulife Financial Corporation (“MFC”) and its subsidiaries. All amounts are reported in Canadian dollars, unless otherwise indicated. Any information contained in, or otherwise accessible through, websites mentioned in this MD&A does not form a part of this document.

Contents

A. TOTAL COMPANY PERFORMANCE 1. Profitability 2. Business performance 3. Financial strength 4. Revenue 5. Assets under management and administration 6. Impact of fair value accounting 7. Impact of foreign currency exchange rates 8. Business highlights 9. Transition to IFRS 17 B. PERFORMANCE BY SEGMENT 1. Asia 2. Canada 3. U.S. 4. Global Wealth and Asset Management 5. Corporate and Other

C. RISK MANAGEMENT AND RISK FACTORS UPDATE 1. Variable annuity and segregated fund guarantees 2. Caution related to sensitivities 3. Publicly traded equity performance risk 4. Interest rate and spread risk sensitivities and exposure measures 5. Alternative long-duration asset performance risk 6. Credit risk exposure measures 7. Risk factors – strategic risk from changes in tax laws D. CRITICAL ACTUARIAL AND ACCOUNTING POLICIES 1. Critical actuarial and accounting policies 2. Actuarial methods and assumptions 3. Sensitivity of earnings to asset related assumptions 4. Accounting and reporting changes E. OTHER 1. Outstanding common shares - selected information 2. Legal and regulatory proceedings 3. Non-GAAP and other financial measures 4. Caution regarding forward-looking statements 5. Quarterly financial information 6. Other

Manulife Financial Corporation – Third Quarter 2022

A TOTAL COMPANY PERFORMANCE

A1	Profitability
									YTD Results
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
( millions, unless otherwise stated)	3Q22			2Q22			3Q21			2022			2021
Net income attributed to shareholders	1,347		$	1,086		$	1,592		$	5,403		$	5,021
Core earnings(1)	1,322		$	1,562		$	1,517		$	4,436		$	4,828
Diluted earnings per common share ()	0.68		$	0.53		$	0.80		$	2.72		$	2.51
Diluted core earnings per common share (“core EPS”) ()(2)	0.67		$	0.78		$	0.76		$	2.22		$	2.41
Return on common shareholders’ equity (“ROE”)	10.5	%		8.3	%		12.6	%		14.0	%		13.7	%
Core ROE(2)	10.3	%		12.1	%		12.0	%		11.4	%		13.2	%
Expense efficiency ratio(2)	53.9	%		49.2	%		51.3	%		51.0	%		48.9	%
General expenses	1,900		$	1,843		$	1,904		$	5,641		$	5,828

All values are in US Dollars.

^(1)^	This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more information.
^(2)^	This item is a non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information.
---	---

Quarterly profitability

Manulife’s net income attributed to shareholders was $1,347 million in the third quarter of 2022 (“3Q22”) compared with $1,592 million in the third quarter of 2021 (“3Q21”). Net income attributed to shareholders is comprised of core earnings (consisting of items we believe reflect the underlying earnings capacity of the business), which amounted to $1,322 million in 3Q22 compared with $1,517 million in 3Q21, and items excluded from core earnings, which amounted to a net gain of $25 million in 3Q22 compared with a net gain of $75 million in 3Q21. The effective tax rate on net income attributed to shareholders in 3Q22 was 19% compared with 10% in 3Q21, reflecting differences in the jurisdictional mix of pre-tax profits and losses.

Net income attributed to shareholders decreased $245 million compared with 3Q21 primarily driven by lower gains from investment-related experience and lower core earnings, partially offset by a smaller charge from the direct impact of markets. The direct impact of markets in 3Q21 included a $0.5 billion charge related to the impact of updated Ultimate Reinvestment Rate (“URR”) assumptions issued by the Canadian Actuarial Standards Board. Investment-related experience in 3Q22 reflected the favourable impact of fixed income reinvestment activities and favourable credit experience, partially offset by lower-than-expected returns (including fair value changes) on alternative long-duration assets (“ALDA”) primarily related to real estate. The charge from the direct impact of markets in 3Q22 was primarily driven by the impact of unfavourable equity market performance, losses from the sale of available-for-sale (“AFS”) bonds and swap spread movements, partially offset by gains due to rising interest rates in the U.S., a flattening of the yield curve in Canada, and widening corporate spreads in the U.S.

Core earnings decreased $195 million or 14% on a constant exchange rate basis^1^ compared with 3Q21. The decrease in core earnings was driven by a $256 million charge in our Property and Casualty (“P&C”) Reinsurance business for estimated losses related to Hurricane Ian (compared with a $152 million charge in 3Q21 for estimated losses related to Hurricane Ida and the European floods), a net charge of $53 million in 3Q22 in Corporate and Other from the unfavourable impact of markets on seed money investments in new segregated funds and mutual funds and sales of AFS equities compared with a $41 million year-to-date net gain, lower new business gains in Asia and the U.S., lower U.S. Annuities in-force earnings of $51 million due to the variable annuity reinsurance transaction that closed in the first quarter of 2022 (“1Q22”), and a higher charge from net unfavourable U.S. policyholder experience. These items were partially offset by higher yields on fixed income investments and lower expenses in Corporate and Other, and in-force business growth in Asia and Canada. Lower expenses in Corporate and Other reflect lower supplemental pension expense primarily due to market impacts and lower variable incentive compensation. In 3Q22, core earnings included a net charge of $104 million ($125 million pre-tax) related to insurance and annuity policyholder experience compared with a net charge of $50 million ($53

^1^

Percentage growth / declines in core earnings, core general expenses, pre-tax core earnings, assets under management and administration, assets under management, core EBITDA, general expenses, Manulife Bank average net lending assets and Global Wealth and Asset Management (“Global WAM”) revenue are stated on a constant exchange rate basis, a non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information.

Manulife Financial Corporation – Third Quarter 2022

million pre-tax) in 3Q21.^1^ Actions to improve the capital efficiency of our legacy business resulted in $51 million lower core earnings in 3Q22 compared with 3Q21. Excluding these actions, in-force business increased 5%^2^ compared with 3Q21.

The components of the items excluded from core earnings are outlined in the table below and the annual review of actuarial methods and assumptions is discussed in section D2 “Actuarial methods and assumptions” below.

Year-to-date profitability

Net income attributed to shareholders for the nine months ended September 30, 2022 was $5,403 million compared with $5,021 million for the nine months ended September 30, 2021. Year-to-date core earnings amounted to $4,436 million in 2022 compared with $4,828 million in the same period of 2021, and items excluded from year-to-date core earnings amounted to a net gain of $967 million in 2022 compared with a net gain of $193 million in the same period of 2021. The effective tax rate on year-to-date net income attributed to shareholders was 19% in 2022 compared with 13% for the same period in 2021, reflecting differences in the jurisdictional mix of pre-tax profits and losses.

The increase of $382 million in year-to-date net income attributed to shareholders in 2022 compared with 2021 reflects a decline in year-to-date core earnings of $392 million and a net gain of $967 million in items excluded from year-to-date core earnings in 2022 compared with a net gain in items excluded from year-to-date core earnings of $193 million in 2021.

The $392 million or 9% decrease in year-to-date core earnings compared with the same period of 2021 was driven by a year-to-date net charge of $153 million in 2022 in Corporate and Other from the unfavourable impact of markets on seed money investments in new segregated funds and mutual funds and sales of AFS equities compared with a $145 million year-to-date net gain in 2021, lower new business gains in Asia and the U.S., lower in-force earnings in U.S. Annuities of $136 million due to the 1Q22 variable annuity reinsurance transaction, a $256 million charge in our P&C Reinsurance business in 3Q22 for estimated losses related to Hurricane Ian (compared with a $152 million charge in 3Q21 for estimated losses related to Hurricane Ida and the European floods), and lower net fee income from lower average assets under management and administration (“average AUMA”)^3^ and lower fee spread in Global Wealth and Asset Management (“Global WAM”). These items were partially offset by higher yields on fixed income investments and lower expenses in Corporate and Other, higher in-force business growth in Asia and Canada, and higher net experience gains in Canada. Lower expenses in Corporate and Other reflect lower supplemental pension expense primarily due to market impacts and lower variable incentive compensation. Year-to-date, the net insurance and annuity policyholder experience charge was $70 million ($70 million pre-tax) in 2022 compared with a charge of $13 million ($7 million pre-tax) in the same period of 2021.^1^ Actions to improve the capital efficiency of our legacy businesses resulted in $136 million lower year-to-date core earnings in 2022 compared with 2021. Excluding these actions, in-force business increased 6%^2^ compared with 2021.

On a year-to-date basis, the items excluded from core earnings were a net gain of $967 million in 2022 consisting primarily of a net gain from investment-related experience and a $811 million after-tax net gain related to the U.S. variable annuity reinsurance transaction partially offset by a net charge from the direct impact of markets.

^1^	Policyholder experience includes quarterly gains of nil post-tax in 3Q22 (3Q21 – gains of $5 million post-tax) and year-to-date gains of $20 million in 2022 (2021 – gains of $24<br> million post-tax) from the release of margins on medical policies in Hong Kong that have lapsed for customers who have opted to change their existing policies to the new Voluntary Health Insurance Scheme (“VHIS”) products. These gains did<br> not have a material impact on core earnings as they were mostly offset by new business strain.
^2^	Excludes $65 million (pre-tax) and $173 million (pre-tax) in 3Q22 and year-to-date 2022, respectively, of lost expected profit on in-force relating to the U.S. variable annuity<br> reinsurance transaction that closed in 1Q22. Percentage growth is based on the pre-tax impact of these actions, and is stated on a constant exchange rate basis.
---	---
^3^	For more information on this metric, see “Non-GAAP and other financial measures” below.
---	---

Manulife Financial Corporation – Third Quarter 2022

Core earnings by segment is presented in the table below.

Core earnings by segment									YTD Results
( millions, unaudited)	3Q22			2Q22			3Q21			2022			2021
Asia	513		$	513		$	533		$	1,563		$	1,629
Canada	350			345			311			1,009			893
U.S.	384			456			490			1,326			1,469
Global Wealth and Asset Management	345			305			351			974			1,019
Corporate and Other (excluding core investment gains)	(370	)		(157	)		(268	)		(736	)		(482	)
Core investment gains(1),(2)	100			100			100			300			300
Total core earnings	1,322		$	1,562		$	1,517		$	4,436		$	4,828

All values are in US Dollars.

^(1)^	This item is disclosed under the Office of the Superintendent of Financial Institution’s (“OSFI’s”) Source of Earnings Disclosure (Life Insurance Companies) guideline.
^(2)^	As outlined in our definition of core earnings in section E3 “Non-GAAP and other financial measures”: Up to $400 million of net favourable investment-related experience will be<br> reported in core earnings in a single year, which are referred to as “core investment gains”. This means up to $100 million in the first quarter, up to $200 million on a year-to-date basis in the second quarter, up to $300 million on a<br> year-to-date basis in the third quarter and up to $400 million on a full year basis in the fourth quarter. Any investment-related experience losses reported in a quarter will be offset against the net year-to-date investment-related<br> experience gains with the difference being included in core earnings subject to a maximum of the year-to-date core investment gains and a minimum of zero, which reflects our expectation that investment-related experience will be positive<br> through-the-business cycle.
---	---

^(1)^

This item is disclosed under the Office of the Superintendent of Financial Institution’s (“OSFI’s”) Source of Earnings Disclosure (Life Insurance Companies) guideline.

^(2)^

As outlined in our definition of core earnings in section E3 “Non-GAAP and other financial measures”: Up to $400 million of net favourable investment-related experience will be reported in core earnings in a single year, which are referred to as “core investment gains”. This means up to $100 million in the first quarter, up to $200 million on a year-to-date basis in the second quarter, up to $300 million on a year-to-date basis in the third quarter and up to $400 million on a full year basis in the fourth quarter. Any investment-related experience losses reported in a quarter will be offset against the net year-to-date investment-related experience gains with the difference being included in core earnings subject to a maximum of the year-to-date core investment gains and a minimum of zero, which reflects our expectation that investment-related experience will be positive through-the-business cycle.

---

The table below presents net income attributed to shareholders consisting of core earnings and items excluded from core earnings.

									YTD Results
( millions, unaudited)	3Q22			2Q22			3Q21			2022			2021
Core earnings	1,322		$	1,562		$	1,517		$	4,436		$	4,828
Items excluded from core earnings:(1)
Investment-related experience outside of core earnings(2)	125			591			700			1,274			1,516
Direct impact of equity markets and interest rates and<br> variable annuity guarantee liabilities(3)	(54	)		(1,067	)		(597	)		(1,024	)		(1,215	)
Direct impact of equity markets and variable<br> annuity<br> guarantee liabilities	(371	)		(623	)		(15	)		(1,104	)		165
Fixed income reinvestment rates assumed in<br> the<br> valuation of policy liabilities	460			(365	)		(44	)		446			(800	)
Sale of AFS bonds and<br> derivative positions in the<br> Corporate and Other<br> segment	(143	)		(79	)		(6	)		(366	)		(48	)
Changes to the ultimate<br> reinvestment rate	-			-			(532	)		-			(532	)
Change in actuarial methods and assumptions(4)	36			-			(41	)		36			(41	)
Restructuring charge(5)	-			-			-			-			(115	)
Reinsurance transactions, tax-related items and other(6)	(82	)		-			13			681			48
Total items excluded from core earnings	25			(476	)		75			967			193
Net income attributed to shareholders	1,347		$	1,086		$	1,592		$	5,403		$	5,021

All values are in US Dollars.

^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
^(2)^	Total investment-related experience in 3Q22 was a net gain of $225 million, compared with a net gain of $800 million in 3Q21, and in accordance with our definition of core<br> earnings, we included $100 million of investment-related experience gains in core earnings and a $125 million gain in items excluded from core earnings in 3Q22 ($100 million of core investment gains and a gain of $700 million, respectively,<br> in 3Q21). Investment-related experience gains in 3Q22 reflected the favourable impact of fixed income reinvestment activities and favourable credit experience, partially offset by lower-than-expected returns (including fair value changes)<br> on ALDA primarily related to real estate. Investment-related experience gains in 3Q21 reflected higher-than-expected returns (including fair value changes) on ALDA primarily driven by fair value gains on private equity investments, the<br> favourable impact of fixed income reinvestment activities and favourable credit experience.
---	---
^(3)^	The direct impact of markets was a net charge of $54 million in 3Q22 primarily driven by the impact of unfavourable equity market performance, losses from the sale of AFS bonds and<br> swap spread movements, partially offset by gains due to rising interest rates in the U.S., a flattening of the yield curve in Canada and widening corporate spreads in the U.S. The direct impact of markets was a net charge of $597 million in<br> 3Q21 and included a $532 million charge related to changes to the URR. In June 2021, the Canadian Actuarial Standards Board issued a new promulgation with reductions to the URR and updates to the calibration criteria for stochastic<br> risk-free rates. The updated standard included a reduction of 15 basis points in the URR and a corresponding change to stochastic risk-free rate modeling and was effective October 15, 2021. The long-term URR for risk-free rates in Canada is<br> prescribed at 2.9% and we use the same assumption for the U.S. Our assumption for Japan is 1.5%. The net charges for fixed income reinvestment rates reflected the steepening of the yield curve in Canada and lower interest rates in China,<br> partially offset by widening corporate and swap spreads in the U.S.
---	---
^(4)^	Refer to section D2 “Actuarial methods and assumptions” below for detail.
---	---
^(5)^	In the first quarter of 2021 (“1Q21”), we reported a restructuring charge of $150 million pre-tax ($115 million post-tax) related to actions that are expected to result in<br> recurring total annual expense savings of $250 million (pre-tax) by 2023; $100 million (pre-tax) of these expected total annual savings were realized in 2021, and $200 million (pre-tax) of total annual savings are expected in 2022.^1^
---	---
^(6)^	The 3Q22 charge of $82 million primarily includes a $31 million and $17 million charge related to reinsurance transactions in U.S. variable annuities and Asia, respectively, and a<br> $13 million increase to an existing legal provision in the U.S. In 3Q21, reinsurance transactions in Asia contributed gains of $13 million.
---	---

^1^	See “Caution regarding forward-looking statements” below.

Manulife Financial Corporation – Third Quarter 2022

Net income attributed to shareholders by segment is presented in the following table.

Net income attributed to shareholders by segment									YTD Results
( millions, unaudited)	3Q22			2Q22			3Q21			2022			2021
Asia	521		$	361		$	822		$	1,655		$	2,412
Canada	578			85			(26	)		1,210			738
U.S.	641			832			697			3,540			1,586
Global Wealth and Asset Management	345			305			351			974			1,019
Corporate and Other	(738	)		(497	)		(252	)		(1,976	)		(734	)
Total net income attributed to shareholders	1,347		$	1,086		$	1,592		$	5,403		$	5,021

All values are in US Dollars.

The expense efficiency ratio was 53.9% for 3Q22, compared with 51.3% in 3Q21. The 2.6 percentage point increase in the ratio compared with 3Q21 was driven by a 13% decrease in pre-tax core earnings^1^ partially offset by a 2% decrease in core general expenses^1^. The decline in core general expenses reflected lower variable incentive compensation expense and lower pension costs primarily due to market impacts, partially offset by investments to support increased productivity, including digital capabilities and regulatory requirements. Expense management, including initiatives to improve productivity, remains an important strategic priority as we aim to maintain an expense efficiency ratio of less than 50%.

Total general expenses in 3Q22 were in line with 3Q21 on both a constant and actual exchange rate basis reflecting the items noted above for core general expenses and a true up to an existing legal provision in the U.S. recorded outside of core earnings.

On a year-to-date basis, the expense efficiency ratio was 51.0% in 2022 compared with 48.9% in 2021. The 2.1 percentage point increase in the ratio compared with 2021 was driven by a 9% decrease in year-to-date pre-tax core earnings. Year-to-date core general expenses were in line with 2021 driven by higher workforce costs offset by lower distribution-related and discretionary expenses reflecting lower 2022 sales and lower pension expenses primarily due to market impacts.

Total year-to-date general expenses in 2022 decreased 3% compared with 2021 on both a constant and actual exchange rate basis due to the items noted above for core general expenses and a number of items recorded outside of core earnings. These include the non-recurrence of a restructuring charge and the establishment of a legal provision in 2021, partially offset by a 2022 integration charge in our Vietnam operation, expenses associated with the U.S. variable annuity reinsurance transaction and the above-noted true-up to the U.S. legal provision.

^1^	This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more information.

Manulife Financial Corporation – Third Quarter 2022

A2	Business performance
						YTD Results
---	---	---	---	---	---	---	---	---	---
( millions, unless otherwise stated) (unaudited)	3Q22		2Q22		3Q21		2022		2021
Asia APE sales	854	$	838	$	930	$	2,740	$	3,160
Canada APE sales	285	$	361	$	303	$	1,009	$	932
U.S. APE sales	207	$	209	$	203	$	615	$	544
Total APE sales(1)	1,346	$	1,408	$	1,436	$	4,364	$	4,636
Asia new business value	333	$	337	$	399	$	1,010	$	1,275
Canada new business value	89	$	82	$	71	$	275	$	225
U.S. new business value	92	$	92	$	69	$	253	$	188
Total new business value(1)	514	$	511	$	539	$	1,538	$	1,688
Global Wealth and Asset Management net flows ( billions)(1)	3.0	$	1.7	$	9.8	$	11.6	$	19.8
Global Wealth and Asset Management gross flows<br> ( billions)(1)	32.0	$	33.6	$	35.2	$	104.1	$	108.7
Global Wealth and Asset Management assets under<br> management and administration ( billions)(2)	748.8	$	744.7	$	823.6	$	748.8	$	823.6
Global Wealth and Asset Management total invested assets<br> ( billions)	3.7	$	4.0	$	4.3	$	3.7	$	4.3
Global Wealth and Asset Management segregated funds net<br> assets ( billions)	214.5	$	213.3	$	244.6	$	214.5	$	244.6
Total assets under management and administration<br> (billions)(2),(3)	1,277.1	$	1,264.7	$	1,381.6	$	1,277.1	$	1.381.6
Total invested assets ( billions)(3)	411.3	$	402.3	$	419.1	$	411.3	$	419.1
Total segregated fund net assets ( billions)(3)	335.2	$	334.9	$	387.8	$	335.2	$	387.8

All values are in US Dollars.

^(1)^	For more information on this metric, see “Non-GAAP and other financial measures” below.
^(2)^	This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more information.
---	---
^(3)^	See section A5 below for more information.
---	---

Annualized premium equivalent (“APE”) sales^^were $1.3 billion in 3Q22, a decrease of 6%^1^ compared with 3Q21. In Asia, APE sales decreased 7% compared with 3Q21, reflecting lower sales in Hong Kong, partially offset by higher sales in Japan and Asia Other^2^. In Hong Kong, APE sales decreased 40% compared with 3Q21 driven by the impact of weaker customer sentiment on financial planning decisions and tighter COVID-19 containment measures in Macau during the quarter. In Japan, APE sales increased 22% compared with 3Q21 as a result of higher individual protection and other wealth sales. Asia Other APE sales increased 6% compared with 3Q21, reflecting higher bancassurance sales in mainland China, Vietnam and Singapore, partially offset by lower agency sales in Singapore and mainland China. In Canada, APE sales decreased 6% compared with 3Q21, primarily driven by lower segregated fund sales and the non-recurrence of a large affinity markets sale in 3Q21, partially offset by normal variability of large-case group insurance sales. In the U.S., APE sales decreased 1% compared with 3Q21, primarily due to lower sales of domestic life insurance products, partially offset by an increase in international sales, which are reported as part of U.S. segment results. APE sales of products with the John Hancock Vitality PLUS feature increased 12% compared with 3Q21, reflecting the increasing attractiveness of the Vitality feature as an option for health-focused life insurance consumers.

Year-to-date APE sales of $4.4 billion in 2022 were 5% lower than the same period of 2021, driven by lower sales in Asia partially offset by higher sales in Canada and the U.S.

New business value (“NBV”) was $514 million in 3Q22, a decrease of 6% compared with 3Q21. In

      Asia, NBV decreased 17% compared with 3Q21 reflecting lower sales in Hong Kong and changes in product mix in Asia Other, partially offset by higher individual protection and other wealth sales in Japan. In

    Canada, NBV increased 25% compared with 3Q21, driven by higher margins in our insurance businesses, partially offset by lower volumes in Annuities. In the U.S., NBV increased 27% compared with 3Q21, driven by improved
      margins due to pricing actions, higher interest rates and changes in product mix.

^1^	Percentage growth / declines in APE sales, gross flows, net flows, and NBV are stated on a constant exchange rate basis.
^2^	Asia Other excludes Hong Kong and Japan.
---	---

Manulife Financial Corporation – Third Quarter 2022

Year-to-date NBV was $1,538 million in 2022, a decrease of 9% compared with the same period of 2021. In Asia, NBV decreased compared with 2021 due to lower sales in Hong Kong and changes in product mix in Asia Other, partially offset by higher individual protection and other wealth sales in Japan. In Canada, NBV increased compared with 2021 due to higher volumes in Group Insurance and higher margins in Individual Insurance. In the U.S., NBV increased compared with 2021 due to improved margins due to pricing actions, higher interest rates, and changes in product mix.

Global Wealth and Asset Management reported net inflows of $3.0 billion in 3Q22 compared with net inflows of $9.8 billion in 3Q21. Net inflows in Retirement were $1.4 billion in 3Q22 compared with net inflows of $0.6 billion in 3Q21, driven by growth in member contributions and lower plan redemptions. Net inflows in Retail were $1.0 billion in 3Q22 compared with net inflows of $7.9 billion in 3Q21, reflecting lower gross flows and higher mutual fund redemption rates due to decreased investor demand amid equity market declines and higher interest rates. Net inflows in Institutional Asset Management were $0.6 billion in 3Q22 compared with net inflows of $1.3 billion in 3Q21, driven by higher redemptions, partially offset by higher sales of equity and fixed income mandates.

Year-to-date net inflows were $11.6 billion in 2022, compared with $19.8 billion in the same period of 2021. The decrease was primarily driven by higher retail mutual fund redemption rates and lower gross flows. This was partially offset by the non-recurrence of a $9.4 billion institutional redemption in Asia in 1Q21 as well as higher retirement gross flows from growth in member contributions.

A3	Financial strength
	Quarterly Results									YTD Results
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
(unaudited)		3Q22			2Q22			3Q21			2022			2021
MLI’s LICAT ratio^(1)^		136	%		137	%		138	%		136	%		138	%
Financial leverage ratio		28.8	%		28.5	%		25.5	%		28.8	%		25.5	%
Consolidated capital ($ billions)^(2)^	$	63.4		$	62.8		$	63.1		$	63.4		$	63.1
Book value per common share ($)	$	26.17		$	25.56		$	25.78		$	26.17		$	25.78
Book value per common share excluding AOCI ($)	$	25.88		$	25.49		$	23.41		$	25.88		$	23.41
^(1)^	This item is disclosed under OSFI’s Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline.
---	---
^(2)^	This item is a capital management measure. For more information on this metric, see “Non-GAAP and other financial measures” below.
---	---

The Life Insurance Capital Adequacy Test (“LICAT”) ratio for The Manufacturers Life Insurance Company (“MLI”) as at September 30, 2022 was 136% compared with 137% as at June 30, 2022. The one percentage point decrease was mainly driven by the

    unfavourable impact of market movements on capital, primarily due to an increase in risk-free rates. The impact of the continued common share buybacks was largely offset by ongoing portfolio optimization initiatives.

MFC’s LICAT ratio was 124% as at September 30, 2022, compared with 125% as at June 30, 2022. The difference between the MLI and MFC ratios as at September 30, 2022 was largely due to the $6.3 billion of MFC senior debt outstanding that does not qualify as available capital at the MFC level but, based on the form it was down-streamed, qualifies as regulatory capital for MLI.

MFC’s financial leverage ratio as at September 30, 2022 was 28.8%, an increase of 0.3 percentage points compared with 28.5% as at June 30, 2022. The increase in the ratio was driven by a reduction in the carrying value of AFS debt securities due to higher interest rates, and continued common share buybacks, partially offset by the impact of a weaker Canadian dollar and growth in retained earnings.

MFC’s consolidated capital was $63.4 billion as at September 30, 2022, a decrease of $2.6 billion compared with $66.0 billion as at December 31, 2021, driven by a decline in total equity due to a reduction in the carrying value of AFS debt securities due to higher interest rates, and continued common share buybacks, partially offset by growth in retained earnings and the impact of a weaker Canadian dollar.

Manulife Financial Corporation – Third Quarter 2022

Cash and cash equivalents and marketable securities^1^ was $239.2 billion as at September 30, 2022 compared with $268.4 billion as at December 31, 2021. The reduction was primarily driven by the lower market value of fixed income instruments due to higher interest rates and the lower market value of public equities due to a decline in equity markets.

Book value per common share as at September 30, 2022 was $26.17, a 2% decrease compared with $26.78 as at December 31, 2021. Book value per common share excluding accumulated other comprehensive income (“AOCI”) was $25.88 as at September 30, 2022, a 7% increase compared with $24.12 as at December 31, 2021. The number of common shares outstanding was 1,888 million as at September 30, 2022 and was 1,943 million as at December 31, 2021.

A4	Revenue
									YTD Results
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
( millions, unaudited)	3Q22			2Q22			3Q21			2022			2021
Gross premiums	10,794		$	10,876		$	11,233		$	33,324		$	32,839
Premiums ceded to reinsurers	(1,322	)		(1,249	)		(1,250	)		(4,723	)		(3,834	)
Net premium income	9,472			9,627			9,983			28,601			29,005
Investment income	3,883			3,675			3,964			10,975			11,277
Other revenue	2,377			2,057			2,994			6,425			8,391
Revenue before realized and unrealized investment gains<br> and losses	15,732			15,359			16,941			46,001			48,673
Realized and unrealized gains and losses on assets<br> supporting insurance and investment contract liabilities<br> and on the macro hedge program(1)	(7,955	)		(17,760	)		(958	)		(44,255	)		(8,463	)
Total revenue	7,777		$	(2,401	)	$	15,983		$	1,746		$	40,210

All values are in US Dollars.

^(1)^	See section A6 “Impact of fair value accounting”. Also see section A1 “Profitability” for information on the direct impact of equity markets and interest rates<br> and variable annuity guarantee liabilities.

Total revenue in 3Q22 was $7.8 billion compared with $16.0 billion in 3Q21. The amount of revenue reported in any fiscal period can be significantly affected by fair value accounting, which can materially impact the reported realized and unrealized investment gains or losses on assets supporting insurance and investment contract liabilities and on the macro hedge program, a component of revenue (see section A7 “Impact of fair value accounting” below). Accordingly, we discuss specific drivers of revenue in each segment before realized and unrealized investment gains and losses in section B “Performance by Segment” below.

3Q22 revenue before realized and unrealized investment gains and losses on assets supporting insurance and investment contract liabilities and on the macro hedge program (“net realized and unrealized investment gains and losses”) of $15.7 billion decreased $1.2 billion compared with 3Q21, driven by lower other revenue, due to the impact of unfavourable markets and the 1Q22 U.S. variable annuity reinsurance transaction, and lower premiums in Asia. Net realized and unrealized investment gains and losses was a net charge of $8.0 billion in 3Q22 compared with a net charge of $1.0 billion in 3Q21. The charge in 3Q22 was primarily driven the impact of higher interest rates in the U.S. and Asia, and lower equity markets. The 3Q21 charge was primarily driven by the impact of interest rate increases in North America and Asia and lower equity markets in Asia, partially offset by fair value gains in ALDA.

On a year-to-date basis, revenue before net realized and unrealized investment gains and losses of $46.0 billion was $2.7 billion lower than the same period of 2021 due to similar factors noted above as well as higher ceded premiums from the U.S. variable annuity reinsurance transaction noted above and higher premiums in Canada due to business growth. Year-to-date net realized and unrealized investment gains and losses was a net charge of $44.3 billion in 2022 compared with a net charge of $8.5 billion in 2021. The year-to-date charge in 2022 was primarily driven by the impact of interest rate increases and lower equity markets partially offset by fair value gains in other invested assets. The year-to-date charge in 2021 was primarily due to the impact of interest rate increases partially offset by fair value gains in ALDA and overall growth in equity markets.

^1^	Includes cash & cash equivalents, comprised of cash on deposit, Canadian and U.S. Treasury Bills and high quality short-term investments, and marketable assets, comprised of<br> investment grade government and agency bonds, investment grade corporate bonds, investment grade securitized instruments, publicly traded common stocks and preferred shares.

Manulife Financial Corporation – Third Quarter 2022

See section A6 “Impact of fair value accounting” below. Also, see section A1 “Profitability” for additional information on the impact on 3Q22 net income attributed to shareholders from the direct impact of equity markets and interest rates and variable annuity guarantee liabilities.

A5	Assets under management and administration (“AUMA”)

AUMA as at September 30, 2022 was $1.3 trillion, a decrease of 14% compared with December 31, 2021, primarily due to the impact of higher interest rates and lower equity markets, partially offset by year-to-date net inflows. Total invested assets and segregated funds net assets decreased 4% and 16%, respectively, on an actual exchange rate basis primarily due to the impact of higher interest rates and lower equity markets.

A6	Impact of fair value accounting

Fair value accounting policies affect the measurement of both our assets and our liabilities. The difference between the reported amounts of our assets and liabilities determined as of the balance sheet date and the immediately preceding balance sheet date in accordance with the applicable fair value accounting principles is reported as investment-related experience and the direct impact of equity markets and interest rates and variable annuity guarantees, each of which impacts net income attributed to shareholders (see section A1 “Profitability” above for discussion of 3Q22 experience).

Net realized and unrealized investment losses on assets supporting insurance and investment contract liabilities and on the macro hedge program were $8.0 billion for 3Q22 (3Q21 – net loss of $1.0 billion) and on a year-to-date basis, were net losses of $44.3 billion in 2022 (2021 – net losses of $8.5 billion). See “Revenue” section above for discussion of results.

As outlined in “Critical Actuarial and Accounting Policies” in the MD&A in our 2021 Annual Report, net insurance contract liabilities under IFRS are determined using Canadian Asset Liability Method (“CALM”), as required by the Canadian Institute of Actuaries (“CIA”). The measurement of policy liabilities includes the estimated value of future policyholder benefits and settlement obligations to be paid over the term remaining on in-force policies, including the costs of servicing the policies, reduced by the future expected policy revenues and future expected investment income on assets supporting the policies. Investment returns are projected using current asset portfolios and projected reinvestment strategies. Experience gains and losses are reported when current period activity differs from what was assumed in the policy liabilities at the beginning of the period. We classify gains and losses by assumption type. For example, current period investing activities that increase (decrease) the future expected investment income on assets supporting the policies will result in an investment-related experience gain (loss). See description of investment-related experience in “Non-GAAP and other financial measures” below.

A7	Impact of foreign currency exchange rates

Changes in foreign currency exchange rates from 3Q21 to 3Q22, decreased core earnings by $3 million in 3Q22 primarily due to a stronger Canadian dollar compared with the Japanese Yen. Changes in foreign currency exchange rates increased year-to-date core earnings by $11 million in 2022 compared with the same period of 2021 primarily due to a weaker Canadian dollar compared with the U.S. dollar. The impact of foreign currency exchange rates on items excluded from core earnings does not provide relevant information given the nature of those items.

A8	Business highlights

Manulife Financial Corporation – Third Quarter 2022

through John Hancock Vitality. As the first life insurance carrier to make GRAIL’s Galleri® test available, we are enabling eligible customers to take proactive steps to better understand and make more informed choices about their health. In Global WAM, we expanded our Environmental, Social and Governance investment offerings with the launch of the Global Climate Action strategy in Europe to meet increasing demand for sustainable investment solutions.

A9	Transition to IFRS 17^1^

^^

As noted in “Critical Actuarial and Accounting Policies – Future Accounting and Reporting Changes” in the MD&A in our 2021 Annual Report, IFRS 17 “Insurance Contracts” will replace IFRS 4 “Insurance Contracts” effective for years beginning on January 1, 2023. The new standard will materially change the recognition and measurement of insurance contracts and the corresponding presentation and disclosures in the Company’s financial statements. We will be electing the option to record changes in insurance contract liabilities arising from changes in interest rates through other comprehensive income and will classify debt instruments as fair value through other comprehensive income under IFRS 9 “Financial Instruments”. The impacts of IFRS 17 are expected to include:

•	The establishment of a Contractual Service Margin (“CSM”) on our in-force business which is expected to lead to an increase in insurance contract liabilities. The CSM represents unearned profits<br> that are expected to amortize into income as services are provided. We continue to evaluate the potential impacts of all other changes including available accounting policy choices under IFRS 17 on the measurement of our insurance<br> contract liabilities. While there is a range of outcomes for the CSM and all other changes impacting insurance contract liabilities, a significant portion of the impact to equity is expected to result from establishing a CSM on our<br> in-force business. The overall impact of establishing the CSM, as well as other measurement impacts on our assets and liabilities, is expected to decrease equity upon transition by approximately 20%. We expect the impact of IFRS 17 to be<br> approximately neutral to the LICAT capital ratio based on markets as of June 30, 2022 and calibration adjustments that OSFI made to the LICAT guideline^2^ for 2023, relating to the inclusion of CSM in available capital and the<br> reduction of the scalar on base solvency buffer. We expect our capital position will continue to be strong under IFRS 17. The actual impact at transition will depend on macro-economic conditions as at January 1, 2023.
•	The deferral of the recognition of new business gains via the CSM, and to a substantially lesser extent, the timing of investments results, will shift earnings out into future periods. As a<br> result, on transition, net income and core earnings in 2022 are expected to be lower under IFRS 17 compared with IFRS 4. This impact will be partially offset by the amortization into income of the CSM that will be established on our<br> in-force business. Overall, considering these items along with the various other impacts, on transition we expect 2022 core earnings to decline by approximately 10% under IFRS 17 compared with IFRS 4. A transition impact on our net income<br> attributed to shareholders is difficult to predict as it is also impacted by prevailing market conditions. In addition, we expect IFRS 17 to improve the stability of both our core earnings and net income attributed to shareholders.
---	---

•

The establishment of a Contractual Service Margin (“CSM”) on our in-force business which is expected to lead to an increase in insurance contract liabilities. The CSM represents unearned profits that are expected to amortize into income as services are provided. We continue to evaluate the potential impacts of all other changes including available accounting policy choices under IFRS 17 on the measurement of our insurance contract liabilities. While there is a range of outcomes for the CSM and all other changes impacting insurance contract liabilities, a significant portion of the impact to equity is expected to result from establishing a CSM on our in-force business. The overall impact of establishing the CSM, as well as other measurement impacts on our assets and liabilities, is expected to decrease equity upon transition by approximately 20%. We expect the impact of IFRS 17 to be approximately neutral to the LICAT capital ratio based on markets as of June 30, 2022 and calibration adjustments that OSFI made to the LICAT guideline^2^ for 2023, relating to the inclusion of CSM in available capital and the reduction of the scalar on base solvency buffer. We expect our capital position will continue to be strong under IFRS 17. The actual impact at transition will depend on macro-economic conditions as at January 1, 2023.

•

The deferral of the recognition of new business gains via the CSM, and to a substantially lesser extent, the timing of investments results, will shift earnings out into future periods. As a result, on transition, net income and core earnings in 2022 are expected to be lower under IFRS 17 compared with IFRS 4. This impact will be partially offset by the amortization into income of the CSM that will be established on our in-force business. Overall, considering these items along with the various other impacts, on transition we expect 2022 core earnings to decline by approximately 10% under IFRS 17 compared with IFRS 4. A transition impact on our net income attributed to shareholders is difficult to predict as it is also impacted by prevailing market conditions. In addition, we expect IFRS 17 to improve the stability of both our core earnings and net income attributed to shareholders.

---

^1^	See “Caution regarding forward-looking statements” below. The information presented reflects the Company’s current interpretation of IFRS 17 based on its facts and circumstances as<br> of the date hereof. Such interpretation, or the underlying relevant facts and circumstances, may change. The Company’s interpretation may also change pending the final issuance of regulatory and industry guidance relating to IFRS 17.
^2^	As indicated in OSFI’s final Life Insurance Capital Adequacy Test (LICAT) 2023 guideline issued on July 21, 2022.
---	---

^1^

See “Caution regarding forward-looking statements” below. The information presented reflects the Company’s current interpretation of IFRS 17 based on its facts and circumstances as of the date hereof. Such interpretation, or the underlying relevant facts and circumstances, may change. The Company’s interpretation may also change pending the final issuance of regulatory and industry guidance relating to IFRS 17.

^2^

As indicated in OSFI’s final Life Insurance Capital Adequacy Test (LICAT) 2023 guideline issued on July 21, 2022.

---

Manulife Financial Corporation – Third Quarter 2022

•	Core earnings will remain a key performance metric and the definition will be adapted to align with IFRS 17. Under the revised definition, core earnings will exclude items such as the direct<br> impact of markets and interest rates, including investment experience from ALDA, realized gains and losses on fixed income assets, hedge ineffectiveness, and changes in methods and assumptions recorded directly in profit or loss. We<br> believe that the revised core earnings definition represents our operating performance and the long-term earnings capacity of the business.
•	The treatment of new business gains under IFRS 17 is materially different from IFRS 4. The CSM is an intrinsic part of the value of an insurance business and is a measure of growth and future<br> earnings generation capability. This highlights the importance of the CSM as a GAAP performance measure and as such, on transition, we will be adding two new medium-term targets:
---	---
i.)	15% growth per year for new business CSM, and
---	---
ii.)	8% to 10% growth per year in the CSM balance.
---	---

In 1Q22, we confirmed our medium-term financial and operating targets under IFRS 17, and upon transition, will adjust certain targets as follows:

•	Core ROE will be increased to 15%+ (from 13%+ currently) due to the expected changes to core earnings and equity,
•	Common share core dividend payout ratio^1^ will be increased to 35% to 45% (from 30% to 40%<br> currently) due to the expected changes to core earnings, and
---	---
•	Leverage ratio definition will be adjusted to include the CSM in the denominator given the CSM represents unearned profit and available capital under LICAT.
---	---

We reported $220 million (post-tax) from the impact of new business^2^, which is included in core earnings and net income attributed to shareholders in 3Q22 (3Q21 – $262 million). On a year-to-date basis, the impact of new business was $633 million (post-tax) in 2022 (2021 – $820 million). Under IFRS 17, the impact of new business will be recorded in the CSM and amortized into earnings as services are provided, unless the contracts are onerous^3^ at issue, which does not necessarily mean that the contract is not profitable over its lifetime, in which case the impact will be recorded directly in earnings.

^1^	This item is a non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information.
^2^	The impact of new business represents the financial impact of all new business written in the period, including acquisition expenses.
---	---
^3^	Under IFRS 17, an insurance contract is onerous at the date of initial recognition if the fulfilment cash flows allocated to the contract and premiums, acquisition expenses and<br> commissions arising from the contract at the date of initial recognition, in total are a net outflow (i.e. if there is a loss at initial recognition). An onerous designation does not necessarily mean that the contract is not profitable over<br> its lifetime.
---	---

Manulife Financial Corporation – Third Quarter 2022

B PERFORMANCE BY SEGMENT

B1	Asia
( millions, unless otherwise stated)	Quarterly Results						YTD<br> Results
---	---	---	---	---	---	---	---	---	---
Canadian dollars	3Q22		2Q22		3Q21		2022		2021
Net income attributed to shareholders(1)	521	$	361	$	822	$	1,655	$	2,412
Core earnings(1)	513		513		533		1,563		1,629
Annualized premium equivalent sales	854		838		930		2,740		3,160
New business value	333		337		399		1,010		1,275
Revenue	3,843		2,499		6,658		9,354		21,620
Revenue before realized and unrealized investment gains<br> and losses(2)	6,667		6,654		7,191		20,889		21,015
Assets under management ( billions)(3)	143.3		139.0		149.8		143.3		149.8
Total invested assets ( billions)	121.3		117.1		124.9		121.3		124.9
Segregated fund invested assets ( billions)	22.0		21.9		24.9		22.0		24.9
U.S. dollars
Net income attributed to shareholders(1)	399	US$	283	US$	654	US$	1,292	US$	1,924
Core earnings(1)	394		401		424		1,219		1,301
Annualized premium equivalent sales	655		656		738		2,138		2,521
New business value	255		264		317		787		1,018
Revenue	2,943		1,957		5,285		7,277		17,321
Revenue before realized and unrealized investment gains<br> and losses(2)	5,107		5,211		5,708		16,293		16,785
Assets under management ( billions)(3)	104.3		107.8		117.6		104.3		117.6
Total invested assets ( billions)	88.3		90.8		98.0		88.3		98.0
Segregated fund invested assets ( billions)	16.0		17.0		19.6		16.0		19.6

All values are in US Dollars.

^(1)^	See “Non-GAAP and other financial measures” below for a reconciliation of core earnings to net income (loss) attributed to shareholders.
^(2)^	See section A6 “Impact of fair value accounting”.
---	---
^(3)^	This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more information.
---	---

Asia’s 3Q22 net income attributed to shareholders was $521 million compared with $822 million in 3Q21. Net income attributed to shareholders is comprised of core earnings, which was $513 million in 3Q22 compared with $533 million in 3Q21, and items excluded from core earnings, which amounted to a net gain of $8 million in 3Q22 compared with a net gain of $289 million in 3Q21. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of core earnings to net income (loss) attributed to shareholders, and section A1 “Profitability” above, for explanations of the items excluded from core earnings. The changes in net income attributed to shareholders and core earnings expressed in Canadian dollars were due to the factors described below and, in addition, the change in core earnings reflected a net $16 million unfavourable impact due to changes in foreign currency exchange rates versus the Canadian dollar.

Expressed in U.S. dollars, the presentation currency of the segment, net income attributed to shareholders was US$399 million in 3Q22 compared with US$654 million in 3Q21 and core earnings were US$394 million in 3Q22 compared with US$424 million in 3Q21. Items excluded from core earnings were a net gain of US$5 million in 3Q22 compared with a net gain of US$230 million in 3Q21.

Core earnings in 3Q22 decreased 2% compared with 3Q21 driven by lower new business volumes primarily in Hong Kong, partially offset by changes in product mix and in-force business growth. In addition, higher investment income on allocated capital increased core earnings by US$12 million compared with 3Q21 (see Corporate and Other segment).

Year-to-date net income attributed to shareholders was US$1,292 million in 2022 compared with US$1,924 million in the same period of 2021. Year-to-date core earnings of US$1,219 million in 2022 decreased 3% compared with the same period of 2021 driven by lower new business volumes in Hong Kong and Asia Other, as well as changes in product mix and unfavourable policyholder experience in mainland China. These items were partially offset by in-force business growth across the segment and favourable policyholder experience in Japan. In addition, higher year-to-date investment income on allocated capital increased core earnings by US$37 million compared with 2021 (see Corporate and Other segment). Items excluded from year-to-date core earnings were a net gain of

Manulife Financial Corporation – Third Quarter 2022

US$73 million in 2022 compared with a net gain of US$623 million for the same period of 2021. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders. Expressed in Canadian dollars, year-to-date core earnings reflected a net $28 million unfavourable impact of changes in foreign currency exchange rates versus the Canadian dollar.

APE sales in 3Q22 were US$655 million, a decrease of 7% compared with 3Q21. The decrease reflects lower sales in Hong Kong, partially offset by higher individual protection and other wealth sales in Japan and higher sales in Asia Other. NBV in 3Q22 was US$255 million, a 17% decrease compared with 3Q21, reflecting lower sales in Hong Kong and changes in product mix in Asia Other, partially offset by higher individual protection and other wealth sales in Japan. Year-to-date APE sales were US$2,138 million in 2022, a decrease of 12%, compared with the same period of 2021, driven by adverse impacts from COVID-19 in the first half of 2022 and the impact of weaker customer sentiment in 3Q22 in Hong Kong, lower corporate-owned life insurance product sales in Japan and lower sales in Asia Other, partially offset by higher individual protection and other wealth sales in Japan. Year-to-date NBV was US$787 million in 2022, a decrease of 21%, compared with the same period of 2021, driven by lower sales in Hong Kong and changes in product mix in Asia Other, partially offset by higher individual protection and other wealth sales in Japan. New business value margin (“NBV margin”)^1^^^was 42.3% in 3Q22 compared with 46.0% in 3Q21.

•	Hong Kong APE sales in 3Q22 were US$133 million, a 40% decrease compared with 3Q21. The decrease in sales was driven by the impact of weaker customer sentiment<br> on financial planning decisions, and tighter COVID-19 containment measures in Macau during the quarter. Restrictions on travel<br> between Hong Kong and mainland China continued to impact cross-border commerce. Hong Kong NBV was US$110 million in 3Q22, a decrease of 30% compared with 3Q21 due to lower sales volumes. Hong Kong NBV margin<br> was 82.7% in 3Q22, an increase of 12.1 percentage points compared with 3Q21 driven by changes in product mix.
•	Japan APE sales in 3Q22 were US$74 million, a 22% increase compared with 3Q21, as a result of higher individual protection and other wealth sales. Japan NBV in 3Q22 of US$27 million increased 112% compared with 3Q21 due to higher sales volumes and a higher non corporate-owned life insurance product mix. Japan NBV margin was 36.7% in 3Q22, an increase<br> of 15.6 percentage points compared with 3Q21 driven by changes in product mix and improved margins.
---	---
•	Asia Other APE sales in 3Q22 were US$448 million, a 6% increase compared with 3Q21 reflecting higher bancassurance sales in mainland China, Vietnam and Singapore,<br> partially offset by lower agency sales in Singapore and mainland China. Asia Other NBV in 3Q22 of US$118 million decreased 15% compared with 3Q21, primarily due to changes in product mix. Asia Other NBV margin was 29.8% in 3Q22, a<br> decrease of 7.1 percentage points compared with 3Q21.
---	---

Assets under management^^were US$104.3 billion as at September 30, 2022, a decrease of US$17.7 billion or 8.5% compared with December 31, 2021. The decrease was driven by the impact of market movements resulting from higher interest rates and unfavourable equity market performance on invested assets and segregated funds net assets, partially offset by net customer inflows of US$8.0 billion.

Revenue was US$2.9 billion in 3Q22 compared with US$5.3 billion in 3Q21. The reduction in revenue reflected higher net realized and unrealized investment losses in 3Q22 driven by the impact of higher interest rates and unfavourable equity market performance on total invested assets. Revenue before realized and unrealized investment gains and losses was US$5.1 billion in 3Q22, a decrease of US$0.6 billion compared with 3Q21, driven by lower new business premiums, partially offset by recurring premium growth from in-force business. Year-to-date revenue was US$7.3 billion in 2022 compared with US$17.3 billion in the same period of 2021. Year-to-date revenue before realized and unrealized investment gains and losses was US$16.3 billion in 2022, compared with US$16.8 billion in the same period of 2021.

Business highlights – In 3Q22, we:

•	accelerated the utilization of ManuAcademy, our regional digital learning platform rolled out to Vietnam last quarter. Since the roll-out, the platform has enabled the onboarding of<br> over 11,000 newly-recruited insurance agents, and delivered over 150,000 training hours to approximately 45,000 insurance agents.

^1^	For more information on this metric, see “Non-GAAP and other financial measures” below.

Manulife Financial Corporation – Third Quarter 2022

Our new training series, Manulife MasterClass, captures best practices from our Million Dollar Round Table agents and shares them across all agents<br> through the platform; and
•	enhanced our digital capabilities as we:
---	---
o	continued to drive the adoption of ePOS, our proprietary digital onboarding app, to enhance the distributor experience and enable faster, error-free new business application<br> submissions with case adoption at 90%, an increase of 9 percentage points compared with 3Q21; and
---	---
o	further increased utilization of our digital claims platform, with 77% of claims being submitted digitally, an increase of 15 percentage points compared with 3Q21 driven by strong<br> improvements in Japan and continued high customer adoption across Asia.
---	---
B2	Canada
---	---
								YTD Results
---	---	---	---	---	---	---	---	---	---	---	---
( millions, unless otherwise stated)	3Q22		2Q22			3Q21			2022		2021
Net income (loss) attributed to shareholders(1)	578	$	85		$	(26	)	$	1,210	$	738
Core earnings(1)	350		345			311			1,009		893
Annualized premium equivalent sales	285		361			303			1,009		932
Manulife Bank average net lending assets ( billions)(2)	24.6		24.3			23.0			24.0		23.0
Revenue	4,342		(1,736	)		2,911			323		6,266
Revenue before realized and unrealized investment<br> income gains and losses	4,124		4,102			3,847			12,159		11,317
Assets under management ( billions)	144.5		142.8			157.8			144.5		157.8
Total invested assets ( billions)	109.7		107.2			117.6			109.7		117.6
Segregated funds net assets ( billions)	34.8		35.6			40.2			34.8		40.2

All values are in US Dollars.

^(1)^	See “Non-GAAP and other financial measures” below for a reconciliation of core earnings to net income (loss) attributed to shareholders.
^(2)^	This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more information.
---	---

Canada’s 3Q22 net income attributed to shareholders was $578 million compared with a net loss of $26 million in 3Q21. Net income attributed to shareholders is comprised of core earnings, which were $350 million in 3Q22 compared with $311 million in 3Q21, and items excluded from core earnings, which amounted to a net gain of $228 million in 3Q22 compared with a net charge of $337 million in 3Q21. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of core earnings to net income (loss) attributed to shareholders, and section A1 “Profitability” above, for explanations of the items excluded from core earnings.

Core earnings of $350 million increased by $39 million or 13% compared with 3Q21, primarily reflecting more favourable experience gains in Group Insurance, higher in-force earnings, higher Manulife Bank earnings and several smaller favourable items, partially offset by unfavourable claims experience in Individual Insurance.

Year-to-date net income attributed to shareholders was $1,210 million in 2022 compared with $738 million in the same period of 2021 and year-to-date core earnings were $1,009 million in 2022 compared with $893 million in the same period of 2021. The increase in year-to-date core earnings of $116 million was primarily driven by higher in-force earnings and more favourable net experience gains in all businesses. Items excluded from year-to-date core earnings were a net gain of $201 million in 2022 compared with a net charge of $155 million for the same period of 2021. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders.

APE sales of $285 million in 3Q22 decreased by $18 million or 6% compared with 3Q21, primarily driven by lower segregated fund sales and the non-recurrence of a large affinity markets sale in 3Q21, partially offset by normal variability of large-case group insurance sales. Year-to-date APE sales in 2022 were $1,009 million, $77 million or 8% higher than in the same period of 2021, primarily driven by higher large-case group insurance sales, partially offset by lower segregated fund sales.

•	Individual insurance APE sales in 3Q22 of $102 million decreased $14 million or 12% compared with 3Q21, primarily due to the non-recurrence of a large affinity markets sale, lower universal life<br> sales, partially offset by higher par and travel insurance sales.
•	Group insurance APE sales in 3Q22 of $133 million increased $33 million or 33% compared with 3Q21, primarily due to normal variability of large-case sales.
---	---

Manulife Financial Corporation – Third Quarter 2022

•	Annuities APE sales in 3Q22 of $50 million decreased $37 million or 43% compared with 3Q21, primarily due to the impact of market uncertainty on the demand for segregated fund products.

Manulife Bank average net lending assets for the quarter were $25 billion as at September 30, 2022, up $1.3 billion or 5% compared with the quarter ended December 31, 2021.

Assets under management were $144.5 billion as at September 30, 2022, a decrease of $17.5 billion or 11% compared with December 31, 2021, due to lower total invested assets and segregated funds net assets, primarily reflecting the impact of higher interest rates and a decline in equity markets.

Revenue in 3Q22 was $4.3 billion compared with $2.9 billion in 3Q21, an increase of $1.4 billion compared with 3Q21, reflecting the non-recurrence of net realized and unrealized investment losses in 3Q21 compared with a net gain in 3Q22. Revenue before realized and unrealized investment gains and losses was $4.1 billion in 3Q22, an increase of $0.3 billion compared with 3Q21, primarily due to business growth. Year-to-date revenue was $0.3 billion in 2022 compared with $6.3 billion in the same period of 2021, a decrease of $5.9 billion compared with the same period of 2021, driven by the impact of markets as noted above. Year-to-date revenue before realized and unrealized investment gains and losses was $12.2 billion in 2022, an increase of 7% compared with the same period of 2021, also driven by similar factors noted above for the quarter.

Business highlights – In 3Q22, we announced an expansion of the Manulife Vitality program, making it available to new term and universal life insurance policyholders effective November, 2022.

B3	U.S.
( millions, unless otherwise stated)								YTD Results
---	---	---	---	---	---	---	---	---	---	---	---	---
Canadian dollars	3Q22			2Q22			3Q21		2022			2021
Net income attributed to shareholders(1)	641		$	832		$	697	$	3,540		$	1,586
Core earnings(1)	384			456			490		1,326			1,469
Annualized premium equivalent sales	207			209			203		615			544
Revenue	(1,567	)		(4,329	)		4,650		(11,240	)		7,540
Revenue before realized and unrealized investment<br> income gains and losses	3,817			3,593			4,175		9,783			11,623
Assets under management ( billions)	218.7			213.7			240.9		218.7			240.9
Total invested assets ( billions)	154.7			149.5			162.7		154.7			162.7
Segregated funds net assets ( billions)	64.0			64.2			78.2		64.0			78.2
U.S. dollars
Net income attributed to shareholders(1)	491		US$	651		US$	553	US$	2,775		US$	1,275
Core earnings(1)	294			357			389		1,035			1,174
Annualized premium equivalent sales	159			164			161		480			435
Revenue	(1,201	)		(3,391	)		3,689		(8,812	)		6,188
Revenue before realized and unrealized investment<br> income gains and losses	2,922			2,815			3,312		7,612			9,288
Assets under management ( billions)	159.2			165.7			189.1		159.2			189.1
Total invested assets ( billions)	112.6			115.9			127.7		112.6			127.7
Segregated funds net assets ( billions)	46.6			49.8			61.4		46.6			61.4

All values are in US Dollars.

^(1)^	See “Non-GAAP and other financial measures” below for a reconciliation of core earnings to net income (loss) attributed to shareholders.

U.S. 3Q22 net income attributed to shareholders was $641 million compared with $697 million in 3Q21. Net income attributed to shareholders is comprised of core earnings, which amounted to $384 million in 3Q22 compared with $490 million in 3Q21, and items excluded from core earnings, which amounted to a net gain of $257 million in 3Q22 compared with a net gain of $207 million in 3Q21. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of core earnings to net income (loss) attributed to shareholders, and section A1 “Profitability” above, for explanations of the items excluded from core earnings. The changes in net income attributed to shareholders and core earnings expressed in Canadian dollars were due to the factors described below and, in addition, the change in core earnings reflected a $13 million favourable impact from the strengthening of the U.S. dollar compared with the Canadian dollar.

Manulife Financial Corporation – Third Quarter 2022

Expressed in U.S. dollars, the functional currency of the segment, 3Q22 net income attributed to shareholders was US$491 million compared with US$553 million in 3Q21, core earnings were US$294 million in 3Q22 compared with US$389 million in 3Q21, and items excluded from core earnings were a net gain of US$197 million in 3Q22 compared with a net gain of US$164 million in 3Q21.

Core earnings decreased US$95 million or 24% compared with 3Q21, due to lower core earnings in Annuities and Insurance. The decline in Annuities core earnings was driven primarily by reduced in-force earnings of US$39 million related to the reinsurance of a significant portion of the variable annuity block in 1Q22. Insurance core earnings were lower primarily due to unfavourable policyholder experience and lower new business gains. Insurance policyholder experience worsened due to increased unfavourable life insurance policyholder experience and unfavourable long-term care policyholder experience, compared with favourable policyholder experience in the prior year. In addition, higher investment income on allocated capital increased core earnings by US$6 million compared with 3Q21 (see Corporate and Other segment).

Year-to-date net income attributed to shareholders was US$2,775 million in 2022 compared with US$1,275 million in the same period of 2021 and year-to-date core earnings were US$1,035 million in 2022 compared with US$1,174 million in the same period of 2021. Year-to-date core earnings decreased US$139 million due to lower in-force earnings in Annuities of US$106 million related to the previously mentioned variable annuity reinsurance transaction in 1Q22, net unfavourable policyholder experience, lower new business gains, and the non-recurrence of prior year gains from the Annuity Guaranteed Minimum Withdrawal Benefit offer program. These items were partially offset by improved and net positive other experience gains. Compared with the same period of 2021, less favourable long-term care and annuities policyholder experience was partially offset by improved unfavourable life insurance policyholder experience. In addition, higher year-to-date investment income on allocated capital increased core earnings by US$18 million compared with 2021 (see Corporate and Other segment). Items excluded from year-to-date core earnings were a net gain of US$1,740 million in 2022 compared with a net gain of US$101 million for the same period of 2021. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders. Items excluded from year-to-date core earnings included a gain of US$641 million related to the previously mentioned variable annuity reinsurance transaction in 1Q22. Expressed in Canadian dollars, year-to-date core earnings reflected a $31 million favourable impact of changes in foreign currency exchange rates versus the Canadian dollar.

APE sales in 3Q22 of US$159 million decreased 1% compared with 3Q21 due to lower sales of domestic life insurance products, partially offset by an increase in international sales. Lower sales of domestic life insurance products reflect the impact of higher inflation on life insurance products that are purchased primarily to protect household income. Year-to-date APE sales in 2022 of US$480 million increased 10% compared with the same period of 2021 primarily due to higher customer demand for international, domestic variable universal life and indexed universal life product offerings, partially offset by lower sales of domestic protection-oriented insurance products for the reason mentioned above. 3Q22 APE sales of products with the John Hancock Vitality PLUS feature increased 12% compared with 3Q21 and on a year-to-date basis, 2022 APE sales increased 28% compared with the same period in 2021, reflecting the increasing attractiveness of the Vitality feature as an option for health-focused life insurance consumers.

Assets under management as at September 30, 2022 were US$159.2 billion, a decrease of 17% compared with December 31, 2021. The decrease in total invested assets and segregated funds net assets was primarily due to the impact from markets, reflecting an increase in interest rates and a decline in equity markets, and the continued run-off of the annuity business, including the impact on total invested assets from the above-noted variable annuity reinsurance transaction.

Revenue in 3Q22 was a net loss of US$1.2 billion compared with a net gain of US$3.7 billion in 3Q21. The 3Q22 net loss reflected net realized and unrealized investment losses driven by the impact of markets on total invested assets as noted above. Revenue before net realized and unrealized investment gains and losses was US$2.9 billion in 3Q22 compared with US$3.3 billion in 3Q21. The US$0.4 billion decrease was driven by the unfavourable impact of markets and the above-noted variable annuity reinsurance transaction. Year-to-date revenue was a net loss of US$8.8 billion in 2022, compared with a net gain of US$6.2 billion in the same period of 2021. The

Manulife Financial Corporation – Third Quarter 2022

US$15.0 billion decrease was driven by similar factors noted above. Year-to-date revenue before realized and unrealized investment gains and losses was US$7.6 billion in 2022 compared with US$9.3 billion in the same period of 2021. The US$1.7 billion decrease was primarily driven by the year-to-date impact of the above-noted variable annuity reinsurance transaction.

Business highlights – In 3Q22, we:

•	continued to innovate our wellness offerings and announced a partnership with GRAIL, a healthcare company, offering access to Galleri®, their leading edge, multi-cancer early detection test to a<br> pilot group of customers through John Hancock Vitality. As the first life insurance carrier to make GRAIL’s Galleri® test available, we are enabling eligible customers to take proactive steps to better understand and make more informed<br> choices about their health; and
•	achieved the following digital successes which improved the customer experience while contributing to a more cost-efficient operation:
---	---
o	reduced call centre volumes by 22% by optimizing the customer registration and login processes of our John Hancock Vitality program; and
---	---
o	reduced the amount of time to onboard producers within our traditional brokerage channel by 92% by automating the background check process.
---	---
B4	Global Wealth and Asset Management
---	---
									YTD Results
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
( millions, unless otherwise stated)	3Q22			2Q22			3Q21			2022			2021
Net income attributed to shareholders(1)	345		$	305		$	351		$	974		$	1,019
Core earnings(1)	345			305			351			974			1,019
Core EBITDA(2)	504			467			529			1,461			1,519
Core EBITDA margin (%)(3)	32.7	%		30.7	%		31.5	%		31.4	%		31.6	%
Sales
Wealth and asset management gross flows	32,024			33,602			35,229			104,095			108,677
Wealth and asset management net flows	3,012			1,713			9,824			11,616			19,809
Revenue	1,542			1,521			1,680			4,649			4,814
Assets under management and administration ( billions)	748.8			744.7			823.6			748.8			823.6
Total invested assets ( billions)	3.7			4.0			4.3			3.7			4.3
Segregated funds net assets ( billions)	214.5			213.3			244.9			214.5			244.9
Average assets under management and administration (<br> billions)(4)	771.8			776.8			815.9			785.4			786.0

All values are in US Dollars.

^(1)^	See “Non-GAAP and other financial measures” below for a reconciliation of core earnings to net income (loss) attributed to shareholders.
^(2)^	This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more information.
---	---
^(3)^	This item is a non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information.
---	---
^(4)^	For more information on this metric, see “Non-GAAP and other financial measures” below.
---	---

Global Wealth and Asset Management’s 3Q22 net income attributed to shareholders was $345 million compared with $351 million in 3Q21. Net income attributed to shareholders is comprised of core earnings, which were $345 million in 3Q22 compared with $351 million in 3Q21 and items excluded from core earnings, which were nil in both 3Q22 and 3Q21. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of core earnings to net income (loss) attributed to shareholders.

Core earnings in 3Q22 decreased 3% compared with 3Q21 driven by a decrease in net fee income from lower average AUMA due to equity market declines and higher interest rates in 2022. This was partially offset by lower variable incentive compensation expense and higher tax benefits. Net income attributed to shareholders decreased $6 million in 3Q22 compared with 3Q21 driven by the same factors noted above for core earnings.

Core EBITDA was $503 million in 3Q22, a decrease of 7% compared with 3Q21, driven by lower fee income, partially offset by lower variable incentive compensation expense as mentioned above. Core EBITDA margin was 32.7% in 3Q22, an increase of 120 basis points compared with 3Q21 driven by lower variable incentive compensation expense, partially offset by a decline in net fee income from lower average AUMA. See section E3 “Non-GAAP and other financial measures” below, for additional information on core EBITDA and core EBITDA margin. Income before income taxes for Global WAM was $395 million in 3Q22, a decrease of $22 million compared with 3Q21, driven by similar factors as noted above for core EBITDA.

Manulife Financial Corporation – Third Quarter 2022

Year-to-date net income attributed to shareholders was $974 million in 2022 compared with $1,019 million in the same period of 2021 and year-to-date core earnings were $974 million in 2022 compared with $1,019 million in the same period of 2021. The decrease in year-to-date core earnings of $45 million or 6% was due to a decline in net fee income from lower average AUMA and lower fee spread partially offset by several smaller positive items. Items excluded from year-to-date core earnings were nil in both 2022 and 2021. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of core earnings to net income (loss) attributed to shareholders. Year-to-date net income attributed to shareholders decreased $45 million in 2022 compared with 2021 driven by the same factors noted above for year-to-date core earnings.

Year-to-date core EBITDA was $1,461 million in 2022 compared with $1,519 million in the same period of 2021. The decrease in year-to-date core EBITDA of $58 million or 5% was driven by the factors noted above for year-to-date core earnings. Year-to-date core EBITDA margin was 31.4% in 2022 compared with 31.6% in the same period of 2021. The decrease of 20 basis points was driven by the factors as noted above for year-to-date core earnings. See section E3 “Non-GAAP and other financial measures” below, for additional information on year-to-date core EBITDA and year-to-date core EBITDA margin. Year-to-date income before income taxes for Global WAM was $1,143 million in 2022, a decrease of $60 million compared with 2021, driven by similar factors as noted above for year-to-date core EBITDA.

Wealth and asset management gross flows were $32.0 billion in 3Q22, a decline of 10% compared with 3Q21. The 3Q22 results by business line were:

•	Retirement gross flows of $12.8 billion, in line with 3Q21, driven by growth in member contributions offset by lower new plan sales.
•	Retail gross flows of $15.5 billion, a decrease of 21% compared with 3Q21, driven by lower investor demand amid equity market declines and higher interest rates.
---	---
•	Institutional Asset Management gross flows of $3.7 billion, an increase of 13% compared with 3Q21, driven by higher sales of equity and fixed income mandates.
---	---

Year-to-date gross flows were $104.1 billion in 2022, a decrease of 5% compared with the same period of 2021, mainly driven by lower retail gross flows due to the factors mentioned above. This was partially offset by higher retirement gross flows from growth in member contributions. Gross flows in Institutional Asset Management were in line with the prior year as lower sales of fixed income mandates offset a $1.9 billion sale of an equity mandate.

Wealth and asset management net inflows were $3.0 billion in 3Q22, compared with net inflows of $9.8 billion in 3Q21. By business line, the results were:

•	Retirement net inflows were $1.4 billion in 3Q22 compared with net inflows of $0.6 billion in 3Q21, reflecting higher gross flows as mentioned above and lower plan redemptions.
•	Net inflows in Retail were $1.0 billion in 3Q22 compared with net inflows of $7.9 billion in 3Q21, reflecting lower gross flows as mentioned above and higher mutual fund redemption rates.
---	---
•	Net inflows in Institutional Asset Management were $0.6 billion in 3Q22 compared with net inflows of $1.3 billion in 3Q21, driven by higher redemptions, partially offset by higher gross flows as<br> mentioned above.
---	---

Year-to-date net inflows were $11.6 billion in 2022, compared with $19.8 billion in same period of 2021. The decrease was primarily driven by higher retail mutual fund redemption rates and lower gross flows. This was partially offset by the non-recurrence of a $9.4 billion institutional redemption in Asia in 1Q21 as well as higher retirement gross flows from growth in member contributions.

Assets under management and administration of $748.8 billion as at September 30, 2022 decreased 17% compared with December 31, 2021. The decrease was driven by equity market declines and the impact of higher interest rates, partially offset by year-to-date net inflows of $11.6 billion. As at September 30, 2022, Global WAM also managed $220.6 billion in assets for the Company’s non-WAM reporting segments. Including those managed assets, AUMA managed by Global WAM^1^ was $969.3 billion compared with $1,102.7 billion as at December 31, 2021.

^1^	This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more information.

Manulife Financial Corporation – Third Quarter 2022

Segregated funds net assets were $214.5 billion for September 30, 2022, 15% lower compared with December 31, 2021 on an actual exchange rate basis, driven by equity market declines and the impact of higher interest rates. Total invested assets in our general fund form a small portion of Global WAM AUMA.

Revenue in 3Q22 was $1.5 billion, a decrease of 10% compared with 3Q21, driven by lower average AUMA. Year-to-date revenue in 2022 was $4.6 billion, a decrease of 5% compared with the same period of 2021, driven by lower average AUMA and lower fee spread, as well as lower investment income.

Business highlights – In 3Q22, we:

•	made a number of enhancements to our digital platform in Retirement including rolling out functionality that enables members in Canada to book one-on-one meetings with a Manulife PlanRight<br> financial advisor directly in the mobile app, which generated successful engagement, and resulted in approximately 1,400 advisor meeting requests in 3Q22. In addition, we recently enhanced digital service features which enable members in<br> the U.S. to self-serve to a greater extent, resulting in a reduction of approximately 10,000 calls to the call centre this quarter; and
•	expanded our Environmental, Social and Governance investment offerings with the launch of the Global Climate Action strategy in Europe to meet<br> increasing demand for sustainable investment solutions.
---	---
B5	Corporate and Other
---	---
									YTD Results
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
( millions, unless otherwise stated)	3Q22			2Q22			3Q21			2022			2021
Net income (loss) attributed to shareholders(1)	(738	)	$	(497	)	$	(252	)	$	(1,976	)	$	(734	)
Core loss excluding core investment gains(1)	(370	)	$	(157	)	$	(268	)	$	(736	)	$	(482	)
Core investment gains	100			100			100			300			300
Total core earnings (loss)	(270	)	$	(57	)	$	(168	)	$	(436	)	$	(182	)
Revenue	(383	)	$	(356	)	$	84		$	(1,340	)	$	(30	)

All values are in US Dollars.

^(1)^	See “Non-GAAP and other financial measures” below for a reconciliation of core earnings to net income (loss) attributed to shareholders.

Corporate and Other is composed of investment performance on assets backing capital, net of amounts allocated to operating segments; financing costs; costs incurred by the corporate office related to shareholder activities (not allocated to the operating segments); our Property and Casualty (“P&C”) Reinsurance business; as well as our run-off reinsurance operation including variable annuities and accident and health.

For segment reporting purposes, settlement costs for macro equity hedges and other non-operating items are included in Corporate and Other earnings. This segment is also where we reclassify favourable investment-related experience to core earnings from items excluded from core earnings, subject to certain limits (see “Non-GAAP and other financial measures” below). In each of the operating segments, we report all investment-related experience in items excluded from core earnings.

Corporate and Other reported a 3Q22 net loss attributed to shareholders of $738 million compared with net loss attributed to shareholders of $252 million in 3Q21. The core loss was $270 million in 3Q22 compared with a core loss of $168 million in 3Q21 and the items excluded from core earnings amounted to a net charge of $468 million in 3Q22 compared with a net charge of $84 million in 3Q21. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of core earnings (loss) to net income (loss) attributed to shareholders.

The $102 million increase in core loss was primarily due to a $256 million charge in our P&C Reinsurance business for estimated losses relating to Hurricane Ian compared with a $152 million charge for estimated losses related to Hurricane Ida and the European floods in 3Q21. In addition, the core loss includes $56 million of lower net gains on sales of AFS equities, $38 million of higher losses on seed money investments in segregated funds and mutual funds and higher interest on allocated capital to operating segments in 3Q22, which was substantially offset by higher yields on fixed income investments; and lower pension expenses that were primarily due to market impacts and lower variable incentive compensation.

The 3Q22 items excluded from core loss was a net charge of $468 million, primarily driven by losses on sales of AFS bonds and other direct impacts of markets and the reclassification of $100 million of the total Company’s favourable investment-related experience to core earnings.

Manulife Financial Corporation – Third Quarter 2022

On a year-to-date basis, the net loss attributed to shareholders was $1,976 million in 2022 compared with a net loss attributed to shareholders of $734 million in the same period of 2021. The year-to-date core loss was $436 million in 2022 compared with a core loss of $182 million in the same period of 2021. The increase in the year-to-date core loss of $254 million was primarily attributable to the year-to-date net charge of $153 million from the unfavourable impact of markets on seed money investments in new segregated funds and mutual funds and sales of AFS equities in 2022 compared with a $145 million year-to-date net gain in 2021, higher P&C Reinsurance provisions compared with prior year and $87 million of higher year-to-date interest on allocated capital to operating segments in 2022. These losses were partially offset by higher yields on fixed income investments; and lower pension expenses that are primarily due to market impacts and lower variable compensation expense. Items excluded from the year-to-date core loss were a net loss of $1,540 million in 2022 compared with a net loss of $552 million in the same period of 2021. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of core earnings to net income (loss) attributed to shareholders.

Revenue in 3Q22 was a loss of $383 million compared with a gain of $84 million in 3Q21. The $467 million variance was primarily driven by higher net realized losses on the sale of AFS bonds in 3Q22, higher losses from seed money investments, lower gains from AFS equities and higher interest on allocated capital to operating segments. These amounts were partially offset by gains on derivative positions in 3Q22 compared with a loss in 3Q21 and higher yields on fixed income investments.

Year-to-date revenue was a loss of $1,340 million in 2022 compared with a loss of $30 million in the same period of 2021. The increase in the loss was largely due to similar items noted above other than derivative positions which contributed lower losses in 2022 compared with 2021.

C RISK MANAGEMENT AND RISK FACTORS UPDATE

This section provides an update to our risk management practices and risk factors outlined in the MD&A in our 2021 Annual Report (“2021 MD&A”). Text and tables in this section of the MD&A represent our disclosure on market and liquidity risk in accordance with IFRS 7 “Financial Instruments – Disclosures”. Disclosures in accordance with IFRS 7 are identified by a vertical line in the left margin of each page. The identified text and tables represent an integral part of our unaudited Interim Consolidated Financial Statements.

C1	Variable annuity and segregated fund guarantees

As described in the MD&A in our 2021 Annual Report, guarantees on variable annuity products and segregated funds may include one or more of death, maturity, income and withdrawal guarantees. Variable annuity and segregated fund guarantees are contingent and only payable upon the occurrence of the relevant event, if fund values at that time are below guaranteed values. Depending on future equity market levels, liabilities on current in-force business would be due primarily in the period from 2022 to 2042.

We seek to mitigate a portion of the risks embedded in our retained (i.e. net of reinsurance) variable annuity and segregated fund guarantee business through the combination of our dynamic and macro hedging strategies (see section C3 “Publicly traded equity performance risk” below).

The table below shows selected information regarding the Company’s variable annuity and segregated fund investment-related guarantees gross and net of reinsurance.

Manulife Financial Corporation – Third Quarter 2022

Variable annuity and segregated fund guarantees, net of reinsurance

	September 30, 2022						December 31, 2021
As at<br><br> <br>($ millions)	Guarantee<br><br> <br>value^(1)^		Fund value		Amount at<br><br> <br>risk^(1),(2),(3)^		Guarantee<br><br> <br>value^(1)^		Fund value		Amount at<br><br> risk^(1),(2),(3)^
Guaranteed minimum income benefit	$	4,499	$	2,679	$	1,823	$	4,419	$	3,603	$	918
Guaranteed minimum withdrawal benefit		38,953		33,917		6,412		39,098		41,809		2,233
Guaranteed minimum accumulation benefit		20,240		20,036		314		19,820		20,226		12
Gross living benefits^(4)^		63,692		56,632		8,549		63,337		65,638		3,163
Gross death benefits^(5)^		10,837		14,754		2,673		11,105		22,920		618
Total gross of reinsurance		74,529		71,386		11,222		74,442		88,558		3,781
Living benefits reinsured		26,245		22,184		5,329		3,788		3,102		771
Death benefits reinsured		3,833		2,488		1,150		639		547		253
Total reinsured^(6)^		30,078		24,672		6,479		4,427		3,649		1,024
Total, net of reinsurance	$	44,451	$	46,714	$	4,743	$	70,015	$	84,909	$	2,757
^(1)^	Guaranteed Value and Net Amount at Risk in respect of guaranteed minimum withdrawal business in Canada and the U.S. reflect the time value of money of these claims.
---	---
^(2)^	Amount at risk (in-the-money amount) is the excess of guarantee values over fund values on all policies where the guarantee value exceeds the fund value. For guaranteed minimum<br> death benefit, the amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance and assumes that all claims are immediately payable. In practice,<br> guaranteed death benefits are contingent and only payable upon the eventual death of policyholders if fund values remain below guarantee values. For guaranteed minimum withdrawal benefit, the amount at risk assumes that the benefit is<br> paid as a lifetime annuity commencing at the earliest contractual income start age. These benefits are also contingent and only payable at scheduled maturity/income start dates in the future, if the policyholders are still living and have<br> not terminated their policies and fund values remain below guarantee values. For all guarantees, the amount at risk is floored at zero at the single contract level.
---	---
^(3)^	The amount at risk net of reinsurance at September 30, 2022 was $4,743 million (December 31, 2021 – $2,757 million) of which: US$1,124 million (December 31, 2021 – US$1,336<br> million) was on our U.S. business, $2,485 million (December 31, 2021 – $886 million) was on our Canadian business, US$242 million (December 31, 2021 – US$53 million) was on our Japan business and US$277 million (December 31, 2021 – US$87<br> million) was related to Asia (other than Japan) and our run-off reinsurance business.
---	---
^(4)^	Where a policy includes both living and death benefits, the guarantee in excess of the living benefit is included in the death benefit category as outlined in footnote 5.
---	---
^(5)^	Death benefits include standalone guarantees and guarantees in excess of living benefit guarantees where both death and living benefits are provided on a policy.
---	---
^(6)^	Reinsured amounts at September 30, 2022 reflect the U.S. variable annuity reinsurance transaction which closed on February 1, 2022.
---	---
C2	Caution related to sensitivities
---	---

In this document, we provide sensitivities and risk exposure measures for certain risks. These include sensitivities due to specific changes in market prices and interest rate levels projected using internal models as at a specific date, and are measured relative to a starting level reflecting the Company’s assets and liabilities at that date and the actuarial factors, investment activity and investment returns assumed in the determination of policy liabilities. The risk exposures measure the impact of changing one factor at a time and assume that all other factors remain unchanged. Actual results can differ significantly from these estimates for a variety of reasons including the interaction among these factors when more than one changes; changes in actuarial and investment return and future investment activity assumptions; actual experience differing from the assumptions, changes in business mix, effective tax rates and other market factors; and the general limitations of our internal models. For these reasons, the sensitivities should only be viewed as directional estimates of the underlying sensitivities for the respective factors based on the assumptions outlined below. Given the nature of these calculations, we cannot provide assurance that the actual impact on net income attributed to shareholders or on MLI’s LICAT ratio will be as indicated.

Market movements affect LICAT capital sensitivities both through income and other components of the regulatory capital framework. For example, LICAT is affected by changes to other comprehensive income.

C3	Publicly traded equity performance risk

As outlined in our 2021 Annual Report, we have net exposure to equity risk through asset and liability mismatches; our variable annuity guarantee dynamic hedging strategy is not designed to completely offset the sensitivity of policy liabilities to all risks associated with the guarantees embedded in these products. The macro hedging strategy is designed to mitigate public equity risk arising from variable annuity guarantees not dynamically hedged and from other unhedged exposures in our insurance liabilities (see pages 58 and 59 of our 2021 Annual Report).

Manulife Financial Corporation – Third Quarter 2022

Changes in public equity prices may impact other items including, but not limited to, asset-based fees earned on assets under management and administration or policyholder account value, and estimated profits and amortization of deferred policy acquisition and other costs. These items are not hedged.

The table below shows the potential impact on net income attributed to shareholders resulting from an immediate 10%, 20% and 30% change in market values of publicly traded equities followed by a return to the expected level of growth assumed in the valuation of policy liabilities. If market values were to remain flat for an entire year, the potential impact would be roughly equivalent to an immediate decline in market values equal to the expected level of annual growth assumed in the valuation of policy liabilities. Further, if after market values dropped 10%, 20% or 30% they continued to decline, remained flat, or grew more slowly than assumed in the valuation the potential impact on net income attributed to shareholders could be considerably more than shown. Refer to section D3 “Sensitivity of earnings to asset related assumptions” for more information on the level of growth assumed and on the net income sensitivity to changes in these long-term assumptions. The potential impact is shown after taking into account the impact of the change in markets on the hedge assets. While we cannot reliably estimate the amount of the change in dynamically hedged variable annuity guarantee liabilities that will not be offset by the profit or loss on the dynamic hedge assets, we make certain assumptions for the purposes of estimating the impact on net income attributed to shareholders.

This estimate assumes that the performance of the dynamic hedging program would not completely offset the gain/loss from the dynamically hedged variable annuity guarantee liabilities. It assumes that the hedge assets are based on the actual position at the period end, and that equity hedges in the dynamic program are rebalanced at 5% intervals. In addition, we assume that the macro hedge assets are rebalanced in line with market changes.

It is also important to note that these estimates are illustrative, and that the dynamic and macro hedging programs may underperform these estimates, particularly during periods of high realized volatility and/or periods where both interest rates and equity market movements are unfavourable.

The Standards of Practice for the valuation of insurance contract liabilities and guidance published by the CIA constrain the investment return assumptions for public equities and certain ALDA assets based on historical return benchmarks for public equities. The potential impact on net income attributed to shareholders does not take into account possible changes to investment return assumptions resulting from the impact of declines in public equity market values on these historical return benchmarks.

Manulife Financial Corporation – Third Quarter 2022

Potential immediate impact on net income attributed to shareholders arising from changes to public equity returns^(1),(2),(3)^

As at September 30, 2022
( millions)	-30	%		-20	%		-10	%		+10	%		+20	%		+30	%
Underlying sensitivity to net income attributed to shareholders(4)
Variable annuity guarantees	(1,250	)	$	(760	)	$	(350	)	$	290		$	530		$	720
General fund equity investments(5)	(1,500	)		(1,000	)		(500	)		440			820			1,200
Total underlying sensitivity before hedging	(2,750	)		(1,760	)		(850	)		730			1,350			1,920
Impact of macro and dynamic hedge assets(6)	970			590			280			(270	)		(490	)		(680	)
Net potential impact on net income attributed to shareholders after impact of<br> hedging(7)	(1,780	)	$	(1,170	)	$	(570	)	$	460		$	860		$	1,240
As at December 31, 2021
( millions)	-30	%		-20	%		-10	%		+10	%		+20	%		+30	%
Underlying sensitivity to net income attributed to shareholders(4)
Variable annuity guarantees	(2,560	)	$	(1,480	)	$	(630	)	$	440		$	750		$	960
General fund equity investments(5)	(1,430	)		(890	)		(440	)		450			880			1,320
Total underlying sensitivity before hedging	(3,990	)		(2,370	)		(1,070	)		890			1,630			2,280
Impact of macro and dynamic hedge assets(6)	2,060			1,190			500			(470	)		(820	)		(1,110	)
Net potential impact on net income attributed to shareholders after impact of<br> hedging(7)	(1,930	)	$	(1,180	)	$	(570	)	$	420		$	810		$	1,170

All values are in US Dollars.

^(1)^	See “Caution related to sensitivities” above.
^(2)^	The tables above show the potential impact on net income attributed to shareholders resulting from an immediate 10%, 20% and 30% change in market values of publicly traded<br> equities followed by a return to the expected level of growth assumed in the valuation of policy liabilities, excluding impacts from asset-based fees earned on assets under management and policyholder account value.
---	---
^(3)^	Please refer to section D3 “Sensitivity of earnings to asset related assumptions” for more information on the level of growth assumed and on the net income sensitivity to changes<br> in these long-term assumptions.
---	---
^(4)^	Defined as earnings sensitivity to a change in public equity markets including settlements on reinsurance contracts, but before the offset of hedge assets or other risk<br> mitigants.
---	---
^(5)^	This impact for general fund equity investments includes general fund investments supporting our policy liabilities, investment in seed money investments (in segregated and<br> mutual funds made by Corporate and Other segment) and the impact on policy liabilities related to the projected future fee income on variable universal life and other unit linked products. The impact does not include: (i) any potential<br> impact on public equity weightings; (ii) any gains or losses on AFS public equities held in the Corporate and Other segment; or (iii) any gains or losses on public equity investments held in Manulife Bank. The participating policy funds<br> are largely self-supporting and generate no material impact on net income attributed to shareholders as a result of changes in equity markets.
---	---
^(6)^	Includes the impact of rebalancing equity hedges in the macro and dynamic hedging program. The impact of dynamic hedge rebalancing represents the impact of rebalancing equity<br> hedges for dynamically hedged variable annuity guarantee best estimate liabilities at 5% intervals, but does not include any impact in respect of other sources of hedge ineffectiveness (e.g. fund tracking, realized volatility and equity,<br> interest rate correlations different from expected among other factors).
---	---
^(7)^	The sensitivity on net income attributed to shareholders from changes in public equity returns after the impact of hedging is largely unchanged as at September 30, 2022 compared<br> with December 31, 2021. This is due to the decline in sensitivities in 1Q22 as a result of the U.S. variable annuity reinsurance transaction being largely offset by the increase in sensitivities in the second quarter of 2022 (“2Q22”) and<br> 3Q22 as a result of the impact of equity market declines on our variable universal life business projected fee income.
---	---

Changes in equity markets impact our available and required components of the LICAT total ratio. The following table shows the potential impact to MLI’s LICAT total ratio resulting from changes in public equity market values.

Potential immediate impact on MLI’s LICAT total ratio arising from public equity returns different than the expected returns assumed in the valuation of policy liabilities^(1),(2),(3)^

	Impact on MLI's LICAT total ratio
Percentage points		-30	%	-20	%	-10	%	+10	%	+20	%	+30	%
September 30, 2022		(2	)	(1	)	-		1		1		1
December 31, 2021		(1	)	-		-		-		1		-
^(1)^	See “Caution related to sensitivities” above. In addition, estimates exclude changes to the net actuarial gains/losses with respect to the Company’s pension obligations as a result<br> of changes in equity markets, as the impact on the quoted sensitivities is not considered to be material.
---	---
^(2)^	The potential impact is shown assuming that the change in value of the hedge assets does not completely offset the change in the dynamically hedged variable annuity guarantee<br> liabilities. The estimated amount that would not be completely offset relates to our practices of not hedging the provisions for adverse deviation and of rebalancing equity hedges for dynamically hedged variable annuity liabilities at 5%<br> intervals.
---	---
^(3)^	The Office of the Superintendent of Financial Institutions (“OSFI”) rules for segregated fund guarantees reflect full capital impacts of shocks over 20 quarters within a prescribed<br> range. As such, the deterioration in equity markets could lead to further increases in capital requirements after the initial shock.
---	---

Manulife Financial Corporation – Third Quarter 2022

C4	Interest rate and spread risk sensitivities and exposure measures

As at September 30, 2022, we estimated the sensitivity of our net income attributed to shareholders to a 50 basis point parallel decline in interest rates to be neutral, and to a 50 basis point parallel increase in interest rates to be neutral.

The table below shows the potential impact on net income attributed to shareholders from a 50 basis point parallel move in interest rates. This includes a change of 50 basis points in current government, swap and corporate rates for all maturities across all markets with no change in credit spreads between government, swap and corporate rates, and with a floor of zero on government rates where government rates are not currently negative (currently zero floor applies to all countries we operate in except Japan), relative to the rates assumed in the valuation of policy liabilities, including embedded derivatives. For variable annuity guarantee liabilities that are dynamically hedged, it is assumed that interest rate hedges are rebalanced at 20 basis point intervals.

As the sensitivity to a 50 basis point change in interest rates includes any associated change in the applicable reinvestment scenarios, the impact of changes to interest rates for less than, or more than 50 basis points is unlikely to be linear. Furthermore, our sensitivities are not consistent across all regions in which we operate, and the impact of yield curve changes will vary depending upon the geography where the change occurs. Reinvestment assumptions used in the valuation of policy liabilities tend to amplify the negative effects of a decrease in interest rates and dampen the positive effects of interest rate increases. This is because the reinvestment assumptions used in the valuation of our insurance liabilities are based on interest rate scenarios and calibration criteria set by the Canadian Actuarial Standards Board. Therefore, in any particular quarter, changes to the reinvestment assumptions are not fully aligned to changes in current market interest rates especially when there is a significant change in the shape of the interest rate curve. As a result, the impact from non-parallel movements may be materially different from the estimated impact of parallel movements. For example, if long-term interest rates increase more than short-term interest rates (sometimes referred to as a steepening of the yield curve) in North America, the decrease in the value of our swaps may be greater than the decrease in the value of our insurance liabilities. This could result in a charge to net income attributed to shareholders in the short-term even though the rising and steepening of the yield curve, if sustained, may have a positive long-term economic impact.

The interest rate and spread risk sensitivities are determined in isolation of each other and therefore do not reflect the combined impact of changes in government rates and credit spreads between government, swap and corporate rates occurring simultaneously. As a result, the impact of the summation of each individual sensitivity may be materially different from the impact of sensitivities to simultaneous changes in interest rate and spread risk.

The potential impact on net income attributed to shareholders does not take into account any future potential changes to our ultimate reinvestment rate (“URR”) assumptions or calibration criteria for stochastic risk-free rates. At September 30, 2022, we estimated the sensitivity of our net income attributed to shareholders to a 10 basis point reduction in the ultimate reinvestment rate (“URR”) in all geographies, and a corresponding change to stochastic risk-free modeling, to be a charge of $300 million (post-tax); and note that the impact of changes to the URR are not linear. The long-term URR for risk-free rates in Canada is prescribed at 2.9% and we use the same assumption for the U.S. Our assumption for Japan is 1.5%.

The potential impact on net income attributable to shareholders does not take into account other potential impacts of lower interest rate levels, for example, increased strain on the sale of new business or lower interest earned on our surplus assets. The impact on net income attributed to shareholders also does not reflect any unrealized gains or losses on AFS fixed income assets held in our Corporate and Other segment. Changes in the market value of these assets may provide a natural economic offset to the interest rate risk arising from our product liabilities. In order for there to also be an accounting offset, the Company would need to realize a portion of the AFS fixed income asset unrealized gains or losses. It is not certain we would realize any of the unrealized gains or losses available.

The impact does not reflect any potential effect of changing interest rates to the value of our ALDA assets. Rising interest rates could negatively impact the value of our ALDA (see “Critical Actuarial and Accounting Policies – Fair

Manulife Financial Corporation – Third Quarter 2022

Value of Invested Assets”, on page 95 of our 2021 Annual Report). More information on ALDA assets can be found under the section C5 “Alternative long-duration asset performance risk”.

Under LICAT, changes in unrealized gains or losses in our AFS bond portfolio resulting from interest rate shocks tend to dominate capital sensitivities. As a result, the reduction in interest rates improves LICAT ratios and vice-versa.

The following table shows the potential impact on net income attributed to shareholders as well as the change in the market value of AFS fixed income assets held in our Corporate and Other segment, which could be realized through the sale of these assets.

Potential impact on net income attributed to shareholders and MLI’s LICAT ratio of an immediate parallel change in interest rates relative to rates assumed in the valuation of policy liabilities^(1),(2),(3),(4)^

						December 31, 2021
As at	-50	bp		+50	bp		-50	bp		+50	bp
Net income attributed to shareholders ( millions)	nil		$	nil		$	(200	)	$	nil
Changes in other comprehensive income from fair value changes in AFS fixed<br> income assets held in the Corporate and Other segment ( millions)	1,600			(1,400	)		2,100			(1,900	)
MLI's LICAT ratio (change in percentage points)(5)	3			(3	)		5			(4	)

All values are in US Dollars.

^(1)^	See “Caution related to sensitivities” above. In addition, estimates exclude changes to the net actuarial gains/losses with respect to the Company’s pension<br> obligations as a result of changes in interest rates, as the impact on the quoted sensitivities is not considered to be material.
^(2)^	Includes guaranteed insurance and annuity products, including variable annuity contracts as well as adjustable benefit products where benefits are generally<br> adjusted as interest rates and investment returns change, a portion of which have minimum credited rate guarantees. For adjustable benefit products subject to minimum rate guarantees, the sensitivities are based on the assumption that<br> credited rates will be floored at the minimum.
---	---
^(3)^	The amount of gain or loss that can be realized on AFS fixed income assets held in the Corporate and Other<br> segment will depend on the aggregate amount of unrealized gain or loss.
---	---
^(4)^	Sensitivities are based on projected asset and liability cash flows and the impact of realizing fair value changes in AFS fixed income is based on the<br> holdings at the end of the period.
---	---
^(5)^	LICAT impacts include realized and unrealized fair value changes in AFS fixed income assets. LICAT impacts do not reflect the impact of the<br> scenario switch discussed below.
---	---

The following tables show the potential impact on net income attributed to shareholders resulting from a change in corporate spreads and swap spreads over government bond rates for all maturities across all markets with a floor of zero on the total interest rate, relative to the spreads assumed in the valuation of policy liabilities.

Potential impact on net income attributed to shareholders and

      MLI’s LICAT ratio arising from changes to corporate spreads and swap spreads relative to spreads assumed in the valuation of policy liabilities^\(1\),\(2\),\(3\)^

Corporate spreads^(4),(5)^		September 30, 2022							December 31, 2021
As at			-50	bp			+50	bp		-50	bp		+50	bp
Net income attributed to shareholders ($ millions)^(6)^	$	nil			$	nil			$	(600	)	$	500
MLI’s LICAT ratio (change in percentage points)^(7)^			(3	)			3			(3	)		4
Swap spreads		September 30, 2022							December 31, 2021
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
As at			-20	bp			+20	bp		-20	bp		+20	bp
Net income attributed to shareholders ($ millions)	$	100			$	nil			$	nil		$	nil
MLI’s LICAT ratio (change in percentage points)^(7)^			nil				nil			nil			nil
^(1)^	See “Caution related to sensitivities” above.
---	---
^(2)^	The impact on net income attributed to shareholders assumes no gains or losses are realized on our AFS fixed income assets held in the Corporate<br><br><br><br><br><br><br><br><br><br><br><br><br> and Other segment and excludes the impact of changes in segregated fund bond values due to changes in credit spreads. The participating policy funds are largely self-supporting and generate no material impact<br> on net income attributed to shareholders as a result of changes in corporate and swap spreads.
---	---
^(3)^	Sensitivities are based on projected asset and liability cash flows.
---	---
^(4)^	Corporate spreads are assumed to grade to the long-term average over five years.
---	---
^(5)^	As the sensitivity to a 50 basis point decline in corporate spreads includes the impact of a change in deterministic reinvestment scenarios where applicable,<br> the impact of changes to corporate spreads for less than, or more than, the amounts indicated are unlikely to be linear.
---	---
^(6)^	The sensitivity on net income attributed to shareholders due to changes in corporate spreads decreased significantly as at September 30, 2022<br> compared with December 31, 2021, as the rise in risk-free interest rates reduced projected reinvestments in the actuarial valuation models.
---	---
^(7)^	LICAT impacts include realized and unrealized fair value change in AFS fixed income assets. Under LICAT, spread movements are determined from a selection of<br> investment grade bond indices with BBB and better bonds for each jurisdiction. For LICAT, we use the following indices: FTSE TMX Canada All Corporate Bond Index, Barclays USD Liquid Investment Grade Corporate Index, and Nomura-BPI (Japan).<br> LICAT impacts presented for corporate spreads do not reflect the impact of the scenario switch discussed below.
---	---

Manulife Financial Corporation – Third Quarter 2022

LICAT Scenario Switch

Typically, a reduction in interest rates improves LICAT ratios and vice-versa. However, when interest rates decline past a certain threshold, reflecting the combined movement in risk-free rates and corporate spreads, a different prescribed interest rate stress scenario needs to be taken into account in the LICAT ratio calculation in accordance with OSFI guidelines for LICAT.

The LICAT guideline specifies four stress scenarios for interest rates and prescribes the methodology to determine the most adverse scenario to apply for each LICAT geographic region^1^ based on current market inputs and the Company’s balance sheet.

With the rise in interest rates in 2022, the probability of a scenario switch has decreased significantly. In a lower interest rate environment, we would estimate the incremental impact of a potential switch in the scenarios to be approximately a one-time six percentage point decrease in MLI’s LICAT ratio. Should a scenario switch be triggered in a LICAT geographic region, the full impact would be reflected immediately for non-participating products while the impact for participating products would be reflected over six quarters using a rolling average of interest rate risk capital, in line with the smoothing approach prescribed in the OSFI Advisory effective January 1, 2021.

The potential negative impact of a switch in scenarios is not reflected in the stated risk-free rate and corporate spread sensitivities, as it is a one-time impact. After this one-time event, further decreases in risk-free interest rates would continue to improve the LICAT capital position, similar to the sensitivity above.

The level of interest rates and corporate spreads that would trigger a switch in the scenarios is dependent on market conditions and movements in the Company’s asset and liability position. The scenario switch, if triggered, could reverse in response to subsequent increases in interest rates and/or corporate spreads.

C5	Alternative long-duration asset performance risk

The following table shows the potential impact on net income attributed to shareholders resulting from an immediate 10% change in market values of ALDA followed by a return to the expected level of growth assumed in the valuation of policy liabilities. If market values were to remain flat for an entire year, the potential impact would be roughly equivalent to an immediate decline in market values equal to the expected level of annual growth assumed in the valuation of policy liabilities. Further, if after market values dropped 10% they continued to decline, remained flat, or grew more slowly than assumed in the valuation of policy liabilities, the potential impact on net income attributed to shareholders could be considerably more than shown. Refer to section D3 “Sensitivity of earnings to asset related assumptions”, for more information on the level of growth assumed and on the net income sensitivity to changes in these long-term assumptions.

ALDA includes commercial real estate, timber and farmland real estate, infrastructure, and private equities, some of which relate to oil and gas.

^1^	^LICAT geographic locations include North America, the United Kingdom, Europe, Japan, and Other Region.^

Manulife Financial Corporation – Third Quarter 2022

Potential impact on net income attributed to shareholders and MLI LICAT ratio arising from changes in ALDA returns relative to returns assumed in the valuation of policy liabilities^(1),(2),(3),(4),(5),(6)^

As at						December 31, 2021
( millions)	-10	%		+10	%		-10	%		+10	%
Net income attributed to shareholders
Real estate, agriculture and timber assets	(1,300	)	$	1,300		$	(1,400	)	$	1,400
Private equities and other ALDA	(1,600	)		1,500			(1,900	)		1,800
Total(7)	(2,900	)	$	2,800		$	(3,300	)	$	3,200
MLI’s LICAT ratio (change in percentage points)	(3	)		2			(4	)		3

All values are in US Dollars.

^(1)^	See “Caution Related to Sensitivities” above.
^(2)^	This impact is calculated as at a point-in-time impact and does not include: (i) any potential impact on ALDA weightings; or (ii) any gains or losses on ALDA held in the<br> Corporate and Other segment.
---	---
^(3)^	The participating policy funds are largely self-supporting and generate no material impact on net income attributed to shareholders as a result of changes in ALDA returns. For<br> some classes of ALDA, where there is not an appropriate long-term benchmark available, the return assumptions used in valuation are not permitted by the Standards of Practice and CIA guidance to result in a lower reserve than an<br> assumption based on a historical return benchmark for public equities in the same jurisdiction.
---	---
^(4)^	Net income impact does not consider any impact of the market correction on assumed future return assumptions.
---	---
^(5)^	Please refer to section D3 “Sensitivity of earnings to asset related assumptions” for more information on the level of growth assumed and on the net income sensitivity to changes<br> in these long-term assumptions.
---	---
^(6)^	The impact of changes to the portfolio asset mix supporting our North American legacy businesses are reflected in the sensitivities when the changes take place.
---	---
^(7)^	The decrease in net income sensitivity under each ALDA returns scenario was primarily driven by the increase in fixed income yields since December 31, 2021. This led to higher<br> fixed income reinvestment rates relative to ALDA returns, which decreases the ALDA sensitivity because more fixed income assets are held compared to ALDA.
---	---
C6	Credit risk exposure measures
---	---

Allowances for losses on loans are established taking into consideration normal historical credit loss levels and future expectations, with an allowance for adverse deviations. Additionally, we make general provisions for credit losses from future asset impairments in the determination of policy liabilities. The amount of the provision for credit losses included in policy liabilities is established through regular monitoring of all credit related exposures, considering such information as general market conditions, industry and borrower specific credit events and any other relevant trends or conditions. To the extent that an asset is written off, or disposed of, any allowance and general provisions for credit losses are released.

Our general provision for credit losses included in policyholder liabilities as at September 30, 2022 was $3,699 million compared with $4,109 million as at December 31, 2021. The decline in the provision compared with December 31, 2021 is primarily due to the impact of higher interest rates. This provision represents 1.4% of our fixed income assets^1^ supporting policy liabilities reported on our Consolidated Statements of Financial Position as at September 30, 2022.

The impact of a 50% increase in fixed income credit default rates over the next year in excess of the rates assumed in policy liabilities would reduce net income attributed to shareholders by $75 million and $70 million, respectively, as at September 30, 2022 and December 31, 2021.

Credit downgrades of fixed income investments would adversely impact our regulatory capital, as required capital levels for these investments are based on the credit quality of each instrument. In addition, credit downgrades could also lead to a higher general provision for credit losses than had been assumed in policy liabilities, resulting in an increase in policy liabilities and a reduction in net income attributed to shareholders. The estimated impact of a one-notch^2^ ratings downgrade across 25% of fixed income assets would result in an increase to policy liabilities and a decrease to our net income attributed to shareholders of $250 million post-tax. This ratings downgrade would result in a one percentage point reduction to our LICAT ratio.

Approximately 19% of the impact from the one-notch ratings downgrade on our policy liabilities and net income attributed to shareholders noted above relates to fixed income assets rated below investment grade. Approximately 1% of our fixed income assets as of September 30, 2022 is rated below investment grade.

^1^	Includes debt securities, private placements and mortgages.
^2^	A one-notch downgrade is equivalent to a ratings downgrade from A to A- or BBB- to BB+.
---	---

Manulife Financial Corporation – Third Quarter 2022

The table below shows net impaired assets and allowances for loan losses.

Net impaired assets and loan losses

As at<br><br> <br>($ millions, unless otherwise stated)	September 30, 2022			December 31, 2021
Net impaired fixed income assets	$	303		$	228
Net impaired fixed income assets as a % of total invested assets		0.074	%		0.053	%
Allowance for loan losses	$	52		$	44
C7	Risk factors – strategic risk from changes in tax laws^1^
---	---

As noted in “Risk Management and Risk Factors – Strategic Risk Factors” in the MD&A in our 2021 Annual Report, we outlined risk factors that could impact on our financial plans and ability to implement our business strategy. The macro-economic environment can be significantly impacted by the actions of both the government sector, including central banks, and the private sector. Changes in tax laws, tax regulations, or interpretations of such laws or regulations could make some of our products less attractive to consumers, could increase our corporate taxes or cause us to change the value of our deferred tax assets and liabilities as well as our tax assumptions included in the valuation of our policy liabilities. This could have a material adverse effect on our business, results of operations and financial condition.

•	In 2021, 136 of the 140 members of the Organization for Economic Co-Operation and Development (“OECD”) / G20 Inclusive Framework agreed on a two-pillar solution to address tax challenges from the<br> digital economy, and to close the gaps in international tax systems. These include a new approach to allocating certain profits of multinational entities amongst countries and a global minimum income tax rate of 15%. These rules are<br> targeted to be effective in 2023, pending release of implementation guidelines, enactment of domestic tax laws and amendment of bilateral tax treaties beforehand. On April 7, 2022, the Canadian government reaffirmed its commitment to the<br> two-pillar solution in its 2022 Budget statement. The Company is closely monitoring developments and potential impacts and, in particular, for issues unique to the insurance industry. If enacted, we expect an increase in the effective tax<br> rate, pending further details on timing and specific implementation in both Canada and other affected countries.
•	Canada’s 2022 Budget statement also provided clarity on how the one-time Canada Recovery Dividend and permanent corporate tax rate increase for certain financial institutions would be applied. Both<br> tax measures are expected to apply to Canada’s insurance and banking operations. Draft legislation was released for consultation on August 9, 2022. The proposed form of the Canada Recovery Dividend is a one-time 15% tax applicable to the<br> average taxable income for 2020 and 2021 in excess of $1 billion and is not expected to be a material cost to the Company. Upon substantive enactment in 2022, the 1.5% corporate tax rate increase on Canadian taxable income over $100 million<br> is estimated to have an immediate favourable impact on the value of our existing deferred tax asset, offset over time by a slight increase to our effective tax rate as future Canadian insurance and banking earnings are taxed at the new<br> higher federal corporate tax rate of 16.5%.
---	---
•	The August 9, 2022 draft legislation also provided proposed rules to govern the transition to IFRS 17 for Canadian tax purposes. The five-year transition period for both insurance reserves and<br> revaluations of investments under IFRS 9 should generally smooth the current tax impact of the change in accounting standard but is not expected to have a material effect on the Company’s annual cash tax payable.
---	---
•	The U.S. Inflation Reduction Act of 2022 was signed into law on August 16, 2022, which includes a 15% minimum tax based on financial statement income, effective starting in 2023. Many related<br> regulations remain to be drafted to clarify how the tax will operate, but at this time we do not expect our IFRS effective tax rate to be materially affected by this new tax, though the timing of cash tax payments could be accelerated.
---	---

^1^	See “Caution regarding forward-looking statements” below.

Manulife Financial Corporation – Third Quarter 2022

D CRITICAL ACTUARIAL AND ACCOUNTING POLICIES

D1	Critical actuarial and accounting policies

Our significant accounting policies are described in note 1 to our Consolidated Financial Statements for the year ended December 31, 2021. The critical actuarial and accounting policies and estimation processes relate to the determination of insurance and investment contract liabilities, assessment of control over other entities for consolidation, estimation of fair value of invested assets, evaluation of invested asset impairment, accounting for derivative financial instruments, determination of pension and other post-employment benefit obligations and expenses, accounting for income taxes and uncertain tax positions and valuation and impairment of goodwill and intangible assets starting on page 87 of our 2021 Annual Report.

D2	Actuarial methods and assumptions

A comprehensive review of actuarial methods and assumptions is performed annually. The review is designed to reduce the Company’s exposure to uncertainty by ensuring assumptions for both asset and liability related risks remain appropriate. This is accomplished by monitoring experience and selecting assumptions which represent a current best estimate view of expected future experience, and margins for adverse deviations that are appropriate for the risks assumed. While the assumptions selected represent the Company’s current best estimates and assessment of risk, the ongoing monitoring of experience and changes in the economic environment are likely to result in future changes to the actuarial assumptions, which could materially impact the measurement of insurance contract liabilities.

The completion of the 2022 annual review of actuarial methods and assumptions resulted in a decrease in insurance contract liabilities, net of reinsurance, of $80 million, and a net gain to net income attributed to shareholders of $36 million post-tax.

	Change in insurance contract liabilities, net of<br><br> <br>reinsurance
For the three and nine months ended September 30, 2022<br><br> <br>($ millions)	Total			Attributed to participating policyholders’ account^(1)^			Attributed to shareholders’ account			Change in net income<br><br> <br>attributed to<br><br> <br>shareholders<br><br> <br>(post-tax)
Long-term care triennial review	$	19		$	-		$	19		$	(15	)
Mortality and morbidity updates		157			(5	)		162			(126	)
Lapses and policyholder behaviour updates		317			74			243			(192	)
Investment related updates		(210	)		(1	)		(209	)		157
Other updates		(363	)		(145	)		(218	)		212
Net impact	$	(80	)	$	(77	)	$	(3	)	$	36
^(1)^	The change in insurance contract liabilities, net of reinsurance, attributable to the participating policyholders’ account was primarily driven by an increase in expected long-term<br> interest rates within the valuation models to reflect the higher interest rate environment, partially offset by the lapse assumption update in Canada.
---	---

Long-term care triennial review

U.S. Insurance completed a comprehensive long-term care (“LTC”) experience study. The review included all aspects of claim assumptions, as well as the progress on future premium rate increases. The impact of the LTC review resulted in a net $15 million post-tax charge to net income attributed to shareholders.

The experience study showed that claim costs established in our last triennial review remain appropriate in aggregate for our older blocks of business^1^ supported by robust claims data on this mature block. Insurance contract liabilities were strengthened for claim costs on our newer block of business^2^. This was driven by lower active life mortality^3^ supported by Company experience and a recent industry study, as well as higher utilization of benefits, which included the impact of reflecting higher inflation in the cost-of-care up to the current year. We also reviewed and updated incidence and claim termination assumptions which, on a net basis, provided a partial offset to the increase in insurance contract liabilities on active life mortality and utilization. In addition,

^1^	First generation policies issued prior to 2002.
^2^	Second generation policies with an average issue date of 2007 and Group policies with an average issue date of 2003.
---	---
^3^	The mortality rate of LTC policyholders who are currently not on claim.
---	---

Manulife Financial Corporation – Third Quarter 2022

some policyholders are electing to reduce their benefits in lieu of paying increased premiums which resulted in a reduction in insurance contract liabilities. The overall claims experience review led to a post-tax charge to net income attributed to shareholders of approximately $2.3 billion (US$1.7 billion).

Experience continues to support the assumptions of both future morbidity and mortality improvement, resulting in no changes to these assumptions.

As of September 30, 2022, we have received actual premium increase approvals of $2.5 billion pre-tax (US$1.9 billion pre-tax) on a present value basis since the last triennial review in 2019. This aligns with the full amount assumed in our insurance contract liabilities at that time and demonstrates our continued strong track record of progress in securing premium rate increases.^1^ In 2022, the review of future premium increases assumed in insurance contract liabilities resulted in a post-tax gain to net income attributed to shareholders of approximately $2.1 billion (US$1.6 billion), in comparison to a total estimated ask of $6.7 billion (US$5.1 billion). This reflects expected future premium increases that are due to our 2022 review of morbidity, mortality, and lapse assumptions, as well as outstanding amounts from prior state filings. Premium increases averaging approximately 30% will be sought on about one-half of the business, excluding the carryover of 2019 amounts requested. Our assumptions reflect the estimated timing and amount of state approved premium increases.

Other refinements to LTC valuation resulted in a post-tax gain of approximately $0.2 billion (US$0.2 billion) to net income attributed to shareholders.

Mortality and morbidity updates

Mortality and morbidity updates resulted in a $126 million post-tax charge to net income attributed to shareholders, driven by a detailed review of the mortality and morbidity assumptions for our Canada insurance business, and by updates to morbidity assumptions in Vietnam to align with experience.

Lapses and policyholder behaviour updates

Updates to lapses and policyholder behaviour assumptions resulted in a $192 million post-tax charge to net income attributed to shareholders.

We completed a detailed review of lapse assumptions for Singapore, and increased lapse rates to align with experience on our index-linked products, which reduced projected future fee income to be received on these products.

We also increased lapse rates on Canada’s term insurance products for policies approaching their renewal date, reflecting emerging experience in our study.

Investment-related updates

Updates to investment return assumptions resulted in a $157 million post-tax gain to net income attributed to shareholders, primarily driven by annual updates to our valuation models to reflect market movements during the year. No changes were made to our long-term assumed returns.

Other updates

Other updates resulted in a $212 million post-tax gain to net income attributed to shareholders, which included refinements to the projection of our tax and liability cash flows, as well as various other modelling updates.

Impact of changes in actuarial methods and assumptions by segment

The impact of changes in actuarial methods and assumptions in Canada resulted in a $35 million post-tax gain to net income attributed to shareholders. The gain was primarily driven by refinements to our valuation models, due to annual updates to reflect market movements during the year, partially offset by updates of mortality and morbidity assumptions for our insurance business and lapse assumptions for certain term insurance products.

The impact of changes in actuarial methods and assumptions in the U.S. resulted in a $36 million post-tax gain, driven by refinements to our valuation models, due to annual updates to reflect market movements during the year. The triennial review of long-term care was net neutral overall.

^1^	Our actual experience obtaining premium increases could be materially different than what we have assumed, resulting in further increases or decreases in insurance contract<br> liabilities, which could be material. See “Caution regarding forward-looking statements” below.

Manulife Financial Corporation – Third Quarter 2022

The impact of changes in actuarial methods and assumptions in Asia resulted in a $45 million post-tax charge to net income attributed to shareholders. The charge was primarily driven by updates to lapse assumptions in Singapore and morbidity updates in Vietnam, partially offset by refinements to the projection of tax and liability cash flows in Vietnam.

The impact of changes in actuarial methods and assumptions in Corporate and Other (which includes our Reinsurance businesses) resulted in a $10 million post-tax gain to net income attributed to shareholders.

D3	Sensitivity of earnings to asset related assumptions

When the assumptions underlying our determination of policy liabilities are updated to reflect recent and emerging experience or change in outlook, the result is a change in the value of policy liabilities which in turn affects net income attributed to shareholders. The sensitivity of net income attributed to shareholders to changes in certain asset related assumptions underlying policy liabilities is shown below and assumes that there is a simultaneous change in the assumptions across all business units.

For changes in asset related assumptions, the sensitivity is shown net of the corresponding impact on net income attributed to shareholders of the change in the value of the assets supporting policy liabilities. In practice, experience for each assumption will frequently vary by geographic market and business, and assumption updates are made on a business/geographic specific basis. Actual results can differ materially from these estimates for a variety of reasons including the interaction among these factors when more than one changes, changes in actuarial and investment return and future investment activity assumptions, actual experience differing from the assumptions, changes in business mix, effective tax rates and other market factors, and the general limitations of our internal models.

Potential impact on net income attributed to shareholders arising from changes to asset related assumptions supporting actuarial liabilities

	Increase (decrease) in after-tax net income attributed<br><br> <br>to shareholders
As at	September 30, 2022						December 31, 2021
($ millions)	Increase			Decrease			Increase			Decrease
Asset related assumptions updated periodically in valuation basis changes
100 basis point change in future annual returns for public equities^(1)^	$	400		$	(400	)	$	500		$	(500	)
100 basis point change in future annual returns for ALDA^(2)^		3,300			(3,600	)		3,900			(4,700	)
100 basis point change in equity volatility assumption for stochastic segregated fund modelling^(3)^		(100	)		100			(200	)		200
^(1)^	The sensitivity to public equity returns above includes the impact on both segregated fund guarantee reserves and on other policy liabilities. Expected long-term annual market<br> growth assumptions for public equities are based on long-term historical observed experience and compliance with actuarial standards. As at September 30, 2022, the growth rates inclusive of dividends in the major markets used in the<br> stochastic valuation models for valuing segregated fund guarantees are 9.0% per annum in Canada, 9.6% per annum in the U.S. and 6.2% per annum in Japan. Growth assumptions for European equity funds are market-specific and vary between 8.3%<br> and 9.9%.
---	---
^(2)^	ALDA include commercial real estate, timber, farmland, infrastructure and private equities, some of which relate to oil and gas. Expected long-term return assumptions for ALDA and<br> public equity are set in accordance with the Standards of Practice for the valuation of insurance contract liabilities and guidance published by the CIA. Annual best estimate return assumptions for ALDA and public equity include market<br> growth rates and annual income, such as rent, production proceeds and dividends, and will vary based on our holding period. As of September 30, 2022, over a 20-year horizon, our best estimate return assumptions range between 5.25% and<br> 11.5%, with an average of 9.2% based on the current asset mix backing our guaranteed insurance and annuity business. As of September 30, 2022, our return assumptions including the margins for adverse deviations in our valuation, which take<br> into account the uncertainty of achieving the returns, range between 2.5% and 7.5%, with an average of 6.0% based on the asset mix backing our guaranteed insurance and annuity business.
---	---
^(3)^	Volatility assumptions for public equities are based on long-term historical observed experience and compliance with actuarial standards. As of September 30, 2022, the resulting<br> volatility assumptions are 16.5% per annum in Canada and 17.1% per annum in the U.S. for large-cap public equities, and 19.1% per annum in Japan. For European equity funds, the volatility varies between 16.3% and 17.7%.
---	---
D4	Accounting and reporting changes
---	---

For accounting and reporting changes during the quarter, refer to note 2 of our unaudited Interim Consolidated Financial Statements for the three and nine months ended September 30, 2022.

E OTHER

E1	Outstanding common shares - selected information

As at October 31, 2022, MFC had 1,883,636,606 common shares outstanding.

Manulife Financial Corporation – Third Quarter 2022

E2	Legal and regulatory proceedings

We are regularly involved in legal actions, both as a defendant and as a plaintiff. Information on legal and regulatory proceedings can be found in note 12 of our unaudited Interim Consolidated Financial Statements for the three and nine months ended September 30, 2022.

E3	Non-GAAP and other financial measures

The Company prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure in respect of “specified financial measures” (as defined therein).

Non-GAAP financial measures include core earnings (loss); pre-tax core earnings; core earnings available to common shareholders; core earnings before income taxes, depreciation and amortization (“core EBITDA”); core general expenses; Manulife Bank net lending assets; Manulife Bank average net lending assets; assets under management (“AUM”); assets under management and administration (“AUMA”); Global WAM managed AUMA; and net annualized fee income. In addition, non-GAAP financial measures include the following stated on a constant exchange rate (“CER”) basis: any of the foregoing non-GAAP financial measures; Global WAM revenue; net income attributed to shareholders; and common shareholders’ net income.

Non-GAAP ratios include core ROE; diluted core earnings per common share (“core EPS”); common share core dividend payout ratio (“dividend payout ratio”); expense efficiency ratio; core EBITDA margin; effective tax rate on core earnings and net fee income yield. In addition, non-GAAP ratios include the percentage growth/decline on a CER basis in any of the above non-GAAP financial measures; Global WAM revenue; net income attributed to shareholders; common shareholders’ net income; pre-tax net income attributed to shareholders; general expenses; basic earnings per common share (“basic EPS”); and diluted earnings per common share (“diluted EPS”).

Other specified financial measures include assets under administration (“AUA”); consolidated capital; new business value (“NBV”); new business value margin (“NBV margin”); sales; annualized premium equivalent (“APE”) sales; gross flows; net flows; average assets under management and administration (“average AUMA”), Global WAM average managed AUMA; average assets under administration; remittances; any of the foregoing specified financial measures stated on a CER basis; and percentage growth/decline in any of the foregoing specified financial measures on a CER basis.

Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP.

Core earnings (loss) is a financial measure which we believe aids investors in better understanding the long-term earnings capacity and valuation of the business. Core earnings allows investors to focus on the Company’s operating performance by excluding the direct impact of changes in equity markets and interest rates, changes in actuarial methods and assumptions as well as a number of other items, outlined below, that we believe are material, but do not reflect the underlying earnings capacity of the business. For example, due to the long-term nature of our business, the mark-to-market movements of equity markets, interest rates, foreign currency exchange rates and commodity prices from period-to-period can, and frequently do, have a substantial impact on the reported amounts of our assets, liabilities and net income attributed to shareholders. These reported amounts are not actually realized at the time and may never be realized if the markets move in the opposite direction in a subsequent period. This makes it very difficult for investors to evaluate how our businesses are performing from period-to-period and to compare our performance with other issuers.

We believe that core earnings better reflect the underlying earnings capacity and valuation of our business. We use core earnings as the basis for management planning and reporting and, along with net income attributed to

Manulife Financial Corporation – Third Quarter 2022

shareholders, as a key metric used in our short and mid-term incentive plans at the total Company and operating segment level. We also base our mid and long-term strategic priorities on core earnings.

While core earnings is relevant to how we manage our business and offers a consistent methodology, it is not insulated from macro-economic factors which can have a significant impact. See below for reconciliation of core earnings to net income attributed to shareholders and income before income taxes. Net income attributed to shareholders excludes net income attributed to participating policyholders and non-controlling interests.

The items included in core earnings and items excluded from core earnings are determined in accordance with the methodology under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline and are listed below.

Any future changes to the core earnings definition referred to below, will be disclosed.

Items included in core earnings:

1.	Expected earnings on in-force policies, including expected release of provisions for adverse deviation, fee income, margins on group business and spread business such as Manulife Bank and asset<br> fund management.
2.	Macro hedging costs based on expected market returns.
---	---
3.	New business strain and gains.
---	---
4.	Policyholder experience gains or losses.
---	---
5.	Acquisition and operating expenses compared with expense assumptions used in the measurement of policy liabilities.
---	---
6.	Up to $400 million of net favourable investment-related experience reported in a single year, which are referred to as “core investment<br> gains”. This means up to $100 million in the first quarter, up to $200 million on a year-to-date basis in the second quarter, up to $300 million on a year-to-date basis in the third quarter and up to $400 million on a full year basis in the<br> fourth quarter. Any investment-related experience losses reported in a quarter will be offset against the net year-to-date investment-related experience gains with the difference being included in core earnings<br> subject to a maximum of the year-to-date core investment gains and a minimum of zero, which reflects our expectation that investment-related experience will be positive through-the-business cycle. To the extent any investment-related<br> experience losses cannot be fully offset in a quarter they will be carried forward to be offset against investment-related experience gains in subsequent quarters in the same year, for purposes of determining core investment gains.<br> Investment-related experience relates to fixed income investing, ALDA returns, credit experience and asset mix changes other than those related to a strategic change. An example of a strategic asset mix change is outlined below.
---	---
•	This favourable and unfavourable investment-related experience is a combination of reported investment experience as well as the impact of investing activities on the measurement of our policy<br> liabilities. We do not attribute specific components of investment-related experience to amounts included or excluded from core earnings.
---	---
•	The $400 million threshold represents the estimated average annualized amount of net favourable investment-related experience that the Company reasonably expects to achieve through-the-business<br> cycle based on historical experience. It is not a forecast of expected net favourable investment-related experience for any given fiscal year.
---	---
•	Our average net annualized investment-related experience, including core investment gains, calculated from the introduction of core earnings in 2012 to the end of 2021 was $546 million (2012 to the<br> end of 2020 was $380 million).
---	---
•	The decision announced on December 22, 2017 to reduce the allocation to ALDA in the portfolio asset mix supporting our legacy businesses was the first strategic asset mix change since we introduced<br> the core earnings metric in 2012. We refined our description of investment-related experience in 2017 to note that asset mix changes other than those related to a strategic change are taken into consideration<br> in the investment-related experience component of core investment gains.
---	---

Manulife Financial Corporation – Third Quarter 2022

•

While historical investment return time horizons may vary in length based on underlying asset classes generally exceeding 20 years, for purposes of establishing the threshold, we look at a business cycle that is five or more years and includes a recession. We monitor the appropriateness of the threshold as part of our annual five-year planning process and would adjust it, either to a higher or lower amount, in the future if we believed that our threshold was no longer appropriate.

•

Specific criteria used for evaluating a potential adjustment to the threshold may include, but are not limited to, the extent to which actual investment-related experience differs materially from actuarial assumptions used in measuring insurance contract liabilities, material market events, material dispositions or acquisitions of assets, and regulatory or accounting changes.

---

Core investment gains are reported in the Corporate and Other segment, with an offsetting adjustment to investment-related experience gains and losses in items excluded from core earnings.

7.	Earnings on surplus other than mark-to-market items. Gains on available-for-sale (“AFS”) equities and seed money investments in segregated and mutual funds are included in core earnings.
8.	Routine or non-material legal settlements.
---	---
9.	All other items not specifically excluded.
---	---
10.	Tax on the above items.
---	---
11.	All tax related items except the impact of enacted or substantively enacted income tax rate changes.
---	---

Items excluded from core earnings:

1.	The direct impact of equity markets and interest rates and variable annuity guarantee liabilities includes the items listed below.
•	The earnings impact of the difference between the net increase (decrease) in variable annuity liabilities that are dynamically hedged and the performance of the related hedge assets. Our variable<br> annuity dynamic hedging strategy is not designed to completely offset the sensitivity of insurance and investment contract liabilities to all risks or measurements associated with the guarantees embedded in these products for a number of<br> reasons, including: provisions for adverse deviation, fund performance, the portion of the interest rate risk that is not dynamically hedged, realized equity and interest rate volatilities and changes to policyholder behaviour.
---	---
•	Gains (charges) on variable annuity guarantee liabilities not dynamically hedged.
---	---
•	Gains (charges) on general fund equity investments supporting policy liabilities and on fee income.
---	---
•	Gains (charges) on macro equity hedges relative to expected costs. The expected cost of macro hedges is calculated using the equity assumptions used in the valuation of insurance and investment<br> contract liabilities.
---	---
•	Gains (charges) on higher (lower) fixed income reinvestment rates assumed in the valuation of insurance and investment contract liabilities.
---	---
•	Gains (charges) on sale of AFS bonds and open derivatives not in hedging relationships in the Corporate and Other segment.
---	---
2.	Net favourable investment-related experience in excess of $400 million per annum or net unfavourable investment-related experience on a year-to-date basis.
---	---
3.	Mark-to-market gains or losses on assets held in the Corporate and Other segment other than gains on AFS equities and seed money investments in new segregated or mutual funds.
---	---
4.	Changes in actuarial methods and assumptions. As noted in the “Critical actuarial and accounting policies” section of our 2021 MD&A, policy liabilities for IFRS are valued in Canada under<br> standards established by the Actuarial Standards Board. The standards require a comprehensive review of actuarial methods and assumptions to be performed annually. The review is designed to reduce the Company’s exposure to uncertainty by<br> ensuring assumptions for both asset related and liability related risks remain appropriate and is accomplished by monitoring experience and selecting assumptions which represent a current best estimate
---	---

Manulife Financial Corporation – Third Quarter 2022

view of expected future experience, and margins that are appropriate for the risks assumed. Changes related to ultimate reinvestment rates (“URR”) are included in the direct impact of equity<br> markets and interest rates and variable annuity guarantee liabilities. By excluding the results of the annual reviews, core earnings assist investors in evaluating our operational performance and comparing our operational performance from<br> period to period with other global insurance companies because the associated gain or loss is not reflective of current year performance and not reported in net income in most actuarial standards outside of Canada.
5.	The impact on the measurement of policy liabilities of changes in product features or new reinsurance transactions, if material.
---	---
6.	Goodwill impairment charges.
---	---
7.	Gains or losses on disposition of a business.
---	---
8.	Material one-time only adjustments, including highly unusual/extraordinary and material legal settlements or other items that are material and exceptional in nature.
---	---
9.	Tax on the above items.
---	---
10.	Net income (loss) attributed to participating policyholders and non-controlling interests.
---	---
11.	Impact of enacted or substantially enacted income tax rate changes.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

							3Q22
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	476		$	819		$	766		$	395		$	(819	)	$	1,637
Income tax (expense) recovery
Core earnings		(61	)		(116	)		(62	)		(50	)		18			(271	)
Items excluded from core earnings		2			(75	)		(52	)		-			64			(61	)
Income tax (expense) recovery		(59	)		(191	)		(114	)		(50	)		82			(332	)
Net income (post-tax)		417			628			652			345			(737	)		1,305
Less: Net income (post-tax) attributed to
Non-controlling interests		(19	)		-			-			-			1			(18	)
Participating policyholders		(85	)		50			11			-			-			(24	)
Net income (loss) attributed to shareholders<br><br> <br>(post-tax)		521			578			641			345			(738	)		1,347
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core<br><br> <br>earnings		(3	)		97			127			-			(96	)		125
Direct impact of equity markets and interest rates<br><br> <br>and variable annuity guarantee liabilities		95			96			137			-			(382	)		(54	)
Change in actuarial methods and assumptions		(45	)		35			36			-			10			36
Restructuring charge		-			-			-			-			-			-
Reinsurance transactions, tax related items and<br><br> other		(39	)		-			(43	)		-			-			(82	)
Core earnings (post-tax)	$	513		$	350		$	384		$	345		$	(270	)	$	1,322
Income tax on core earnings (see above)		61			116			62			50			(18	)		271
Core earnings (pre-tax)	$	574		$	466		$	446		$	395		$	(288	)	$	1,593
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars

				3Q22
(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)		Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
Core earnings (post-tax)	513	$	350	$	384	$	345	$	(270	)	$	1,322
CER adjustment(1)	-		-		-		-		-			-
Core earnings, CER basis (post-tax)	513	$	350	$	384	$	345	$	(270	)	$	1,322
Income tax on core earnings, CER basis(2)	61		116		62		50		(18	)		271
Core earnings, CER basis (pre-tax)	574	$	466	$	446	$	395	$	(288	)	$	1,593
Core earnings (U.S. dollars) - Asia and U.S.<br> segments
Core earnings (post-tax)(3), US	394			$	294
CER adjustment US (1)	-				-
Core earnings, CER basis (post-tax), US	394			$	294

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 3Q22.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

							2Q22
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	216		$	224		$	1,010		$	362		$	(555	)	$	1,257
Income tax (expense) recovery
Core earnings		(74	)		(119	)		(92	)		(57	)		4			(338	)
Items excluded from core earnings		44			64			(82	)		-			54			80
Income tax (expense) recovery		(30	)		(55	)		(174	)		(57	)		58			(258	)
Net income (post-tax)		186			169			836			305			(497	)		999
Less: Net income (post-tax) attributed to
Non-controlling interests		(11	)		-			-			-			-			(11	)
Participating policyholders		(164	)		84			4			-			-			(76	)
Net income (loss) attributed to shareholders<br><br> <br>(post-tax)		361			85			832			305			(497	)		1,086
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core<br><br> <br>earnings		80			86			591			-			(166	)		591
Direct impact of equity markets and interest rates<br><br> <br>and variable annuity guarantee liabilities		(232	)		(346	)		(215	)		-			(274	)		(1,067	)
Change in actuarial methods and assumptions		-			-			-			-			-			-
Restructuring charge		-			-			-			-			-			-
Reinsurance transactions, tax related items and<br><br> <br>other		-			-			-			-			-			-
Core earnings (post-tax)	$	513		$	345		$	456		$	305		$	(57	)	$	1,562
Income tax on core earnings (see above)		74			119			92			57			(4	)		338
Core earnings (pre-tax)	$	587		$	464		$	548		$	362		$	(61	)	$	1,900
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars

					2Q22
(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)			Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
Core earnings (post-tax)	513		$	345	$	456	$	305	$	(57	)	$	1,562
CER adjustment(1)	3			-		10		4		1			18
Core earnings, CER basis (post-tax)	516		$	345	$	466	$	309	$	(56	)	$	1,580
Income tax on core earnings, CER basis(2)	75			119		94		58		(5	)		341
Core earnings, CER basis (pre-tax)	591		$	464	$	560	$	367	$	(61	)	$	1,921
Core earnings (U.S. dollars) - Asia and U.S.<br> segments
Core earnings (post-tax)(3), US	401				$	357
CER adjustment US (1)	(6	)				-
Core earnings, CER basis (post-tax), US	395				$	357

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 2Q22.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

							1Q22
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	681		$	880		$	2,577		$	386		$	(813	)	$	3,711
Income tax (expense) recovery
Core earnings		(74	)		(110	)		(105	)		(61	)		26			(324	)
Items excluded from core earnings		(11	)		(115	)		(405	)		-			46			(485	)
Income tax (expense) recovery		(85	)		(225	)		(510	)		(61	)		72			(809	)
Net income (post-tax)		596			655			2,067			325			(741	)		2,902
Less: Net income (post-tax) attributed to
Non-controlling interests		20			-			-			1			-			21
Participating policyholders		(197	)		108			-			-			-			(89	)
Net income (loss) attributed to shareholders (post-tax)		773			547			2,067			324			(741	)		2,970
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core earnings		64			53			527			-			(86	)		558
Direct impact of equity markets and interest rates and variable annuity guarantee liabilities		180			180			212			-			(475	)		97
Change in actuarial methods and assumptions		-			-			-			-			-			-
Restructuring charge		-			-			-			-			-			-
Reinsurance transactions, tax related items and<br><br> <br>other		(8	)		-			842			-			(71	)		763
Core earnings (post-tax)	$	537		$	314		$	486		$	324		$	(109	)	$	1,552
Income tax on core earnings (see above)		74			110			105			61			(26	)		324
Core earnings (pre-tax)	$	611		$	424		$	591		$	385		$	(135	)	$	1,876
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars

					1Q22
(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)			Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
Core earnings (post-tax)	537		$	314	$	486	$	324	$	(109	)	$	1,552
CER adjustment(1)	(7	)		-		15		6		1			15
Core earnings, CER basis (post-tax)	530		$	314	$	501	$	330	$	(108	)	$	1,567
Income tax on core earnings, CER basis(2)	73			110		108		61		(26	)		326
Core earnings, CER basis (pre-tax)	603		$	424	$	609	$	391	$	(134	)	$	1,893
Core earnings (U.S. dollars) - Asia and U.S. segments
Core earnings (post-tax)(3), US	424				$	384
CER adjustment US (1)	(18	)				-
Core earnings, CER basis (post-tax), US	406				$	384

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 1Q22.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

							4Q21
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	684		$	806		$	614		$	438		$	(61	)	$	2,481
Income tax (expense) recovery
Core earnings		(68	)		(101	)		(117	)		(52	)		(8	)		(346	)
Items excluded from core earnings		(15	)		(77	)		(4	)		2			10			(84	)
Income tax (expense) recovery		(83	)		(178	)		(121	)		(50	)		2			(430	)
Net income (post-tax)		601			628			493			388			(59	)		2,051
Less: Net income (post-tax) attributed to
Non-controlling interests		32			-			-			1			(1	)		32
Participating policyholders		(76	)		12			(1	)		-			-			(65	)
Net income (loss) attributed to shareholders<br><br> <br>(post-tax)		645			616			494			387			(58	)		2,084
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core<br><br> <br>earnings		58			90			58			-			(80	)		126
Direct impact of equity markets and interest<br><br> <br>rates and variable annuity guarantee<br><br> <br>liabilities		32			240			125			-			1			398
Change in actuarial methods and assumptions		-			-			-			-			-			-
Restructuring charge		-			-			-			-			-			-
Reinsurance transactions, tax related items<br><br> and other		8			-			(156	)		-			-			(148	)
Core earnings (post-tax)	$	547		$	286		$	467		$	387		$	21		$	1,708
Income tax on core earnings (see above)		68			101			117			52			8			346
Core earnings (pre-tax)	$	615		$	387		$	584		$	439		$	29		$	2,054
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars

					4Q21
(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)			Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other		Total
Core earnings (post-tax)	547		$	286	$	467	$	387	$	21	$	1,708
CER adjustment(1)	(3	)		-		16		10		1		24
Core earnings, CER basis (post-tax)	544		$	286	$	483	$	397	$	22	$	1,732
Income tax on core earnings, CER basis(2)	68			101		122		51		7		349
Core earnings, CER basis (pre-tax)	612		$	387	$	605	$	448	$	29	$	2,081
Core earnings (U.S. dollars) - Asia and U.S. segments
Core earnings (post-tax)(3), US	435				$	370
CER adjustment US (1)	(18	)				-
Core earnings, CER basis (post-tax), US	417				$	370

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 4Q21.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

							3Q21
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	650		$	(101	)	$	800		$	418		$	(287	)	$	1,480
Income tax (expense) recovery
Core earnings		(52	)		(109	)		(79	)		(66	)		12			(294	)
Items excluded from core earnings		(31	)		153			(16	)		(1	)		23			128
Income tax (expense) recovery		(83	)		44			(95	)		(67	)		35			(166	)
Net income (post-tax)		567			(57	)		705			351			(252	)		1,314
Less: Net income (post-tax) attributed to
Non-controlling interests		48			-			-			-			-			48
Participating policyholders		(303	)		(31	)		8			-			-			(326	)
Net income (loss) attributed to shareholders<br><br> <br>(post-tax)		822			(26	)		697			351			(252	)		1,592
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core<br><br> <br>earnings		62			97			617			-			(76	)		700
Direct impact of equity markets and interest rates<br><br> <br>and variable annuity guarantee liabilities		(129	)		(369	)		(96	)		-			(3	)		(597	)
Change in actuarial methods and assumptions		343			(65	)		(314	)		-			(5	)		(41	)
Restructuring charge		-			-			-			-			-			-
Reinsurance transactions, tax related items and<br><br> <br>other		13			-			-			-			-			13
Core earnings (post-tax)	$	533		$	311		$	490		$	351		$	(168	)	$	1,517
Income tax on core earnings (see above)		52			109			79			66			(12	)		294
Core earnings (pre-tax)	$	585		$	420		$	569		$	417		$	(180	)	$	1,811
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars

					3Q21
(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)			Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
Core earnings (post-tax)	533		$	311	$	490	$	351	$	(168	)	$	1,517
CER adjustment(1)	(8	)		-		18		6		(4	)		12
Core earnings, CER basis (post-tax)	525		$	311	$	508	$	357	$	(172	)	$	1,529
Income tax on core earnings, CER basis(2)	51			110		82		67		(12	)		298
Core earnings, CER basis (pre-tax)	576		$	421	$	590	$	424	$	(184	)	$	1,827
Core earnings (U.S. dollars) - Asia and U.S.<br> segments
Core earnings (post-tax)(3), US	424				$	389
CER adjustment US (1)	(22	)				-
Core earnings, CER basis (post-tax), US	402				$	389

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 3Q21.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

	YTD 2022
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	1,373		$	1,923		$	4,353		$	1,143		$	(2,187	)	$	6,605
Income tax (expense) recovery
Core earnings		(209	)		(345	)		(259	)		(168	)		48			(933	)
Items excluded from core earnings		35			(126	)		(539	)		-			164			(466	)
Income tax (expense) recovery		(174	)		(471	)		(798	)		(168	)		212			(1,399	)
Net income (post-tax)		1,199			1,452			3,555			975			(1,975	)		5,206
Less: Net income (post-tax) attributed to
Non-controlling interests		(10	)		-			-			1			1			(8	)
Participating policyholders		(446	)		242			15			-			-			(189	)
Net income (loss) attributed to shareholders<br><br> <br>(post-tax)		1,655			1,210			3,540			974			(1,976	)		5,403
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core<br><br> <br>earnings		141			236			1,245			-			(348	)		1,274
Direct impact of equity markets and interest rates<br><br> <br>and variable annuity guarantee liabilities		43			(70	)		134			-			(1,131	)		(1,024	)
Change in actuarial methods and assumptions		(45	)		35			36			-			10			36
Restructuring charge		-			-			-			-			-			-
Reinsurance transactions, tax related items and<br><br> <br>other		(47	)		-			799			-			(71	)		681
Core earnings (post-tax)	$	1,563		$	1,009		$	1,326		$	974		$	(436	)	$	4,436
Income tax on core earnings (see above)		209			345			259			168			(48	)		933
Core earnings (pre-tax)	$	1,772		$	1,354		$	1,585		$	1,142		$	(484	)	$	5,369
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars


(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)			Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
Core earnings (post-tax)	1,563		$	1,009	$	1,326	$	974	$	(436	)	$	4,436
CER adjustment(1)	(4	)		-		25		10		2			33
Core earnings, CER basis (post-tax)	1,559		$	1,009	$	1,351	$	984	$	(434	)	$	4,469
Income tax on core earnings, CER basis(2)	209			345		264		169		(49	)		938
Core earnings, CER basis (pre-tax)	1,768		$	1,354	$	1,615	$	1,153	$	(483	)	$	5,407
Core earnings (U.S. dollars) - Asia and U.S.<br> segments
Core earnings (post-tax)(3), US	1,219				$	1,035
CER adjustment US (1)	(24	)				-
Core earnings, CER basis (post-tax), US	1,195				$	1,035

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the three respective quarters that make up 2022 year-to-date core<br> earnings.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

	YTD 2021
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	2,504		$	985		$	1,870		$	1,203		$	(918	)	$	5,644
Income tax (expense) recovery
Core earnings		(254	)		(312	)		(301	)		(182	)		35			(1,014	)
Items excluded from core earnings		(107	)		154			36			(1	)		149			231
Income tax (expense) recovery		(361	)		(158	)		(265	)		(183	)		184			(783	)
Net income (post-tax)		2,143			827			1,605			1,020			(734	)		4,861
Less: Net income (post-tax) attributed to
Non-controlling interests		222			-			-			1			-			223
Participating policyholders		(491	)		89			19			-			-			(383	)
Net income (loss) attributed to shareholders<br><br> <br>(post-tax)		2,412			738			1,586			1,019			(734	)		5,021
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core<br><br> <br>earnings		255			239			1,283			-			(261	)		1,516
Direct impact of equity markets and interest rates<br><br> <br>and variable annuity guarantee liabilities		137			(329	)		(852	)		-			(171	)		(1,215	)
Change in actuarial methods and assumptions		343			(65	)		(314	)		-			(5	)		(41	)
Restructuring charge		-			-			-			-			(115	)		(115	)
Reinsurance transactions, tax related items and<br><br> <br>other		48			-			-			-			-			48
Core earnings (post-tax)	$	1,629		$	893		$	1,469		$	1,019		$	(182	)	$	4,828
Income tax on core earnings (see above)		254			312			301			182			(35	)		1,014
Core earnings (pre-tax)	$	1,883		$	1,205		$	1,770		$	1,201		$	(217	)	$	5,842
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars


(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)			Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
Core earnings (post-tax)	1,629		$	893	$	1,469	$	1,019	$	(182	)	$	4,828
CER adjustment(1)	(22	)		1		64		27		(2	)		68
Core earnings, CER basis (post-tax)	1,607		$	894	$	1,533	$	1,046	$	(184	)	$	4,896
Income tax on core earnings, CER basis(2)	251			313		314		184		(34	)		1,028
Core earnings, CER basis (pre-tax)	1,858		$	1,207	$	1,847	$	1,230	$	(218	)	$	5,924
Core earnings (U.S. dollars) - Asia and U.S. segments
Core earnings (post-tax)(3), US	1,301				$	1,174
CER adjustment US (1)	(69	)				-
Core earnings, CER basis (post-tax), US	1,232				$	1,174

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the three respective quarters that make up 2021 year-to-date core<br> earnings.
---	---

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of core earnings to net income attributed to shareholders

	2021
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Income (loss) before income taxes	$	3,188		$	1,791		$	2,484		$	1,641		$	(979	)	$	8,125
Income tax (expense) recovery
Core earnings		(322	)		(413	)		(418	)		(234	)		27			(1,360	)
Items excluded from core earnings		(122	)		77			32			1			159			147
Income tax (expense) recovery		(444	)		(336	)		(386	)		(233	)		186			(1,213	)
Net income (post-tax)		2,744			1,455			2,098			1,408			(793	)		6,912
Less: Net income (post-tax) attributed to
Non-controlling interests		254			-			-			2			(1	)		255
Participating policyholders		(567	)		101			18			-			-			(448	)
Net income (loss) attributed to shareholders<br><br> <br>(post-tax)		3,057			1,354			2,080			1,406			(792	)		7,105
Less: Items excluded from core earnings^(1)^
Investment-related experience outside of core<br><br> <br>earnings		313			329			1,341			-			(341	)		1,642
Direct impact of equity markets and interest rates<br><br> <br>and variable annuity guarantee liabilities		169			(89	)		(727	)		-			(170	)		(817	)
Change in actuarial methods and assumptions		343			(65	)		(314	)		-			(5	)		(41	)
Restructuring charge		-			-			-			-			(115	)		(115	)
Reinsurance transactions, tax related items and<br><br> <br>other		56			-			(156	)		-			-			(100	)
Core earnings (post-tax)	$	2,176		$	1,179		$	1,936		$	1,406		$	(161	)	$	6,536
Income tax on core earnings (see above)		322			413			418			234			(27	)		1,360
Core earnings (pre-tax)	$	2,498		$	1,592		$	2,354		$	1,640		$	(188	)	$	7,896
^(1)^	These items are disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline.
---	---

Core earnings, CER basis and U.S. dollars


(Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)			Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
Core earnings (post-tax)	2,176		$	1,179	$	1,936	$	1,406	$	(161	)	$	6,536
CER adjustment(1)	(24	)		-		80		37		(1	)		92
Core earnings, CER basis (post-tax)	2,152		$	1,179	$	2,016	$	1,443	$	(162	)	$	6,628
Income tax on core earnings, CER basis(2)	319			413		436		236		(27	)		1,377
Core earnings, CER basis (pre-tax)	2,471		$	1,592	$	2,452	$	1,679	$	(189	)	$	8,005
Core earnings (U.S. dollars) - Asia and U.S. segments
Core earnings (post-tax)(3), US	1,736				$	1,544
CER adjustment US (1)	(87	)				-
Core earnings, CER basis (post-tax), US	1,649				$	1,544

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---
^(3)^	Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rates for the four respective quarters that make up 2021 core earnings.
---	---

Manulife Financial Corporation – Third Quarter 2022

Segment core earnings by business line or geographic source

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

Asia

															YTD Results						Full Year<br><br> <br>Results
(US millions)	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Hong Kong	217		$	216		$	219		$	270		$	248		$	652		$	679		$	949
Japan	89			84			77			77			86			250			246			323
Asia Other(1)	115			132			156			132			125			403			487			619
Mainland China																						96
Singapore																						162
Vietnam																						290
Other Emerging Markets(2)																						71
Regional Office	(27	)		(31	)		(28	)		(44	)		(35	)		(86	)		(111	)		(155	)
Total Asia core earnings	394		$	401		$	424		$	435		$	424		$	1,219		$	1,301		$	1,736

All values are in US Dollars.

^(1)^	Core earnings for Asia Other is reported by country annually, on a full year basis.
^(2)^	Other Emerging Markets includes Indonesia, the Philippines, Malaysia, Thailand, Cambodia and Myanmar.
---	---
															YTD Results						Full Year<br><br> <br>Results
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
(US millions), CER basis(1)	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Hong Kong	217		$	216		$	219		$	270		$	248		$	652		$	679		$	949
Japan	89			79			64			64			68			232			193			257
Asia Other(2)	115			131			151			127			121			397			471			598
Mainland China																						90
Singapore																						156
Vietnam																						287
Other Emerging Markets(3)																						65
Regional Office	(27	)		(31	)		(28	)		(44	)		(35	)		(86	)		(111	)		(155	)
Total Asia core earnings, CER basis	394		$	395		$	406		$	417		$	402		$	1,195		$	1,232		$	1,649

All values are in US Dollars.

^(1)^	Core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
^(2)^	Core earnings for Asia Other is reported by country annually, on a full year basis.
---	---
^(3)^	Other Emerging Markets includes Indonesia, the Philippines, Malaysia, Thailand, Cambodia and Myanmar.
---	---

Canada

										YTD Results				Full Year<br><br> <br>Results
(Canadian millions)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Insurance	240	$	233	$	206	$	184	$	211	$	679	$	586	$	770
Annuities	56		68		70		62		56		194		172		234
Manulife Bank	54		44		38		40		44		136		135		175
Total Canada core earnings	350	$	345	$	314	$	286	$	311	$	1,009	$	893	$	1,179

All values are in US Dollars.

U.S.

										YTD Results				Full Year<br><br> <br>Results
(US millions)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
U.S. Insurance	244	$	316	$	328	$	274	$	279	$	888	$	854	$	1,128
U.S. Annuities	50		41		56		96		110		147		320		416
Total U.S. core earnings	294	$	357	$	384	$	370	$	389	$	1,035	$	1,174	$	1,544

All values are in US Dollars.

Manulife Financial Corporation – Third Quarter 2022

Global WAM by business line

										YTD Results				Full Year<br><br> <br>Results
(Canadian millions)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Retirement	193	$	165	$	177	$	218	$	206	$	535	$	601	$	819
Retail	137		126		141		160		136		404		391		551
Institutional asset<br> management	15		14		6		9		9		35		27		36
Total Global WAM core earnings	345	$	305	$	324	$	387	$	351	$	974	$	1,019	$	1,406

All values are in US Dollars.

										YTD Results				Full Year<br><br> <br>Results
(Canadian millions), CER basis(1)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Retirement	193	$	168	$	181	$	225	$	211	$	542	$	622	$	846
Retail	137		127		143		162		138		407		398		561
Institutional asset<br> management	15		14		6		10		8		35		26		36
Total Global WAM core earnings,<br> CER basis	345	$	309	$	330	$	397	$	357	$	984	$	1,046	$	1,443

All values are in US Dollars.

^(1)^	Core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.

Global WAM by geographic source

										YTD Results				Full Year<br><br> <br>Results
(Canadian millions)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Asia	75	$	76	$	86	$	88	$	103	$	237	$	309	$	397
Canada	116		109		108		119		106		333		310		429
U.S.	154		120		130		180		142		404		400		580
Total Global WAM core earnings	345	$	305	$	324	$	387	$	351	$	974	$	1,019	$	1,406

All values are in US Dollars.

										YTD Results				Full Year<br><br> <br>Results
(Canadian millions), CER basis(1)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Asia	75	$	78	$	87	$	92	$	105	$	240	$	318	$	410
Canada	116		109		108		119		105		333		310		429
U.S.	154		122		135		186		147		411		418		604
Total Global WAM core earnings, CER basis	345	$	309	$	330	$	397	$	357	$	984	$	1,046	$	1,443

All values are in US Dollars.

^(1)^	Core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.

Corporate and Other

															YTD Results						Full Year<br><br> <br>Results
(Canadian millions)	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Corporate and Other excluding core investment gains	(370	)	$	(157	)	$	(209	)	$	(79	)	$	(268	)	$	(736	)	$	(482	)	$	(561	)
Core investment gains	100			100			100			100			100			300			300			400
Total Corporate and Other core earnings	(270	)	$	(57	)	$	(109	)	$	21		$	(168	)	$	(436	)	$	(182	)	$	(161	)

All values are in US Dollars.

Manulife Financial Corporation – Third Quarter 2022

Core earnings available to common shareholders is

    a financial measure that is used in the calculation of core ROE and core EPS. It is calculated as core earnings \(post-tax\) less preferred share dividends.

					Quarterly<br> Results										YTD<br> Results							Full Year<br><br> <br>Results
( millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Core earnings	1,322		$	1,562		$	1,552		$	1,708		$	1,517		$	4,436		$	4,828		$	6,536
Less: Preferred share<br> dividends	(51	)		(60	)		(52	)		(71	)		(37	)		(163	)		(144	)		(215	)
Core earnings available to<br> common shareholders	1,271			1,502			1,500			1,637			1,480			4,273			4,684			6,321
CER adjustment(1)	-			18			15			24			12			33			68			92
Core earnings available to<br> common shareholders,<br> CER basis	1,271		$	1,520		$	1,515		$	1,661		$	1,492		$	4,306		$	4,752		$	6,413

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.

Core ROE measures profitability using core earnings available to common shareholders as a percentage of the capital deployed to earn the core earnings. The Company calculates core ROE using average common shareholders’ equity quarterly, as the average of common shareholders’ equity at the start and end of the quarter, and annually, as the average of the quarterly average common shareholders’ equity for the year.

															YTD Results						Full Year<br><br> <br>Results
( millions, unless otherwise stated)	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Core earnings available to<br> common shareholders	1,271		$	1,502		$	1,500		$	1,637		$	1,480		$	4,273		$	4,684		$	6,321
Annualized core earnings<br> available to common<br> shareholders	5,045		$	6,022		$	6,085		$	6,483		$	5,874		$	5,714		$	6,262		$	6,321
Average common<br> shareholders’ equity (see<br> below)	49,129		$	49,814		$	51,407		$	51,049		$	49,075		$	50,117		$	47,601		$	48,463
Core ROE (annualized) (%)	10.3	%		12.1	%		11.8	%		12.7	%		12.0	%		11.4	%		13.2	%		13.0	%
Average common<br> shareholders’ equity
Total shareholders' and other<br> equity	56,078		$	55,500		$	56,457		$	58,408		$	55,457		$	56,078		$	55,457		$	58,408
Less: Preferred shares and<br> other equity	(6,660	)		(6,660	)		(5,670	)		(6,381	)		(5,387	)		(6,660	)		(5,387	)		(6,381	)
Common shareholders'<br> equity	49,418		$	48,840		$	50,787		$	52,027		$	50,070		$	49,418		$	50,070		$	52,027
Average common<br> shareholders’ equity	49,129		$	49,814		$	51,407		$	51,049		$	49,075		$	50,117		$	47,601		$	48,463

All values are in US Dollars.

Manulife Financial Corporation – Third Quarter 2022

Core EPS is equal to core earnings available to common shareholders divided by diluted weighted average common shares outstanding.

										YTD Results				Full Year<br><br> <br>Results
( millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Core EPS
Core earnings available to<br> common shareholders	1,271	$	1,502	$	1,500	$	1,637	$	1,480	$	4,273	$	4,684	$	6,321
Diluted weighted average<br> common shares outstanding<br> (millions)	1,904		1,924		1,942		1,946		1,946		1,923		1,946		1,946
Core earnings per share	0.67	$	0.78	$	0.77	$	0.84	$	0.76	$	2.22	$	2.41	$	3.25
Core EPS, CER basis
Core earnings available to<br> common shareholders, CER<br> basis	1,271	$	1,520	$	1,515	$	1,661	$	1,492	$	4,306	$	4,752	$	6,413
Diluted weighted average<br> common shares outstanding<br> (millions)	1,904		1,924		1,942		1,946		1,946		1,923		1,946		1,946
Core earnings per share,<br> CER basis	0.67	$	0.79	$	0.78	$	0.85	$	0.77	$	2.24	$	2.44	$	3.30

All values are in US Dollars.

Core earnings related to strategic priorities

The Company measures its progress on certain strategic priorities using core earnings, including core earnings from highest potential businesses. The core earnings for these businesses is calculated consistent with our definition of core earnings.

Highest potential businesses

For the nine months ended September 30,
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period)	2022			2021
Core earnings highest potential businesses^(1)^	$	2,928		$	3,041
Core earnings - All other businesses excl. core investment gains		1,208			1,487
Core investment gains		300			300
Core earnings		4,436			4,828
Items excluded from core earnings		967			193
Net income (loss) attributed to shareholders	$	5,403		$	5,021
Highest Potential Businesses core earnings contribution		66	%		63	%
^(1)^	Includes core earnings from Asia and Global WAM segments, Canada group benefits, and behavioural insurance products.
---	---

The effective tax rate on core earnings is equal to income tax on core earnings divided by pre-tax core earnings.

The Company also uses financial performance measures that are prepared on a constant exchange rate basis, which exclude the impact of currency fluctuations (from local currency to Canadian dollars at a total Company level and from local currency to U.S. dollars in Asia). Such financial measures may be stated on a constant exchange rate basis or the percentage growth/decline in the financial measure on a constant exchange rate basis, using the income statement and balance sheet exchange rates effective for the third quarter of 2022.

Information supporting constant exchange rate basis for GAAP and non-GAAP financial measures is presented below and throughout the rest of this section.

Manulife Financial Corporation – Third Quarter 2022

Net income financial measures on a CER basis

($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

															YTD Results						Full Year<br><br> <br>Results
	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Net income (loss) attributed to<br> shareholders:
Asia	521		$	361		$	773		$	645		$	822		$	1,655		$	2,412		$	3,057
Canada	578			85			547			616			(26	)		1,210			738			1,354
U.S.	641			832			2,067			494			697			3,540			1,586			2,080
Global WAM	345			305			324			387			351			974			1,019			1,406
Corporate and Other	(738	)		(497	)		(741	)		(58	)		(252	)		(1,976	)		(734	)		(792	)
Total net income (loss) attributed<br> to shareholders	1,347			1,086			2,970			2,084			1,592			5,403			5,021			7,105
Preferred share dividends and other<br> equity distributions	(51	)		(60	)		(52	)		(71	)		(37	)		(163	)		(144	)		(215	)
Common shareholders net<br> income (loss)	1,296		$	1,026		$	2,918		$	2,013		$	1,555		$	5,240		$	4,877		$	6,890
CER adjustment(1)
Asia	-		$	25		$	50		$	37		$	6		$	75		$	75		$	113
Canada	-			-			-			-			-			-			-			-
U.S.	-			13			60			21			31			73			96			117
Global WAM	-			4			4			9			2			8			21			30
Corporate and Other	-			(6	)		(13	)		(1	)		(6	)		(19	)		3			1
Total net income (loss) attributed<br> to shareholders	-			36			101			66			33			137			195			261
Preferred share dividends and other<br> equity distributions	-			-			-			-			-			-			-			-
Common shareholders net<br> income (loss)	-		$	36		$	101		$	66		$	33		$	137		$	195		$	261
Net income (loss) attributed to<br> shareholders, CER basis
Asia	521		$	386		$	823		$	682		$	828		$	1,730		$	2,487		$	3,170
Canada	578			85			547			616			(26	)		1,210			738			1,354
U.S.	641			845			2,127			515			728			3,613			1,682			2,197
Global WAM	345			309			328			396			353			982			1,040			1,436
Corporate and Other	(738	)		(503	)		(754	)		(59	)		(258	)		(1,995	)		(731	)		(791	)
Total net income (loss) attributed<br> to shareholders, CER basis	1,347			1,122			3,071			2,150			1,625			5,540			5,216			7,366
Preferred share dividends and other<br> equity distributions, CER basis	(51	)		(60	)		(52	)		(71	)		(37	)		(163	)		(144	)		(215	)
Common shareholders net<br> income (loss), CER basis	1,296		$	1,062		$	3,019		$	2,079		$	1,588		$	5,377		$	5,072		$	7,151
Asia net income attributed to<br> shareholders, U.S. dollars
Asia net income (loss) attributed to<br> shareholders, US (2)	399		$	283		$	610		$	513		$	654		$	1,292		$	1,924		$	2,437
CER adjustment, US (1)	-			12			22			9			(20	)		34			(18	)		(9	)
Asia net income (loss)<br> attributed to shareholders,<br> U.S. , CER basis(1)	399		$	295		$	632		$	522		$	634		$	1,326		$	1,906		$	2,428
Net income (loss) attributed to<br> shareholders (pre-tax)
Net income (loss) attributed to<br> shareholders (post-tax)	1,347		$	1,086		$	2,970		$	2,084		$	1,592		$	5,403		$	5,021		$	7,105
Tax on net income attributed to<br> shareholders	310			188			778			440			171			1,276			745			1,185
Net income (loss) attributed to<br> shareholders (pre-tax)	1,657			1,274			3,748			2,524			1,763			6,679			5,766			8,290
CER adjustment(1)	-			37			92			24			35			129			24			48
Net income (loss) attributed to<br> shareholders (pre-tax), CER basis	1,657		$	1,311		$	3,840		$	2,548		$	1,798		$	6,808		$	5,790		$	8,338

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
^(2)^	Asia net income attributed to shareholders (post-tax) in Canadian dollars is translated to U.S. dollars using the U.S. dollar Statement of Income rate for the reporting period.
---	---

Manulife Financial Corporation – Third Quarter 2022

Basic EPS and diluted EPS, CER basis

($ millions, unless otherwise stated)

	Quarterly Results										YTD Results				Full Year<br><br> <br>Results
		3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Common shareholders net<br><br> <br>income, CER basis^(1)^	$	1,296	$	1,062	$	3,019	$	2,079	$	1,588	$	5,377	$	5,072	$	7,151
Weighted average common<br><br> <br>shares outstanding (millions)		1,902		1,921		1,938		1,943		1,942		1,920		1,942		1,942
Basic EPS, CER basis	$	0.68	$	0.55	$	1.56	$	1.07	$	0.82	$	2.80	$	2.61	$	3.68
Common shareholders net<br><br> <br>income, CER basis^(1)^	$	1,296	$	1,062	$	3,019	$	2,079	$	1,588	$	5,377	$	5,072	$	7,151
Diluted weighted average<br><br> <br>common shares outstanding<br><br> <br>(millions)		1,904		1,924		1,942		1,946		1,946		1,923		1,946		1,946
Diluted EPS, CER basis	$	0.68	$	0.55	$	1.55	$	1.07	$	0.82	$	2.80	$	2.61	$	3.68
^(1)^	Common shareholders net income adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---

General expenses, CER basis

($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

	Quarterly Results										YTD Results				Full Year<br><br> <br>Results
		3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
General expenses	$	1,900	$	1,843	$	1,898	$	2,000	$	1,904	$	5,641	$	5,828	$	7,828
CER adjustment^(1)^		-		11		1		7		1		12		18		25
General expenses, CER<br><br> <br>basis	$	1,900	$	1,854	$	1,899	$	2,007	$	1,905	$	5,653	$	5,846	$	7,853
^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
---	---

Global WAM revenue, CER basis

($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

	Quarterly Results												YTD Results					Full Year<br><br> <br>Results
		3Q22		2Q22			1Q22			4Q21		3Q21		2022			2021		2021
Total revenue	$	7,777	$	(2,401	)	$	(3,630	)	$	21,611	$	15,983	$	1,746		$	40,210	$	61,821
Less: Revenue for segments<br><br> <br>other than Global WAM		6,235		(3,922	)		(5,216	)		19,884		14,303		(2,903	)		35,396		55,280
Global WAM revenue		1,542		1,521			1,586			1,727		1,680		4,649			4,814		6,541
CER adjustment^(1)^		-		19			25			33		27		44			107		140
Global WAM revenue, CER<br><br> <br>basis	$	1,542	$	1,540		$	1,611		$	1,760	$	1,707	$	4,693		$	4,921	$	6,681
^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
---	---

Common share core dividend payout ratio is a ratio that measures the percentage of core earnings paid to common shareholders as dividends. It is calculated as dividends per common share divided by core EPS.

	Quarterly Results															YTD Results						Full Year<br><br> <br>Results
		3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Per share dividend	$	0.33		$	0.33		$	0.33		$	0.33		$	0.28		$	0.99		$	0.84		$	1.17
Core EPS	$	0.67		$	0.78		$	0.77		$	0.84		$	0.76		$	2.22		$	2.41		$	3.25
Common share core dividend payout ratio		49	%		42	%		43	%		39	%		37	%		45	%		35	%		36	%

AUMA is a financial measure of the size of the Company. It is comprised of AUM and AUA. AUM includes assets of general account, consisting of total invested assets and segregated funds net assets, and external client assets for which we provide investment management services, consisting of mutual fund, institutional asset management and other fund net assets. AUA are assets for which we provide administrative services only. Assets under management and administration is a common industry metric for wealth and asset management businesses.

Manulife Financial Corporation – Third Quarter 2022

Our Global WAM business also manages assets on behalf of other segments of the Company. Global WAM-managed AUMA is a financial measure equal to the sum of Global WAM’s AUMA and assets managed by Global WAM on behalf of other segments. It is an important measure of the assets managed by Global WAM.

AUM and AUMA reconciliations

(Canadian $ in millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

												US (4)
												September 30, 2022
As at	Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total		Asia	U.S.
Total Invested Assets
Manulife Bank net<br> lending assets	$	24,637	$	-	$	-	$	-		$	24,637		$	-
Derivative<br> reclassification(1)		-		-		-		5,880			5,880			-
Invested assets<br> excluding above items		85,164		154,739		3,741		15,846			380,775			112,615
Total		109,801		154,739		3,741		21,726			411,292			112,615
Segregated funds net<br> assets
Segregated funds net<br> assets - Institutional		-		-		4,118		-			4,118			-
Segregated funds net<br> assets - Other(2)		34,773		63,996		210,352		(26	)		331,127			46,575
Total		34,773		63,996		214,470		(26	)		335,245			46,575
AUM per financial<br> statements		144,574		218,735		218,211		21,700			746,537			159,190
Mutual funds		-		-		249,520		-			249,520			-
Institutional asset<br> management(3)		-		-		100,361		-			100,361			-
Other funds		-		-		12,910		-			12,910			-
Total AUM		144,574		218,735		581,002		21,700			1,109,328			159,190
Assets under<br> administration		-		-		167,759		-			167,759			-
Total AUMA	$	144,574	$	218,735	$	748,761	$	21,700		$	1,277,087		$	159,190
Total AUMA, US (4)										$	929,433
Total AUMA	$	144,574	$	218,735	$	748,761	$	21,700		$	1,277,087
CER adjustment(5)		-		-		-		-			-
Total AUMA, CER basis	$	144,574	$	218,735	$	748,761	$	21,700		$	1,277,087
Global WAM Managed<br> AUMA
Global WAM AUMA					$	748,761
AUM managed by Global<br> WAM for Manulife's other segments						220,637
Total					$	969,398

All values are in US Dollars.

^(1)^	Corporate and Other consolidation adjustment related to net derivative assets reclassified from total invested assets to other lines on the Statement of Financial Position.
^(2)^	Corporate and Other segregated funds net asset represents elimination of amounts held by the Company.
---	---
^(3)^	Institutional asset management excludes Institutional segregated funds net assets.
---	---
^(4)^	US $ AUMA is calculated as total AUMA in Canadian $ divided by the US $ exchange rate in effect at the end of the quarter.
---	---
^(5)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
---	---

Manulife Financial Corporation – Third Quarter 2022

				CAD								US (4)
												June 30, 2022
As at		Canada		U.S.	Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total		Asia	U.S.
Total Invested Assets
Manulife Bank net<br> lending assets	-	$	24,500		$	-	$	-		$	24,500		$	-
Derivative<br> reclassification(1)	-		-			-		5,233			5,233			-
Invested assets<br> excluding above items	117,128		82,755			3,967		19,240			372,596			115,901
Total	117,128		107,255			3,967		24,473			402,329			115,901
Segregated funds net<br> assets
Segregated funds net<br> assets - Institutional	-		-			4,098		-			4,098			-
Segregated funds net<br> assets - Other(2)	21,874		35,577			209,181		(27	)		330,805			49,770
Total	21,874		35,577			213,279		(27	)		334,903			49,770
AUM per financial<br> statements	139,002		142,832			217,246		24,446			737,232			165,671
Mutual funds	-		-			250,445		-			250,445			-
Institutional asset<br> management(3)	-		-			100,205		-			100,205			-
Other funds	-		-			12,110		-			12,110			-
Total AUM	139,002		142,832			580,006		24,446			1,099,992			165,671
Assets under<br> administration	-		-			164,697		-			164,697			-
Total AUMA	139,002	$	142,832		$	744,703	$	24,446		$	1,264,689		$	165,671
Total AUMA, US (4)										$	980,379
Total AUMA	139,002	$	142,832		$	744,703	$	24,446		$	1,264,689
CER adjustment(5)	5,514		-			33,035		-			52,443
Total AUMA, CER basis	144,516	$	142,832		$	777,738	$	24,446		$	1,317,132
Global WAM Managed<br> AUMA
Global WAM AUMA					$	744,703
AUM managed by Global<br> WAM for Manulife's<br> other segments						220,103
Total					$	964,806

All values are in US Dollars.

Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at September 30, 2022 above.

Manulife Financial Corporation – Third Quarter 2022

				CAD									US (4)
													March 31, 2022
As at		Canada		U.S.	Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total			Asia	U.S.
Total Invested Assets
Manulife Bank net<br> lending assets	-	$	24,004		$	-	$	-		$	24,004			$	-
Derivative<br> reclassification(1)	-		-			-		(270	)		(270	)			-
Invested assets<br> excluding above items	120,529		88,736			3,468		21,945			385,667				120,830
Total	120,529		112,740			3,468		21,675			409,401				120,830
Segregated funds net<br> assets
Segregated funds net<br> assets - Institutional	-		-			4,338		-			4,338				-
Segregated funds net<br> assets - Other(2)	23,868		39,649			232,276		(26	)		367,590				57,476
Total	23,868		39,649			236,614		(26	)		371,928				57,476
AUM per financial<br> statements	144,397		152,389			240,082		21,649			781,329				178,306
Mutual funds	-		-			274,665		-			274,665				-
Institutional asset<br> management(3)	-		-			101,105		-			101,105				-
Other funds	-		-			13,269		-			13,269				-
Total AUM	144,397		152,389			629,121		21,649			1,170,368				178,306
Assets under<br> administration	-		-			178,843		-			178,843				-
Total AUMA	144,397	$	152,389		$	807,964	$	21,649		$	1,349,211			$	178,306
Total AUMA, US (4)										$	1,079,714
Total AUMA	144,397	$	152,389		$	807,964	$	21,649		$	1,349,211
CER adjustment(5)	5,549		-			52,761		-			80,429
Total AUMA, CER basis	149,946	$	152,389		$	860,725	$	21,649		$	1,429,640
Global WAM Managed<br> AUMA
Global WAM AUMA					$	807,964
AUM managed by Global<br> WAM for Manulife's other<br> segments						231,373
Total					$	1,039,337

All values are in US Dollars.

Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at September 30, 2022 above.

Manulife Financial Corporation – Third Quarter 2022

				CAD									US (4)
													December 31, 2021
As at		Canada		U.S.	Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total			Asia	U.S.
Total Invested Assets
Manulife Bank net lending<br> assets	-	$	23,447		$	-	$	-		$	23,447			$	-
Derivative<br> reclassification(1)	-		-			-		(7,475	)		(7,475	)			-
Invested assets excluding<br> above items	129,207		96,425			4,458		16,206			411,126				130,013
Total	129,207		119,872			4,458		8,731			427,098				130,013
Segregated funds net assets
Segregated funds net<br> assets - Institutional	-		-			4,470		-			4,470				-
Segregated funds net<br> assets - Other(2)	25,505		42,124			248,097		(28	)		395,318				62,801
Total	25,505		42,124			252,567		(28	)		399,788				62,801
AUM per financial<br> statements	154,712		161,996			257,025		8,703			826,886				192,814
Mutual funds	-		-			290,863		-			290,863				-
Institutional asset<br> management(3)	-		-			106,407		-			106,407				-
Other funds	-		-			14,001		-			14,001				-
Total AUM	154,712		161,996			668,296		8,703			1,238,157				192,814
Assets under<br> administration	-		-			187,631		-			187,631				-
Total AUMA	154,712	$	161,996		$	855,927	$	8,703		$	1,425,788			$	192,814
Total AUMA, US (4)										$	1,124,616
Total AUMA	154,712	$	161,996		$	855,927	$	8,703		$	1,425,788
CER adjustment(5)	1,955		-			45,465		-			67,839
Total AUMA, CER basis	156,667	$	161,996		$	901,392	$	8,703		$	1,493,627
Global WAM Managed<br> AUMA
Global WAM AUMA					$	855,927
AUM managed by Global WAM for Manulife's other segments						246,773
Total					$	1,102,700

All values are in US Dollars.

Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at September 30, 2022 above.

Manulife Financial Corporation – Third Quarter 2022

													US (4)
													September 30, 2021
As at	Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total			Asia	U.S.
Total Invested Assets
Manulife Bank net<br> lending assets	$	23,139	$	-	$	-	$	-		$	23,139			$	-
Derivative<br> reclassification(1)		-		-		-		(6,226	)		(6,226	)			-
Invested assets<br> excluding above items		94,510		162,720		4,333		15,731			402,174				127,714
Total		117,649		162,720		4,333		9,505			419,087				127,714
Segregated funds net<br> assets
Segregated funds net<br> assets - Institutional		-		-		4,400		-			4,400				-
Segregated funds net<br> assets - Other(2)		40,178		78,223		240,151		(45	)		383,399				61,395
Total		40,178		78,223		244,551		(45	)		387,799				61,395
AUM per financial<br> statements		157,827		240,943		248,884		9,460			806,886				189,109
Mutual funds		-		-		277,421		-			277,421				-
Institutional asset<br> management(3)		-		-		103,732		-			103,732				-
Other funds		-		-		12,562		-			12,562				-
Total AUM		157,827		240,943		642,599		9,460			1,200,601				189,109
Assets under<br> administration		-		-		181,013		-			181,013				-
Total AUMA	$	157,827	$	240,943	$	823,612	$	9,460		$	1,381,614			$	189,109
Total AUMA, US (4)										$	1,084,384
Total AUMA	$	157,827	$	240,943	$	823,612	$	9,460		$	1,381,614
CER adjustment(5)		-		18,839		40,546		-			59,997
Total AUMA, CER basis	$	157,827	$	259,782	$	864,158	$	9,460		$	1,441,611
Global WAM Managed<br> AUMA
Global WAM AUMA					$	823,612
AUM managed by Global WAM for Manulife's<br> other segments						240,798
Total					$	1,064,410

All values are in US Dollars.

Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at September 30, 2022 above.

Manulife Financial Corporation – Third Quarter 2022

Global WAM AUMA and managed AUMA by business line and geographic source

($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

As at	Sept 30,<br><br> <br>2022		Jun 30,<br><br> <br>2022		Mar 31,<br><br> <br>2022		Dec 31,<br><br> <br>2021		Sept 30,<br><br> <br>2021
Global WAM AUMA by business line
Retirement	$	379,687	$	377,674	$	412,689	$	440,831	$	426,742
Retail		263,106		261,354		289,008		303,232		287,717
Institutional asset management		105,968		105,675		106,267		111,864		109,153
Total	$	748,761	$	744,703	$	807,964	$	855,927	$	823,612
Global WAM AUMA by business line, CER basis^(1)^
Retirement	$	379,687	$	396,969	$	444,769	$	469,763	$	453,024
Retail		263,106		271,570		305,522		317,251		300,262
Institutional asset management		105,968		109,199		110,434		114,378		110,872
Total	$	748,761	$	777,738	$	860,725	$	901,392	$	864,158
Global WAM AUMA by geographic source
Asia	$	97,083	$	96,510	$	98,608	$	104,584	$	100,899
Canada		203,988		206,073		227,252		238,798		228,347
U.S.		447,690		442,120		482,104		512,545		494,366
Total	$	748,761	$	744,703	$	807,964	$	855,927	$	823,612
Global WAM AUMA by geographic source, CER basis^(1)^
Asia	$	97,083	$	100,724	$	103,362	$	107,112	$	102,675
Canada		203,988		206,073		227,252		238,798		228,347
U.S.		447,690		470,941		530,111		555,482		533,136
Total	$	748,761	$	777,738	$	860,725	$	901,392	$	864,158
Global WAM Managed AUMA by business line
Retirement	$	379,687	$	377,674	$	412,689	$	440,831	$	426,742
Retail		336,459		335,367		370,999		391,911		373,685
Institutional asset management		253,252		251,765		255,649		269,958		263,983
Total	$	969,398	$	964,806	$	1,039,337	$	1,102,700	$	1,064,410
Global WAM Managed AUMA by business line, CER<br><br> <br>basis^(1)^
Retirement	$	379,687	$	396,969	$	444,769	$	469,763	$	453,024
Retail		336,459		348,586		392,573		410,564		390,490
Institutional asset management		253,252		263,481		272,583		283,896		276,163
Total	$	969,398	$	1,009,036	$	1,109,925	$	1,164,223	$	1,119,677
Global WAM Managed AUMA by geographic source
Asia	$	192,004	$	190,301	$	195,346	$	207,827	$	200,976
Canada		251,603		254,400		279,700		293,902		281,523
U.S.		525,791		520,105		564,291		600,971		581,911
Total	$	969,398	$	964,806	$	1,039,337	$	1,102,700	$	1,064,410
Global WAM Managed AUMA by geographic source,<br><br> <br>CER basis^(1)^
Asia	$	192,004	$	200,624	$	209,742	$	219,002	$	210,606
Canada		251,603		254,400		279,700		293,902		281,523
U.S.		525,791		554,012		620,483		651,319		627,548
Total	$	969,398	$	1,009,036	$	1,109,925	$	1,164,223	$	1,119,677
^(1)^	AUMA adjusted to reflect the foreign exchange rates for the Statement of Financial Position in effect for 3Q22.
---	---

Manulife Financial Corporation – Third Quarter 2022

Average assets under management and administration (“average AUMA”) is the average of Global WAM’s AUMA during the reporting period. It is a measure used in analyzing and explaining fee income and earnings of our Global WAM segment. It is calculated as the average of the opening balance of AUMA and the ending balance of AUMA using daily balances where available and month-end or quarter-end averages when daily averages are unavailable. Similarly, Global WAM average managed AUMA and average AUA are the average of Global WAM’s managed AUMA and AUA, respectively, and are calculated in a manner consistent with average AUMA.

Manulife Bank net lending assets is a financial measure equal to the sum of Manulife Bank’s loans and mortgages, net of allowances. Manulife Bank average net lending assets is a financial measure which is calculated as the quarter-end average of the opening and the ending balance of net lending assets. Both of these financial measures are a measure of the size of Manulife Bank’s portfolio of loans and mortgages and are used to analyze and explain its earnings.

As at<br><br> <br>($ millions)	Sept 30,<br><br> <br>2022		Jun 30,<br><br> <br>2022		Mar 31,<br><br> <br>2022		Dec 31,<br><br> <br>2021		Sept 30,<br><br> <br>2021
Mortgages	$	54,685	$	53,422	$	52,287	$	52,014	$	51,001
Less: mortgages not held by Manulife Bank		32,847		31,704		30,950		31,073		30,202
Total mortgages held by Manulife Bank		21,838		21,718		21,337		20,941		20,799
Loans to bank clients		2,799		2,782		2,667		2,506		2,340
Manulife Bank net lending assets	$	24,637	$	24,500	$	24,004	$	23,447	$	23,139
Manulife Bank average net lending assets
Beginning of period	$	24,500	$	24,004	$	23,447	$	23,139	$	22,884
End of period		24,637		24,500		24,004		23,447		23,139
Manulife Bank average net lending assets by quarter	$	24,569	$	24,252	$	23,726	$	23,293	$	23,012
Manulife Bank average net lending assets – Year-to-date	$	24,042							$	22,951
Manulife Bank average net lending assets – full year							$	23,105

Consolidated capital serves as a foundation of our capital management activities at the MFC level. Consolidated capital is calculated as the sum of: (i) total equity excluding accumulated other comprehensive income (“AOCI”) on cash flow hedges; and (ii) certain other capital instruments that qualify as regulatory capital. For regulatory reporting purposes under the LICAT framework, the numbers are further adjusted for various additions or deductions to capital as mandated by the guidelines defined by OSFI.

As at	Sep 30,			Jun 30,			Mar 31,			Dec 31,			Sep 30,
($ millions)	2022			2022			2022			2021			2021
Total equity	$	56,307		$	55,798		$	56,849		$	58,869		$	55,951
Exclude AOCI gain/(loss) on cash flow hedges		(18	)		(48	)		(70	)		(156	)		(159	)
Total equity excluding AOCI on cash flow hedges		56,325			55,846			56,919			59,025			56,110
Qualifying capital instruments		7,118			7,001			6,950			6,980			6,986
Consolidated capital	$	63,443		$	62,847		$	63,869		$	66,005		$	63,096

Core EBITDA is a financial measure which Manulife uses to better understand the long-term earnings capacity and valuation of our Global WAM business on a basis more comparable to how the profitability of global asset managers is generally measured. Core EBITDA presents core earnings before the impact of interest, taxes, depreciation, and amortization. Core EBITDA excludes certain acquisition expenses related to insurance contracts in our retirement businesses which are deferred and amortized over the expected lifetime of the customer relationship under the CALM. Core EBITDA was selected as a key performance indicator for our Global WAM business, as EBITDA is widely used among asset management peers, and core earnings is a primary profitability metric for the Company overall.

Manulife Financial Corporation – Third Quarter 2022

Reconciliation of Global WAM core earnings to core EBITDA and Global WAM core EBITDA by business line and geographic source

($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

	Quarterly Results										YTD Results				Full Year<br><br> <br>Results
		3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Global WAM core earnings<br><br> <br>(post-tax)	$	345	$	305	$	324	$	387	$	351	$	974	$	1,019	$	1,406
Addback taxes, acquisition<br><br> <br>costs, other expenses and<br><br> <br>deferred sales commissions
Core income tax<br><br> <br>(expense) recovery<br><br> <br>(see above)		50		57		61		52		66		168		182		234
Acquisition costs, other<br><br> <br>expenses		86		80		81		79		86		247		244		323
Deferred sales<br><br> <br>commissions		23		25		24		25		26		72		74		99
Core EBITDA	$	504	$	467	$	490	$	543	$	529	$	1,461	$	1,519	$	2,062
CER adjustment^(1)^		-		5		9		12		11		14		26		38
Core EBITDA, CER basis	$	504	$	472	$	499	$	555	$	540	$	1,475	$	1,545	$	2,100
Core EBITDA by business<br><br> <br>line
Retirement	$	287	$	263	$	277	$	306	$	313	$	827	$	904	$	1,210
Retail		193		179		201		220		199		573		570		790
Institutional asset<br><br> <br>management		24		25		12		17		17		61		45		62
Total	$	504	$	467	$	490	$	543	$	529	$	1,461	$	1,519	$	2,062
Core EBITDA by<br><br> <br>geographic source
Asia	$	111	$	106	$	113	$	115	$	134	$	330	$	396	$	511
Canada		180		171		171		185		172		522		497		682
U.S.		213		190		206		243		223		609		626		869
Total	$	504	$	467	$	490	$	543	$	529	$	1,461	$	1,519	$	2,062
Core EBITDA by business<br><br> <br>line, CER basis^(2)^
Retirement	$	287	$	267	$	284	$	315	$	321	$	838	$	934	$	1,248
Retail		193		180		203		223		201		576		567		790
Institutional asset<br><br> <br>management		24		25		12		17		18		61		44		62
Total, CER basis	$	504	$	472	$	499	$	555	$	540	$	1,475	$	1,545	$	2,100
Core EBITDA by<br><br> <br>geographic source, CER<br><br> <br>basis^(2)^
Asia	$	111	$	107	$	115	$	118	$	137	$	333	$	394	$	512
Canada		180		171		171		185		172		522		497		682
U.S.		213		194		213		252		231		620		654		906
Total, CER basis	$	504	$	472	$	499	$	555	$	540	$	1,475	$	1,545	$	2,100
^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.
---	---
^(2)^	Core EBITDA adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 3Q22.
---	---

Manulife Financial Corporation – Third Quarter 2022

Core EBITDA margin is a financial measure which Manulife uses to better understand the long-term profitability of our Global WAM business on a more comparable basis to how profitability of global asset managers are measured. Core EBITDA margin presents core earnings before the impact of interest, taxes, depreciation, and amortization divided by total revenue from these businesses. Core EBITDA margin was selected as a key performance indicator for our Global WAM business, as EBITDA margin is widely used among asset management peers, and core earnings is a primary profitability metric for the Company overall.

															YTD Results						Full Year<br><br> <br>Results
( millions, unless otherwise stated)	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Core EBITDA margin
Core EBITDA	504		$	467		$	490		$	543		$	529		$	1,461		$	1,519		$	2,062
Global WAM revenue	1,542		$	1,521		$	1,586		$	1,727		$	1,680		$	4,649		$	4,814		$	6,541
Core EBITDA margin	32.7	%		30.7	%		30.9	%		31.4	%		31.5	%		31.4	%		31.6	%		31.5	%

All values are in US Dollars.

Expense efficiency ratio is a financial measure which Manulife uses to measure progress towards our target to be more efficient. It is defined as core general expenses divided by the sum of core earnings before income taxes (“pre-tax core earnings”) and core general expenses. Core general expenses is used to calculate our expense efficiency ratio and is equal to pre-tax general expenses included in core earnings and excludes such items as material legal provisions for settlements, restructuring charges and expenses related to integration and acquisitions.

															YTD Results						Full Year Results
( millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)	3Q22			2Q22			1Q22			4Q21			3Q21			2022			2021			2021
Expense Efficiency Ratio
Core general expenses	1,859		$	1,843		$	1,877		$	1,973		$	1,904		$	5,579		$	5,580		$	7,553
Core earnings (pre-tax)	1,593			1,900			1,876			2,054			1,811			5,369			5,842			7,896
Total - Core earnings (pre-<br> tax) and Core general<br> expenses	3,452		$	3,743		$	3,753		$	4,027		$	3,715		$	10,948		$	11,422		$	15,449
Expense Efficiency Ratio	53.9	%		49.2	%		50.0	%		49.0	%		51.3	%		51.0	%		48.9	%		48.9	%
Core general expenses
General expenses - Financial<br> Statements	1,900		$	1,843		$	1,898		$	2,000		$	1,904		$	5,641		$	5,828		$	7,828
Less: General expenses<br> included in items excluded<br> from core earnings
Restructuring charge	-			-			-			-			-			-			150			150
Integration and<br> acquisition	-			-			8			-			-			8			-			-
Legal provisions and<br> Other expenses	41			-			13			27			-			54			98			125
Total	41		$	-		$	21		$	27		$	-		$	62		$	248		$	275
Core general expenses	1,859		$	1,843		$	1,877		$	1,973		$	1,904		$	5,579		$	5,580		$	7,553
Core general expenses	1,859		$	1,843		$	1,877		$	1,973		$	1,904		$	5,579		$	5,580		$	7,553
CER adjustment(1)	-			11			-			6			1			11			14			20
Core general expenses,<br> CER basis	1,859		$	1,854		$	1,877		$	1,979		$	1,905		$	5,590		$	5,594		$	7,573

All values are in US Dollars.

^(1)^	The impact of updating foreign exchange rates to that which was used in 3Q22.

Embedded value (“EV”) is a measure of the present value of shareholders’ interests in the expected future distributable earnings on in-force business reflected in the Consolidated Statements of Financial Position of Manulife, excluding any value associated with future new business. EV is calculated as the sum of the adjusted net worth and the value of in-force business calculated as at December 31. The adjusted net worth is the IFRS shareholders’ equity adjusted for goodwill and intangible assets, fair value of surplus assets, the fair value of debt, preferred shares, and other equity, and local statutory balance sheet, regulatory reserve, and capital for our Asian

Manulife Financial Corporation – Third Quarter 2022

businesses. The value of in-force business business in Canada and the U.S. is the present value of expected future IFRS earnings, on an IFRS 4 basis, on in-force business less the present value of the cost of holding capital to support the in-force business under the LICAT framework. The value of in-force business in Asia reflects local statutory earnings and capital requirements. The value of in-force excludes Global WAM, Bank or P&C Reinsurance businesses.

Net annualized fee income yield on average AUMA ("Net fee income yield") is a financial measure that represents the net annualized fee income from Global WAM channels over average AUMA. This measure provides information on Global WAM’s adjusted return generated from managing AUMA.

Net annualized fee income is a financial measure that represents Global WAM income before income taxes, adjusted to exclude items unrelated to net fee income, including general expenses, investment income, non-AUMA related net benefits and claims, and net premium taxes. It also excludes the components of Global WAM net fee income from managing assets on behalf of other segments. This measure is annualized based on the number of days in the year divided the number of days in the reporting period.

Reconciliation of income before income taxes to net fee income yield

										YTD Results				Full Year<br><br> <br>Results
( millions, unless otherwise<br> stated)	3Q22		2Q22		1Q22		4Q21		3Q21		2022		2021		2021
Income before income<br> taxes	1,637	$	1,257	$	3,711	$	2,481	$	1,480	$	6,605	$	5,644	$	8,125
Less: Income before income<br> taxes for segments other<br> than Global WAM	1,242		895		3,325		2,043		1,062		5,462		4,441		6,484
Global WAM income before<br> income taxes	395		362		386		438		418		1,143		1,203		1,641
Items unrelated to net fee<br> income	565		580		600		616		599		1,745		1,708		2,324
Global WAM net fee income	960		942		986		1,054		1,017		2,888		2,911		3,965
Less: Net fee income from<br> other segments	112		112		118		122		118		342		336		458
Global WAM net fee income<br> excluding net fee income<br> from other segments	848		830		868		932		899		2,546		2,575		3,507
Net annualized fee income	3,362	$	3,328	$	3,516	$	3,698	$	3,565	$	3,403	$	3,444	$	3,507
Average Assets under<br> Management and<br> Administration	771,812	$	776,833	$	820,393	$	835,494	$	815,927	$	785,440	$	786,034	$	798,022
Net fee income yield (bps)	43.6		42.8		42.9		44.3		43.7		43.3		43.8		43.9

All values are in US Dollars.

New business value (“NBV”) is the change in embedded value as a result of sales in the reporting period. NBV is calculated as the present value of shareholders’ interests in expected future distributable earnings, after the cost of capital calculated under the LICAT framework in Canada and the U.S. and the local capital requirements in Asia, on actual new business sold in the period using assumptions that are consistent with the assumptions used in the calculation of embedded value. NBV excludes businesses with immaterial insurance risks, such as the Company’s Global WAM, Manulife Bank and the P&C Reinsurance businesses. NBV is a useful metric to evaluate the value created by the Company’s new business franchise.

New business value margin (“NBV margin”) is calculated as NBV divided by APE sales excluding non-controlling interests. APE sales are calculated as 100% of regular premiums and deposits sales and 10% of single premiums and deposits sales. NBV margin is a useful metric to help understand the profitability of our new business.

Sales are measured according to product type:

For individual insurance, sales include 100% of new annualized premiums and 10% of both excess and single premiums. For individual insurance, new annualized premiums reflect the annualized premium expected in the first year of a policy that requires premium payments for more than one year. Single premium is the lump sum premium from the sale of a single premium product, e.g. travel insurance. Sales are reported gross before the impact of reinsurance.

Manulife Financial Corporation – Third Quarter 2022

For group insurance, sales include new annualized premiums and administrative services only premium equivalents on new cases, as well as the addition of new coverages and amendments to contracts, excluding rate increases.

Insurance-based wealth accumulation product sales include all new deposits into variable and fixed annuity contracts. As we discontinued sales of new variable annuity contracts in the U.S. in 1Q13, subsequent deposits into existing U.S. variable annuity contracts are not reported as sales. Asia variable annuity deposits are included in APE sales.

APE sales are comprised of 100% of regular premiums and deposits and 10% of excess and single premiums and deposits for both insurance and insurance-based wealth accumulation products.

Gross flows is a new business measure presented for our Global WAM business and includes all deposits into mutual funds, group pension/retirement savings products, private wealth and institutional asset management products. Gross flows is a common industry metric for WAM businesses as it provides a measure of how successful the businesses are at attracting assets.

Net flows is presented for our Global WAM business and includes gross flows less redemptions for mutual funds, group pension/retirement savings products, private wealth and institutional asset management products. In addition, net flows include the net flows of exchange traded funds and non-proprietary product sold by Manulife Securities. Net flows is a common industry metric for WAM businesses as it provides a measure of how successful the businesses are at attracting and retaining assets. When net flows are positive, they are referred to as net inflows. Conversely, negative net flows are referred to as net outflows.

Remittances is defined as the cash remitted or available for distribution to the Manulife Group from operating subsidiaries and excess capital generated by standalone Canadian operations. It is one of the key metrics used by management to evaluate our financial flexibility.

E4	Caution regarding forward-looking statements

From time to time, MFC makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such statements are made pursuant to the “safe harbour” provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995.

The forward-looking statements in this document include, but are not limited to, statements with respect to the expected annual savings related to actions taken in the first quarter of 2021, the impact of IFRS 17 and the Company’s earnings presentation and reporting under the new accounting standard and our medium-term financial and operating targets under IFRS 17, including our core ROE target, dividend payout ratio target and new CSM targets, the impact of changes in tax laws, and the estimated timing and amount of state approved future premium increases on our U.S. LTC business and, also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “suspect”, “outlook”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “forecast”, “objective”, “seek”, “aim”, “continue”, “goal”, “restore”, “embark” and “endeavour” (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts’ expectations in any way.

Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-

Manulife Financial Corporation – Third Quarter 2022

19, including the impacts of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to obtain premium rate increases on in-force policies; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified as available-for-sale; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; geopolitical uncertainty, including international conflicts; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company’s or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.

Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in this document under “Risk Management and Risk Factors Update” and “Critical Actuarial and Accounting Policies”, under “Risk Management and Risk Factors” and “Critical Actuarial and Accounting Policies” in the Management’s Discussion and Analysis in our most recent annual report and, in the “Risk Management” note to the consolidated financial statements in our most recent annual and interim reports and elsewhere in our filings with Canadian and U.S. securities regulators.

The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.

Manulife Financial Corporation – Third Quarter 2022

E5	Quarterly financial information

The following table provides summary information related to our eight most recently completed quarters.

As at and for the three months ended
( millions, except per share amounts or otherwise stated, unaudited)			Jun 30,<br><br> <br>2022			Mar 31,<br><br> <br>2022			Dec 31,<br><br> <br>2021			Sept 30,<br><br> <br>2021			Jun 30,<br><br> <br>2021			Mar 31,<br><br> <br>2021			Dec 31,<br><br> <br>2020
Revenue
Premium income
Life and health insurance	8,710		$	8,783		$	9,521		$	9,159		$	9,269		$	8,716		$	8,986		$	8,651
Annuities and pensions(1)	762			844			(19	)		901			714			698			622			672
Net premium income	9,472			9,627			9,502			10,060			9,983			9,414			9,608			9,323
Investment income	3,883			3,675			3,417			4,350			3,964			4,099			3,214			4,366
Realized and unrealized gains and losses<br> on assets supporting insurance and<br> investment contract liabilities(2)	(7,955	)		(17,760	)		(18,540	)		4,460			(958	)		9,551			(17,056	)		1,683
Other revenue	2,377			2,057			1,991			2,741			2,994			2,760			2,637			2,497
Total revenue	7,777		$	(2,401	)	$	(3,630	)	$	21,611		$	15,983		$	25,824		$	(1,597	)	$	17,869
Income (loss) before income taxes	1,637		$	1,257		$	3,711		$	2,481		$	1,480		$	3,292		$	872		$	2,065
Income tax (expense) recovery	(332	)		(258	)		(809	)		(430	)		(166	)		(610	)		(7	)		(224	)
Net income (loss)	1,305		$	999		$	2,902		$	2,051		$	1,314		$	2,682		$	865		$	1,841
Net income (loss) attributed to<br> shareholders	1,347		$	1,086		$	2,970		$	2,084		$	1,592		$	2,646		$	783		$	1,780
Basic earnings (loss) per common<br> share	0.68		$	0.53		$	1.51		$	1.04		$	0.80		$	1.33		$	0.38		$	0.90
Diluted earnings (loss) per common<br> share	0.68		$	0.53		$	1.50		$	1.03		$	0.80		$	1.33		$	0.38		$	0.89
Segregated funds deposits	9,841		$	10,094		$	12,328		$	10,920		$	10,929		$	10,301		$	12,395		$	9,741
Total assets (in billions)	835		$	821		$	865		$	918		$	898		$	879		$	859		$	880
Weighted average common shares<br> (in millions)	1,902			1,921			1,938			1,943			1,942			1,942			1,941			1,940
Diluted weighted average common<br> shares (in millions)	1,904			1,924			1,942			1,946			1,946			1,946			1,945			1,943
Dividends per common share	0.330		$	0.330		$	0.330		$	0.330		$	0.280		$	0.280		$	0.280		$	0.280
CDN to US1 - Statement of Financial<br> Position	1.3740			1.2900			1.2496			1.2678			1.2741			1.2394			1.2575			1.2732
CDN to US1 - Statement of Income	1.3057			1.2765			1.2663			1.2601			1.2602			1.2282			1.2660			1.3030

All values are in US Dollars.

^(1)^	Includes lower revenue related to the reinsurance of a block of our legacy U.S. variable annuity business of US$0.9 billion in 1Q22.
^(2)^	For fixed income assets supporting insurance and investment contract liabilities and for equities supporting pass-through products and derivatives related to variable hedging<br> programs, the impact of realized and unrealized gains (losses) on the assets is largely offset in the change in insurance and investment contract liabilities.
---	---
E6	Other
---	---

No changes were made in our internal control over financial reporting during the nine months ended September 30, 2022, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

As in prior quarters, MFC’s Audit Committee has reviewed this MD&A and the unaudited interim financial report and MFC’s Board of Directors approved this MD&A prior to its release.

Manulife Financial Corporation – Third Quarter 2022

Consolidated Statements of Financial Position

As at
(Canadian $ in millions, unaudited)	September 30, 2022			December 31, 2021
Assets
Cash and short-term securities	$	20,951		$	22,594
Debt securities		201,358			224,139
Public equities		22,327			28,067
Mortgages		54,685			52,014
Private placements		46,672			42,842
Policy loans		6,833			6,397
Loans to Bank clients		2,799			2,506
Real estate		14,096			13,233
Other invested assets		41,571			35,306
Total invested assets (note 3)		411,292			427,098
Other assets
Accrued investment income		2,910			2,641
Outstanding premiums		1,301			1,294
Derivatives (note 4)		8,935			17,503
Reinsurance assets		48,929			44,579
Deferred tax assets		5,266			5,254
Goodwill and intangible assets		10,067			9,915
Miscellaneous		10,778			9,571
Total other assets		88,186			90,757
Segregated funds net assets (note 14)		335,245			399,788
Total assets	$	834,723		$	917,643
Liabilities and Equity
Liabilities
Insurance contract liabilities (note 5)	$	369,671		$	392,275
Investment contract liabilities (note 5)		3,259			3,117
Deposits from Bank clients		21,669			20,720
Derivatives (note 4)		14,816			10,038
Deferred tax liabilities		2,764			2,769
Other liabilities		17,554			18,205
		429,733			447,124
Long-term debt (note 7)		6,320			4,882
Capital instruments (note 8)		7,118			6,980
Segregated funds net liabilities (note 14)		335,245			399,788
Total liabilities		778,416			858,774
Equity
Preferred shares and other equity (note 9)		6,660			6,381
Common shares (note 9)		22,453			23,093
Contributed surplus		262			262
Shareholders' and other equity holders' retained earnings		26,152			23,492
Shareholders' accumulated other comprehensive income (loss) (“AOCI”):
Pension and other post-employment plans		(97	)		(114	)
Available-for-sale securities		(6,189	)		848
Cash flow hedges		(18	)		(156	)
Real estate revaluation reserve		23			23
Translation of foreign operations		6,832			4,579
Total shareholders' and other equity		56,078			58,408
Participating policyholders' equity		(1,426	)		(1,233	)
Non-controlling interests		1,655			1,694
Total equity		56,307			58,869
Total liabilities and equity	$	834,723		$	917,643
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
Roy Gori	John Cassaday
---	---
President and Chief Executive Officer	Chairman of the Board of Directors

Manulife Financial Corporation – Third Quarter 2022

Consolidated Statements of Income

For the	three months ended<br><br> <br>September 30,						nine months ended<br><br> <br>September 30,
(Canadian $ in millions except per share amounts, unaudited)	2022			2021			2022			2021
Revenue
Premium income
Gross premiums	$	10,794		$	11,233		$	33,324		$	32,839
Premiums ceded to reinsurers		(1,322	)		(1,250	)		(4,723	)		(3,834	)
Net premiums		9,472			9,983			28,601			29,005
Investment income (note 3)
Investment income		3,883			3,964			10,975			11,277
Realized and unrealized gains (losses) on assets supporting<br><br> <br>insurance and investment contract liabilities and on the macro hedge<br><br> <br>program		(7,955	)		(958	)		(44,255	)		(8,463	)
Net investment income (loss)		(4,072	)		3,006			(33,280	)		2,814
Other revenue (note 10)		2,377			2,994			6,425			8,391
Total revenue		7,777			15,983			1,746			40,210
Contract benefits and expenses
To contract holders and beneficiaries
Gross claims and benefits (note 5)		8,280			7,785			24,686			23,065
Increase (decrease) in insurance contract liabilities		(4,119	)		4,023			(35,485	)		2,612
Increase (decrease) in investment contract liabilities		11			1			10			25
Benefits and expenses ceded to reinsurers		(1,667	)		(1,653	)		(5,270	)		(5,032	)
(Increase) decrease in reinsurance assets		(745	)		(9	)		(1,711	)		581
Net benefits and claims		1,760			10,147			(17,770	)		21,251
General expenses		1,900			1,904			5,641			5,828
Investment expenses		428			449			1,317			1,470
Commissions		1,559			1,634			4,688			4,932
Interest expense		373			262			934			771
Net premium taxes		120			107			331			314
Total contract benefits and expenses		6,140			14,503			(4,859	)		34,566
Income before income taxes		1,637			1,480			6,605			5,644
Income tax (expense) recovery		(332	)		(166	)		(1,399	)		(783	)
Net income	$	1,305		$	1,314		$	5,206		$	4,861
Net income (loss) attributed to:
Non-controlling interests	$	(18	)	$	48		$	(8	)	$	223
Participating policyholders		(24	)		(326	)		(189	)		(383	)
Shareholders and other equity holders		1,347			1,592			5,403			5,021
	$	1,305		$	1,314		$	5,206		$	4,861
Net income attributed to shareholders	$	1,347		$	1,592		$	5,403		$	5,021
Preferred share dividends and other equity distributions		(51	)		(37	)		(163	)		(144	)
Common shareholders' net income	$	1,296		$	1,555		$	5,240		$	4,877
Earnings per share
Basic earnings per common share (note 9)	$	0.68		$	0.80		$	2.73		$	2.51
Diluted earnings per common share (note 9)		0.68			0.80			2.72			2.51
Dividends per common share		0.33			0.28			0.99			0.84
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.

Manulife Financial Corporation – Third Quarter 2022

Consolidated Statements of Comprehensive Income

For the	three months ended<br><br> <br>September 30,						nine months ended<br><br> <br>September 30,
(Canadian $ in millions, unaudited)	2022			2021			2022			2021
Net income	$	1,305		$	1,314		$	5,206		$	4,861
Other comprehensive income (loss) ("OCI"), net of tax
Items that may be subsequently reclassified to net income:
Foreign exchange gains (losses) on:
Translation of foreign operations		2,755			1,292			2,715			(302	)
Net investment hedges		(404	)		(138	)		(464	)		54
Available-for-sale financial securities:
Unrealized gains (losses) arising during the period		(2,029	)		(104	)		(7,287	)		(1,601	)
Reclassification of net realized (gains) losses and impairments to net<br><br> <br>income		137			(74	)		247			(109	)
Cash flow hedges:
Unrealized gains (losses) arising during the period		19			7			143			72
Reclassification of realized gains (losses) to net income		11			-			(5	)		(2	)
Share of other comprehensive income (losses) of associates		(10	)		(1	)		(8	)		2
Total items that may be subsequently reclassified to net income		479			982			(4,659	)		(1,886	)
Items that will not be reclassified to net income:
Change in actuarial gains (losses) on pension and other post-employment<br><br> <br>plans		(49	)		(7	)		17			169
Real estate revaluation reserve		-			-			-			(11	)
Total items that will not be reclassified to net income		(49	)		(7	)		17			158
Other comprehensive income (loss), net of tax		430			975			(4,642	)		(1,728	)
Total comprehensive income (loss), net of tax	$	1,735		$	2,289		$	564		$	3,133
Total comprehensive income (loss) attributed to:
Non-controlling interests	$	(18	)	$	48		$	(17	)	$	221
Participating policyholders		(28	)		(325	)		(193	)		(383	)
Shareholders and other equity holders		1,781			2,566			774			3,295

Income Taxes included in Other Comprehensive Income

For the	three months ended<br><br> <br>September 30,						nine months ended<br><br> <br>September 30,
(Canadian $ in millions, unaudited)	2022			2021			2022			2021
Income tax expense (recovery) on:
Unrealized gains (losses) on available-for-sale financial securities	$	(267	)	$	(27	)	$	(1,200	)	$	(290	)
Reclassification of net realized (gains) losses and impairments to net<br><br> <br>income on available-for-sale financial securities		19			(2	)		46			(5	)
Unrealized gains (losses) on cash flow hedges		20			(2	)		51			9
Reclassification of realized gains (losses) to net income on cash flow hedges		4			-			(1	)		-
Unrealized foreign exchange gains (losses) on translation of foreign operations		1			1			1			-
Unrealized foreign exchange gains (losses) on net investment hedges		(19	)		(23	)		(24	)		6
Share of other comprehensive income (loss) of associates		1			1			1			-
Change in pension and other post-employment plans		(18	)		(1	)		7			53
Total income tax expense (recovery)	$	(259	)	$	(53	)	$	(1,119	)	$	(227	)
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.

Manulife Financial Corporation – Third Quarter 2022

Consolidated Statements of Changes in Equity

For the nine months ended September 30,
(Canadian $ in millions, unaudited)	2022			2021
Preferred shares and other equity
Balance, beginning of period	$	6,381		$	3,822
Issued (note 9)		1,000			2,000
Redeemed (note 9)		(711	)		(418	)
Issuance costs, net of tax		(10	)		(17	)
Balance, end of period		6,660			5,387
Common shares
Balance, beginning of period		23,093			23,042
Repurchased (note 9)		(659	)		-
Issued on exercise of stock options and deferred share units		19			45
Balance, end of period		22,453			23,087
Contributed surplus
Balance, beginning of period		262			261
Exercise of stock options and deferred share units		(3	)		(7	)
Stock option expense		3			7
Balance, end of period		262			261
Shareholders' and other equity holders' retained earnings
Balance, beginning of period		23,492			18,887
Net income attributed to shareholders and other equity holders		5,403			5,021
Common shares repurchased (note 9)		(673	)		-
Preferred share dividends and other equity distributions		(163	)		(144	)
Preferred shares redeemed (note 9)		(14	)		(7	)
Common share dividends		(1,893	)		(1,632	)
Balance, end of period		26,152			22,125
Shareholders' accumulated other comprehensive income (loss)
Balance, beginning of period		5,180			6,323
Change in unrealized foreign exchange gains (losses) on net foreign operations		2,253			(248	)
Change in actuarial gains (losses) on pension and other post-employment plans		17			169
Change in unrealized gains (losses) on available-for-sale financial securities		(7,029	)		(1,708	)
Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges		138			70
Change in real estate revaluation reserve		-			(11	)
Share of other comprehensive income (losses) of associates		(8	)		2
Balance, end of period		551			4,597
Total shareholders' and other equity, end of period		56,078			55,457
Participating policyholders' equity
Balance, beginning of period		(1,233	)		(784	)
Net income (loss) attributed to participating policyholders		(189	)		(383	)
Other comprehensive income (losses) attributed to participating policyholders		(4	)		-
Balance, end of period		(1,426	)		(1,167	)
Non-controlling interests
Balance, beginning of period		1,694			1,455
Net income attributed to non-controlling interests		(8	)		223
Other comprehensive income (losses) attributed to non-controlling interests		(9	)		(2	)
Contributions (distributions), net		(22	)		(15	)
Balance, end of period		1,655			1,661
Total equity, end of period	$	56,307		$	55,951
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.

Manulife Financial Corporation – Third Quarter 2022

Consolidated Statements of Cash Flows

For the nine months ended September 30,
(Canadian $ in millions, unaudited)	2022			2021
Operating activities
Net income	$	5,206		$	4,861
Adjustments:
Increase (decrease) in insurance contract liabilities		(34,037	)		2,612
Increase (decrease) in investment contract liabilities		10			25
(Increase) decrease in reinsurance assets		(879	)		581
Amortization of (premium) discount on invested assets		21			120
Other amortization		400			399
Net realized and unrealized (gains) losses and impairment on assets		48,209			9,186
Gain on U.S. variable annuity reinsurance transaction (pre-tax) (note 5)		(1,026	)		-
Deferred income tax expense (recovery)		877			237
Stock option expense		3			7
Cash provided by operating activities before undernoted items		18,784			18,028
Cash decrease due to U.S. variable annuity reinsurance transaction (note 5)		(1,263	)		-
Changes in policy related and operating receivables and payables		(4,773	)		(1,610	)
Cash provided by (used in) operating activities		12,748			16,418
Investing activities
Purchases and mortgage advances		(87,816	)		(89,204	)
Disposals and repayments		74,226			69,938
Change in investment broker net receivables and payables		(218	)		588
Net cash flows from acquisition and disposal of subsidiaries and businesses		-			(4	)
Cash provided by (used in) investing activities		(13,808	)		(18,682	)
Financing activities
Issue of long-term debt, net (note 7)		946			-
Redemption of long-term debt		-			(1,250	)
Redemption of capital instruments (note 8)		-			(818	)
Secured borrowings		735			17
Change in repurchase agreements and securities sold but not yet purchased		(457	)		258
Changes in deposits from Bank clients, net		885			266
Lease payments		(90	)		(96	)
Shareholders' dividends and other equity distributions		(2,070	)		(1,783	)
Common shares repurchased (note 9)		(1,332	)		-
Common shares issued, net (note 9)		19			45
Preferred shares and other equity issued, net (note 9)		990			1,983
Preferred shares redeemed, net (note 9)		(711	)		(418	)
Contributions from (distributions to) non-controlling interests, net		(22	)		(15	)
Cash provided by (used in) financing activities		(1,107	)		(1,811	)
Cash and short-term securities
Increase (decrease) during the period		(2,167	)		(4,075	)
Effect of foreign exchange rate changes on cash and short-term securities		595			(230	)
Balance, beginning of period		21,930			25,583
Balance, end of period		20,358			21,278
Cash and short-term securities
Beginning of period
Gross cash and short-term securities		22,594			26,167
Net payments in transit, included in other liabilities		(664	)		(584	)
Net cash and short-term securities, beginning of period		21,930			25,583
End of period
Gross cash and short-term securities		20,951			22,114
Net payments in transit, included in other liabilities		(593	)		(836	)
Net cash and short-term securities, end of period	$	20,358		$	21,278
Supplemental disclosures on cash flow information
Interest received	$	8,525		$	8,367
Interest paid		836			722
Income taxes paid		1,240			347
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.

Manulife Financial Corporation – Third Quarter 2022

CONDENSED NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Canadian $ in millions except per share amounts or unless otherwise stated, unaudited)

Note 1	Nature of Operations and Significant Accounting Policies
(a)	Reporting entity
---	---

Manulife Financial Corporation (“MFC”) is a publicly traded company and the holding company of The Manufacturers Life Insurance Company (“MLI”), a Canadian life insurance company. MFC and its subsidiaries (collectively, “Manulife” or the “Company”) is a leading financial services group with principal operations in Asia, Canada and the United States. Manulife’s international network of employees, agents and distribution partners offers financial protection and wealth management products and services to personal and business clients as well as asset management services to institutional customers. The Company operates as Manulife in Canada and Asia and as John Hancock in the United States.

These Interim Consolidated Financial Statements and condensed notes have been prepared in accordance with International Accounting Standard (“IAS”) 34 “Interim Financial Reporting” as issued by the International Accounting Standards Board (“IASB”), using accounting policies which are consistent with those used in the Company’s 2021 Annual Consolidated Financial Statements, except as disclosed in note 2.

These Interim Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements for the year ended December 31, 2021, included on pages 129 to 213 of the Company’s 2021 Annual Report, as well as the disclosures on risk in denoted components of the “Risk Management and Risk Factors” section of the Third Quarter 2022 Management Discussion and Analysis (“MD&A”). These risk disclosures are an integral part of these Interim Consolidated Financial Statements.

These Interim Consolidated Financial Statements as at and for the three and nine months ended September 30, 2022 were authorized for issue by MFC’s Board of Directors on November 9, 2022.

(b)	Basis of preparation

Refer to note 1 of the Company’s 2021 Annual Consolidated Financial Statements for a summary of the most significant estimation processes used in the preparation of the Consolidated Financial Statements under IFRS and description of the Company’s measurement techniques in determining carrying values and respective fair values of its assets and liabilities.

The Company’s results and operations have been and may continue to be adversely impacted by COVID -19 and the economic environment. The Company has applied appropriate measurement techniques using reasonable judgment and estimates from the perspective of a market participant to reflect current economic conditions. The impact of these techniques has been reflected in these Interim Consolidated Financial Statements. Changes in the inputs used could materially impact the respective carrying values.

Note 2	Accounting and Reporting Changes
(a)	Changes in accounting and reporting policy
---	---
(I)	Annual Improvements 2018–2020 Cycle
---	---

Annual Improvements 2018–2020 Cycle was issued in May 2020 and is effective on or after January 1, 2022. The IASB issued four minor amendments to different standards as part of the Annual Improvements process, to be applied prospectively. Adoption of these amendments did not have a significant impact on the Company’s Consolidated Financial Statements.

(II)	Amendments to IFRS 3 “Business Combinations”

Amendments to IFRS 3 “Business Combinations” were issued in May 2020, and are effective on or after January 1, 2022, with earlier application permitted. The amendments update references within IFRS 3 to the 2018 Conceptual Framework and require that the principles in IAS 37 “Provisions, Contingent Liabilities and Contingent Assets” be used to identify liabilities and contingent assets arising from a business combination. Adoption of these amendments did not have a significant impact on the Company’s Consolidated Financial Statements.

Manulife Financial Corporation – Third Quarter 2022

(III)	Amendments to IAS 37 “Provisions, Contingent Liabilities and Contingent Assets”

Amendments to IAS 37 “Provisions, Contingent Liabilities and Contingent Assets” were issued in May 2020, and are effective on or after January 1, 2022, with earlier application permitted. The amendments address identifying onerous contracts and specify the cost of fulfilling a contract which includes all costs directly related to the contract. These include incremental direct costs and allocations of other costs that relate directly to fulfilling the contract. Adoption of these amendments did not have a significant impact on the Company’s Consolidated Financial Statements.

(b)	Future accounting and reporting changes
(I)	IFRS 17 “Insurance Contracts” and IFRS 9 “Financial Instruments”
---	---

IFRS 17 “Insurance Contracts” was issued in May 2017 to be effective for years beginning on January 1, 2021. Amendments to IFRS 17 “Insurance Contracts” were issued in June 2020 and include a two-year deferral of the effective date. IFRS 17 as amended, is effective for years beginning on January 1, 2023, to be applied retrospectively. If full retrospective application to a group of contracts is impractical, the modified retrospective or fair value methods may be used. The standard will replace IFRS 4 “Insurance Contracts” and therefore will also replace the Canadian Asset Liability Method (“CALM”) and will materially change the recognition and measurement of insurance contracts and the corresponding presentation and disclosures in the Company’s Financial Statements.

Narrow-scope amendments to IFRS 17 “Insurance Contracts” were issued in December 2021 and are effective on initial application of IFRS 17 and IFRS 9 “Financial Instruments” which the Company will adopt on January 1, 2023. The amendments remove accounting mismatches between insurance contract liabilities and financial assets in scope of IFRS 9 within comparative prior periods when initially applying IFRS 17 and IFRS 9. The amendments allow insurers to present comparative information on financial assets as if IFRS 9 were fully applicable during the comparative period. The amendments do not permit application of IFRS 9 hedge accounting principles to the comparative period. The Company is considering the effect of these amendments on its IFRS 9 transition disclosures.

The principles underlying IFRS 17 differ from CALM as permitted by IFRS 4. While there are many differences, the following outlines some of the key differences:

•	Under IFRS 17 new business gains are recorded on the Consolidated Statements of Financial Position (in the Contractual Service Margin (“CSM”) component of the insurance contract liability) and<br> amortized into income as services are provided. New business losses are recorded into income immediately. Under CALM, both new business gains and new business losses are recognized in income immediately.
•	Under IFRS 17 the discount rate used to estimate the present value of insurance contract liabilities is based on the characteristics of the liability, whereas under CALM, the Company uses the rates<br> of returns for current and projected assets supporting insurance contract liabilities to value the liabilities. The difference in the discount rate approach also impacts the timing of investment results. Under IFRS 17, the impact of<br> investing activities will emerge into earnings over the life of the assets, whereas under CALM, the impact of investing activities is capitalized into reserves and therefore earnings in the period they occur.
---	---
•	Under IFRS 17 the discount rate is not related to the expected return on Alternative Long-Duration Assets (“ALDA”) and public equity assets, and as a result, the earnings sensitivity of a change in<br> return assumptions for ALDA and public equity will be significantly reduced.
---	---
•	Under IFRS 17 the Company will elect the option to record changes in insurance contract liabilities arising from changes in interest rates through other comprehensive income and will classify debt<br> instruments as fair value through other comprehensive income under IFRS 9. Under CALM, changes in insurance contract liabilities are recorded in net income.
---	---

The overall impact of establishing the CSM, as well as other measurement impacts on our assets and liabilities, is expected to decrease equity upon transition by approximately 20%.

The Company continues its assessment of the implications of this standard and expects that it will have a significant impact on the Company’s Consolidated Financial Statements. The establishment of a CSM on in-force

Manulife Financial Corporation – Third Quarter 2022

business is expected to lead to an increase in insurance contract liabilities and a corresponding decrease in equity upon transition. The CSM represents unearned profits that are expected to amortize into income as services are provided. The Company continues to evaluate the potential impacts of all other changes including available accounting policy choices under IFRS 17 on the measurement of its insurance contract liabilities.

Note 3	Invested Assets and Investment Income
(a)	Carrying values and fair values of invested assets
---	---
As at September 30, 2022	FVTPL^(1)^		AFS^(2)^		Other^(3)^		Total carrying<br><br> <br>value		Total fair<br><br> <br>value
---	---	---	---	---	---	---	---	---	---	---
Cash and short-term securities^(4)^	$	1,821	$	12,308	$	6,822	$	20,951	$	20,951
Debt securities^(3),(5),(6)^
Canadian government and agency		15,427		5,867		-		21,294		21,294
U.S. government and agency		10,454		15,001		924		26,379		26,147
Other government and agency		21,735		3,090		-		24,825		24,825
Corporate		119,048		6,875		507		126,430		126,252
Mortgage/asset-backed securities		2,289		141		-		2,430		2,430
Public equities		20,806		1,521		-		22,327		22,327
Mortgages		-		-		54,685		54,685		51,043
Private placements^(6)^		-		-		46,672		46,672		41,004
Policy loans		-		-		6,833		6,833		6,833
Loans to Bank clients		-		-		2,799		2,799		2,785
Real estate
Own use property		-		-		1,921		1,921		3,100
Investment property		-		-		12,175		12,175		12,175
Other invested assets
Alternative long-duration assets^(7)^		25,214		83		11,679		36,976		37,678
Various other		127		-		4,468		4,595		4,595
Total invested assets	$	216,921	$	44,886	$	149,485	$	411,292	$	403,439
As at December 31, 2021	FVTPL^(1)^		AFS^(2)^		Other^(3)^		Total carrying<br><br> <br>value		Total fair<br><br> <br>value
Cash and short-term securities^(4)^	$	2,214	$	14,339	$	6,041	$	22,594	$	22,594
Debt securities^(3),(5),(6)^
Canadian government and agency		18,706		3,964		-		22,670		22,670
U.S. government and agency		12,607		18,792		852		32,251		32,254
Other government and agency		21,888		2,871		-		24,759		24,759
Corporate		133,763		7,332		468		141,563		141,560
Mortgage/asset-backed securities		2,758		138		-		2,896		2,896
Public equities		25,716		2,351		-		28,067		28,067
Mortgages		-		-		52,014		52,014		54,089
Private placements^(6)^		-		-		42,842		42,842		47,276
Policy loans		-		-		6,397		6,397		6,397
Loans to Bank clients		-		-		2,506		2,506		2,503
Real estate
Own use property		-		-		1,812		1,812		3,024
Investment property		-		-		11,421		11,421		11,421
Other invested assets
Alternative long-duration assets^(7)^		21,022		89		10,093		31,204		31,863
Various other		135		-		3,967		4,102		4,102
Total invested assets	$	238,809	$	49,876	$	138,413	$	427,098	$	435,475
^(1)^	FVTPL classification was elected for securities backing insurance contract liabilities to substantially reduce any accounting mismatch arising from changes in the fair value of<br> these assets and changes in the value of the related insurance contract liabilities. If this election had not been made and instead the available-for-sale (“AFS”) classification was selected, there would be an accounting mismatch because<br> changes in insurance contract liabilities are recognized in net income rather than in OCI.
---	---
^(2)^	Securities that are designated as AFS are not actively traded by the Company but sales do occur as circumstances warrant. Such sales result in a reclassification of any accumulated<br> unrealized gain (loss) in AOCI to net income as a realized gain (loss).
---	---
^(3)^	Primarily includes assets classified as loans and carried at amortized cost, own use properties, investment properties, equity method accounted investments, and leveraged leases.<br> Also includes debt securities classified as held-to-maturity which are accounted for at amortized cost.
---	---

Manulife Financial Corporation – Third Quarter 2022

^(4)^	Includes short-term securities with maturities of less than one year at acquisition amounting to $4,930 (December 31, 2021 – $7,314) cash equivalents with maturities of less than<br> 90 days at acquisition amounting to $9,199 (December 31, 2021 – $9,239) and cash of $6,822 (December 31, 2021 – $6,041).
^(5)^	Debt securities include securities which were acquired with maturities of less than one year and less than 90 days of $1,320 and $833, respectively (December 31, 2021 – $2,196 and<br> $347, respectively).
---	---
^(6)^	Floating rate invested assets above which are subject to interest rate benchmark reform, but have not yet transitioned to replacement reference rates, include debt securities<br> benchmarked to CDOR, USD LIBOR and AUD BBSW of $177, $932 and $14 (December 31, 2021 – $176, $1,002 and $nil respectively), and private placements benchmarked to USD LIBOR, AUD BBSW and NZD BKBM of $1,769, $159 and $39 (December 31, 2021 –<br> $1,984, $166 and $43, respectively). Exposures indexed to USD LIBOR represent floating rate invested assets with maturity dates beyond June 30, 2023 while exposures to CDOR represent floating rate invested assets with maturity dates beyond<br> June 28, 2024. The interest rate benchmark reform is expected to have an impact on the valuation of invested assets whose value is tied to the affected interest rate benchmarks. The Company has assessed its exposure at the contract level,<br> by benchmark and instrument type. The Company is monitoring market developments with respect to alternative reference rates and the time horizon during which they will evolve. As at September 30, 2022, the interest rate benchmark reform has<br> not resulted in significant changes in the Company’s risk management strategy.
---	---
^(7)^	Alternative long-duration assets (“ALDA”) include investments in private equity of $13,685, infrastructure of $12,113, oil and gas of $2,167, timber and agriculture of $5,875 and<br> various other ALDA of $3,136 (December 31, 2021 – $11,598, $9,824, $1,950, $5,259 and $2,573, respectively).
---	---
(b)	Investment income
---	---
	three months ended						nine months ended
---	---	---	---	---	---	---	---	---	---	---	---	---
	September 30,						September 30,
For the	2022			2021			2022			2021
Interest income	$	3,110		$	2,914		$	8,866		$	8,605
Dividend, rental income and other income		975			1,007			2,918			2,794
Impairments, provisions and recoveries, net		(17	)		4			(43	)		8
Realized and unrealized gains (losses) on surplus assets<br><br> <br>excluding the macro hedge program		(185	)		39			(766	)		(130	)
		3,883			3,964			10,975			11,277
Realized and unrealized gains (losses) on assets supporting<br><br> <br>insurance and investment contract liabilities and, on the macro<br><br> <br>hedge program
Debt securities		(6,405	)		(1,217	)		(32,355	)		(6,376	)
Public equities		(1,156	)		(359	)		(4,586	)		2,026
Mortgages		(9	)		18			92			83
Private placements		104			(30	)		557			185
Real estate		(118	)		250			249			513
Other invested assets		343			1,103			1,863			2,595
Derivatives, including macro hedge program		(714	)		(723	)		(10,075	)		(7,489	)
		(7,955	)		(958	)		(44,255	)		(8,463	)
Total investment income (loss)	$	(4,072	)	$	3,006		$	(33,280	)	$	2,814

Manulife Financial Corporation – Third Quarter 2022

(c)	Fair value measurement

The following table presents fair values and the fair value hierarchy of invested assets and segregated funds net assets measured at fair value in the Consolidated Statements of Financial Position.

As at September 30, 2022	Total fair<br><br> <br>value		Level 1		Level 2		Level 3
Cash and short-term securities
FVTPL	$	1,821	$	-	$	1,821	$	-
AFS		12,308		-		12,308		-
Other		6,822		6,822		-		-
Debt securities
FVTPL
Canadian government and agency		15,427		-		15,427		-
U.S. government and agency		10,454		-		10,454		-
Other government and agency		21,735		-		21,735		-
Corporate		119,048		-		119,043		5
Residential mortgage-backed securities		7		-		7		-
Commercial mortgage-backed securities		650		-		650		-
Other asset-backed securities		1,632		-		1,578		54
AFS
Canadian government and agency		5,867		-		5,867		-
U.S. government and agency		15,001		-		15,001		-
Other government and agency		3,090		-		3,081		9
Corporate		6,875		-		6,875		-
Residential mortgage-backed securities		1		-		1		-
Commercial mortgage-backed securities		29		-		29		-
Other asset-backed securities		111		-		111		-
Public equities
FVTPL		20,806		20,730		-		76
AFS		1,521		1,521		-		-
Real estate - investment property^(1)^		12,175		-		-		12,175
Other invested assets^(2)^		29,092		17		-		29,075
Segregated funds net assets^(3)^		335,245		301,263		29,574		4,408
Total	$	619,717	$	330,353	$	243,562	$	45,802

Manulife Financial Corporation – Third Quarter 2022

As at December 31, 2021	Total fair<br><br> <br>value		Level 1		Level 2		Level 3
Cash and short-term securities
FVTPL	$	2,214	$	-	$	2,214	$	-
AFS		14,339		-		14,339		-
Other		6,041		6,041		-		-
Debt securities
FVTPL
Canadian government and agency		18,706		-		18,706		-
U.S. government and agency		12,607		-		12,607		-
Other government and agency		21,888		-		21,888		-
Corporate		133,763		-		133,723		40
Residential mortgage-backed securities		8		-		8		-
Commercial mortgage-backed securities		1,103		-		1,103		-
Other asset-backed securities		1,647		-		1,619		28
AFS
Canadian government and agency		3,964		-		3,964		-
U.S. government and agency		18,792		-		18,792		-
Other government and agency		2,871		-		2,871		-
Corporate		7,332		-		7,331		1
Residential mortgage-backed securities		1		-		1		-
Commercial mortgage-backed securities		79		-		79		-
Other asset-backed securities		58		-		58		-
Public equities
FVTPL		25,716		25,716		-		-
AFS		2,351		2,349		2		-
Real estate - investment property^(1)^		11,421		-		-		11,421
Other invested assets^(2)^		24,300		257		-		24,043
Segregated funds net assets^(3)^		399,788		361,447		34,060		4,281
Total	$	708,989	$	395,810	$	273,365	$	39,814
^(1)^	For real estate investment properties, the significant unobservable inputs are capitalization rates (ranging from 2.75% to 9.00% during the period and ranging from 2.25% to 9.00%<br> during the year 2021) and terminal capitalization rates (ranging from 3.50% to 9.50% during the period and ranging from 3.25% to 9.25% during the year 2021). Holding other factors constant, a lower capitalization or terminal capitalization<br> rate will tend to increase the fair value of an investment property. Changes in fair value based on variations in unobservable inputs generally cannot be extrapolated because the relationship between the directional changes of each input is<br> not usually linear.
---	---
^(2)^	Other invested assets measured at fair value are held primarily in infrastructure and timber sectors. The significant inputs used in the valuation of the Company’s infrastructure<br> investments are primarily future distributable cash flows, terminal values and discount rates. Holding other factors constant, an increase to future distributable cash flows or terminal values would tend to increase the fair value of an<br> infrastructure investment, while an increase in the discount rate would have the opposite effect. Discount rates during the period ranged from 7.15% to 15.6% (for the year ended December 31, 2021 – ranged from 7.25% to 20.0%). Disclosure of<br> distributable cash flow and terminal value ranges are not meaningful given the disparity in estimates by project. The significant inputs used in the valuation of the Company’s investments in timberland properties are timber prices and<br> discount rates. Holding other factors constant, an increase to timber prices would tend to increase the fair value of a timberland investment, while an increase in the discount rates would have the opposite effect. Discount rates during the<br> period ranged from 4.25% to 7.0% (for the year ended December 31, 2021 – ranged from 4.5% to 7.0%). A range of prices for timber is not meaningful as the market price depends on factors such as property location and proximity to markets and<br> export yards.
---	---
^(3)^	Segregated funds net assets are measured at fair value. The Company’s Level 3 segregated funds assets are predominantly in real estate investment properties and timberland<br> properties valued as described above.
---	---

Manulife Financial Corporation – Third Quarter 2022

The following table presents fair value of invested assets not measured at fair value by the fair value hierarchy.

As at September 30, 2022	Carrying<br><br> <br>value		Total fair<br><br> <br>value		Level 1		Level 2		Level 3
Mortgages	$	54,685	$	51,043	$	-	$	-	$	51,043
Private placements		46,672		41,004		-		33,696		7,308
Policy loans		6,833		6,833		-		6,833		-
Loans to Bank clients		2,799		2,785		-		2,785		-
Real estate - own use property		1,921		3,100		-		-		3,100
Public Bonds HTM		1,431		1,021		-		1,021		-
Other invested assets^(1)^		12,479		13,181		98		-		13,083
Total invested assets disclosed at fair value	$	126,820	$	118,967	$	98	$	44,335	$	74,534
As at December 31, 2021	Carrying<br><br> <br>value		Total fair<br><br> <br>value		Level 1		Level 2		Level 3
Mortgages	$	52,014	$	54,089	$	-	$	-	$	54,089
Private placements		42,842		47,276		-		42,110		5,166
Policy loans		6,397		6,397		-		6,397		-
Loans to Bank clients		2,506		2,503		-		2,503		-
Real estate - own use property		1,812		3,024		-		-		3,024
Public Bonds HTM		1,320		1,320		-		1,320		-
Other invested assets^(1)^		11,006		11,665		120		-		11,545
Total invested assets disclosed at fair value	$	117,897	$	126,274	$	120	$	52,330	$	73,824
^(1)^	Other invested assets disclosed at fair value include $3,864 (December 31, 2021 – $3,457) of leveraged leases which are disclosed at their carrying values as fair value is not<br> routinely calculated on these investments.
---	---

Transfers between Level 1 and Level 2

The Company records transfers of assets and liabilities between Level 1 and Level 2 at their fair values as at the end of each reporting period, consistent with the date of the determination of fair value. Assets are transferred out of Level 1 when they are no longer transacted with sufficient frequency and volume in an active market. Conversely, assets are transferred from Level 2 to Level 1 when transaction volume and frequency are indicative of an active market. During the three and nine months ended September 30, 2022 and 2021, the Company had $nil transfers between Level 1 and Level 2.

For segregated funds net assets, the Company had $nil and $nil transfers from Level 1 to Level 2 for the three and nine months ended September 30, 2022 (three and nine months ended September 30, 2021 – $28 and $9). The Company had $nil and $nil transfers from Level 2 to Level 1 for the three and nine months ended September 30, 2022 (three and nine months ended September 30, 2021 – $nil and $182).

Invested assets and segregated funds net assets measured at fair value on the Consolidated Statements of Financial Position using significant unobservable inputs (Level 3)

The Company classifies fair values of the invested assets and segregated funds net assets as Level 3 if there are no observable markets for these assets or, in the absence of active markets, most of the inputs used to determine fair value are based on the Company’s own assumptions about market participant assumptions. The Company prioritizes the use of market-based inputs over entity-based assumptions in determining Level 3 fair values. The gains and losses in the table below includes the changes in fair value due to both observable and unobservable factors.

Manulife Financial Corporation – Third Quarter 2022

The following table presents a roll forward for invested assets, net derivatives and segregated funds net assets measured at fair value using significant unobservable inputs (Level 3) for the three months ended September 30, 2022 and 2021.

For the three months ended<br><br> <br>September 30, 2022	Balance,<br><br> <br>July 1,<br><br> <br>2022			Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in net<br><br> <br>income^(1)^			Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in AOCI^(2)^			Purchases		Sales			Settlements			Transfer<br><br> <br>in^(3)^		Transfer<br><br> <br>out^(3)^			Currency<br><br> <br>movement			Balance,<br><br> <br>September<br><br> <br>30, 2022			Change in<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses) on<br><br> <br>assets still<br><br> <br>held
Debt securities
FVTPL
Corporate	$	12		$	(1	)	$	-		$	-	$	-		$	(1	)	$	6	$	(12	)	$	1		$	5		$	(1	)
Other securitized assets		26			1			-			28		-			(2	)		-		-			1			54			1
AFS
Other government & agency		9			-			-			-		-			-			-		-			-			9			-
Corporate		-			-			-			-		-			-			-		-			-			-			-
Public equities
FVTPL		1			1			-			69		(1	)		-			6		-			-			76			1
AFS		-			(1	)		1			-		-			-			-		-			-			-			-
Investment property		11,769			(89	)		-			159		(7	)		-			-		-			343			12,175			(89	)
Other invested assets		26,780			456			(4	)		1,138		(332	)		(451	)		244		-			1,244			29,075			312
Total invested assets		38,597			367			(3	)		1,394		(340	)		(454	)		256		(12	)		1,589			41,394			224
Derivatives, net		(2,061	)		(1,102	)		(1	)		-		-			(44	)		-		146			(177	)		(3,239	)		(1,119	)
Segregated funds net<br><br> <br>assets		4,374			19			-			49		(167	)		(2	)		-		-			135			4,408			(72	)
Total	$	40,910		$	(716	)	$	(4	)	$	1,443	$	(507	)	$	(500	)	$	256	$	134		$	1,547		$	42,563		$	(967	)
For the three months ended<br><br> <br>September 30, 2021	Balance,<br><br> <br>July 1, 2021		Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in net<br><br> <br>income^(1)^			Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in AOCI^(2)^			Purchases		Sales			Settlements			Transfer<br><br> <br>in^(3)^		Transfer<br><br> <br>out^(3)^			Currency<br><br> <br>movement		Balance,<br><br> <br>September<br><br> <br>30, 2021		Change in<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses) on<br><br> <br>assets still<br><br> <br>held
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
Debt securities
FVTPL
Corporate	$	26	$	1		$	-		$	-	$	-		$	-		$	11	$	-		$	2	$	40	$	1
Other securitized assets		25		1			-			-		-			(27	)		-		-			1		-		(4	)
AFS
Corporate		1		-			-			-		-			-			-		-			-		1		-
Public equities
FVTPL		7		(1	)		-			22		(28	)		-			-		-			-		-		-
Investment property		10,873		265			-			52		-			-			-		-			139		11,329		265
Other invested assets		21,284		1,062			3			1,152		(491	)		(355	)		5		-			429		23,089		860
Total invested assets		32,216		1,328			3			1,226		(519	)		(382	)		16		-			571		34,459		1,122
Derivatives, net		1,442		139			(1	)		2		-			(5	)		-		(118	)		38		1,497		138
Segregated funds net<br><br> <br>assets		4,230		62			-			26		(123	)		(3	)		-		-			62		4,254		8
Total	$	37,888	$	1,529		$	2		$	1,254	$	(642	)	$	(390	)	$	16	$	(118	)	$	671	$	40,210	$	1,268
^(1)^	These amounts are included in net investment income in the Consolidated Statements of Income except for the amount related to segregated funds net assets, where the amount is<br> recorded in changes in segregated funds net assets, refer to note 14.
---	---
^(2)^	These amounts are included in AOCI on the Consolidated Statements of Financial Position.
---	---
^(3)^	The Company uses fair values of the assets at the beginning of the period for assets transferred into and out of Level 3 except for derivatives, where the Company uses fair value<br> at the end of the period and at the beginning of the period, respectively.
---	---

Manulife Financial Corporation – Third Quarter 2022

For the nine months ended<br><br> <br>September 30, 2022	Balance,<br><br> <br>January 1,<br><br> <br>2022		Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in net<br><br> <br>income^(1)^			Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in AOCI^(2)^			Purchases		Sales			Settlements			Transfer<br><br> <br>in^(3)^		Transfer<br><br> <br>out^(3)^			Currency<br><br> <br>movement			Balance,<br><br> <br>September<br><br> <br>30, 2022			Change in<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses) on<br><br> <br>assets still<br><br> <br>held
Debt securities
FVTPL
Corporate	$	40	$	(1	)	$	-		$	-	$	-		$	(1	)	$	6	$	(40	)	$	1		$	5		$	(1	)
Other securitized assets		28		4			-			28		-			(4	)		-		-			(2	)		54			4
AFS
Other government & agency		-		-			-			-		-			-			9		-			-			9			-
Corporate		1		-			-			-		-			-			-		(1	)		-			-			-
Public equities
FVTPL		-		2			-			69		(1	)		-			6		-			-			76			1
AFS		-		(1	)		1			-		-			-			-		-			-			-			-
Investment property		11,421		291			-			254		(156	)		-			-		-			365			12,175			286
Other invested assets		24,043		1,732			6			3,591		(630	)		(1,225	)		248		-			1,310			29,075			1,721
Total invested assets		35,533		2,027			7			3,942		(787	)		(1,230	)		269		(41	)		1,674			41,394			2,011
Derivatives, net		2,101		(5,508	)		(27	)		1		-			478			-		(103	)		(181	)		(3,239	)		(4,121	)
Segregated funds net<br><br> <br>assets		4,281		213			-			196		(422	)		(32	)		-		(1	)		173			4,408			22
Total	$	41,915	$	(3,268	)	$	(20	)	$	4,139	$	(1,209	)	$	(784	)	$	269	$	(145	)	$	1,666		$	42,563		$	(2,088	)
For the nine months ended<br><br> <br>September 30, 2021	Balance,<br><br> <br>January 1,<br><br> <br>2021		Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in net<br><br> <br>income^(1)^			Total<br><br> <br>gains<br><br> <br>(losses)<br><br> <br>included<br><br> <br>in AOCI^(2)^		Purchases		Sales			Settlements			Transfer<br><br> <br>in^(3)^		Transfer<br><br> <br>out^(3)^			Currency<br><br> <br>movement			Balance,<br><br> <br>September<br><br> <br>30, 2021		Change in<br><br> <br>unrealized<br><br> <br>gains<br><br> <br>(losses) on<br><br> <br>assets still<br><br> <br>held
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
Debt securities
FVTPL
Corporate	$	510	$	10		$	-	$	-	$	(93	)	$	-		$	11	$	(397	)	$	(1	)	$	40	$	(8	)
Other securitized assets		45		3			-		-		(9	)		(39	)		-		-			-			-		(4	)
AFS
Corporate		3		1			-		-		(3	)		-			-		-			-			1		-
Public equities
FVTPL		-		-			-		62		(62	)		-			-		-			-			-		-
Investment property		10,982		527			-		132		(267	)		-			-		-			(45	)		11,329		498
Other invested assets		19,049		2,508			-		3,399		(751	)		(1,004	)		5		-			(117	)		23,089		2,361
Total invested assets		30,589		3,049			-		3,593		(1,185	)		(1,043	)		16		(397	)		(163	)		34,459		2,847
Derivatives, net		3,443		(1,727	)		2		14		-			(54	)		-		(215	)		34			1,497		(1,443	)
Segregated funds net<br><br> <br>assets		4,202		217			-		52		(209	)		(11	)		-		-			3			4,254		105
Total	$	38,234	$	1,539		$	2	$	3,659	$	(1,394	)	$	(1,108	)	$	16	$	(612	)	$	(126	)	$	40,210	$	1,509
^(1)^	These amounts are included in net investment income in the Consolidated Statements of Income except for the amount related to segregated funds net assets, where the amount is<br> recorded in changes in segregated funds net assets, refer to note 14.
---	---
^(2)^	These amounts are included in AOCI on the Consolidated Statements of Financial Position.
---	---
^(3)^	The Company uses fair values of the assets at the beginning of the year for assets transferred into and out of Level 3 except for derivatives, where the Company uses fair value at<br> the end of the period and at the beginning of the year, respectively.
---	---

Transfers into Level 3 primarily result from securities that were impaired during the periods or securities where a lack of observable market data (versus the previous period) resulted in reclassifying assets into Level 3. Transfers from Level 3 primarily result from observable market data becoming available for the entire term structure of the debt security.

Manulife Financial Corporation – Third Quarter 2022

Note 4	Derivative and Hedging Instruments

Fair value of derivatives

The following table presents gross notional amount and fair value of derivative instruments by the underlying risk exposure for derivatives in qualifying hedge accounting relationships and derivatives not designated in qualifying hedge accounting relationships.

		September 30, 2022								December 31, 2021
As at		Notional<br><br> <br>amount			Fair value					Notional<br><br> <br>amount		Fair value
Type of hedge	Instrument type			Assets			Liabilities				Assets			Liabilities
Derivatives in qualifying hedge accounting<br><br> <br>relationships
Fair value hedges	Foreign currency swaps	$	49		$	6		$	-	$	57	$	1		$	1
Cash flow hedges	Foreign currency swaps		1,129			12			222		1,251		5			379
	Equity contracts		192			3			10		145		10			-
Net investment hedges	Forward contracts		622			35			-		671		9			-
Total derivatives in qualifying hedge accounting<br><br> <br>relationships			1,992			56			232		2,124		25			380
Derivatives not designated in qualifying<br><br> <br>hedge accounting relationships
Interest rate swaps			270,473			5,692			7,271		300,556		11,832			7,347
Interest rate futures			12,739			-			-		11,944		-			-
Interest rate options			9,127			215			-		10,708		514			-
Foreign currency swaps			38,357			2,267			2,208		36,405		790			1,722
Currency rate futures			2,324			-			-		3,086		-			-
Forward contracts			43,759			357			4,724		45,295		2,674			562
Equity contracts			17,191			346			381		18,577		1,667			27
Credit default swaps			138			2			-		44		1			-
Equity futures			4,240			-			-		11,359		-			-
Total derivatives not designated in qualifying<br><br> <br>hedge accounting relationships			398,348			8,879			14,584		437,974		17,478			9,658
Total derivatives		$	400,340		$	8,935		$	14,816	$	440,098	$	17,503		$	10,038

The total notional amount of $400 billion (December 31, 2021 – $440 billion) includes $81 billion (December 31, 2021 – $121 billion) related to derivatives utilized in the Company’s variable annuity guarantee dynamic hedging and macro risk hedging programs. Due to the Company’s variable annuity hedging practices, many trades are in offsetting positions, resulting in materially lower net fair value exposure to the Company than what the gross notional amount would suggest.

The total notional amount above includes $216 billion (December 31, 2021 – $258 billion) of derivative instruments which reference rates that are impacted under the interest rate benchmark reform, with a significant majority to USD LIBOR, and CDOR. Exposures indexed to USD LIBOR and CDOR represent derivatives with maturity dates beyond June 30, 2023 and June 28, 2024, respectively. The exposure in the Company’s hedge accounting programs is primarily to USD LIBOR and CDOR benchmarks. Compared to the overall risk exposure, the effect of interest rate benchmark reform on existing accounting hedges is not significant. The Company continues to apply high probability and high effectiveness expectation assumptions for cash flows and there would be no automatic de-designation of qualifying hedge relationships due to the impact from interest rate benchmark reform.

Manulife Financial Corporation – Third Quarter 2022

The following table presents the fair values of derivative instruments by remaining term to maturity. Fair values disclosed below do not incorporate the impact of master netting agreements (refer to note 6).

	Remaining term to maturity
As at September 30, 2022	Less than<br><br> <br>1 year		1 to 3<br><br> <br>years		3 to 5<br><br> <br>years		Over 5<br><br> <br>years		Total
Derivative assets	$	657	$	584	$	540	$	7,154	$	8,935
Derivative liabilities		2,693		2,367		1,195		8,561		14,816
	Remaining term to maturity
As at December 31, 2021	Less than<br><br> <br>1 year		1 to 3<br><br> <br>years		3 to 5<br><br> <br>years		Over 5<br><br> <br>years		Total
Derivative assets	$	2,500	$	1,803	$	1,000	$	12,200	$	17,503
Derivative liabilities		294		387		379		8,978		10,038

The following table presents fair value of derivative contracts within the fair value hierarchy.

As at September 30, 2022	Fair value		Level 1		Level 2		Level 3
Derivative assets
Interest rate contracts	$	5,971	$	-	$	5,694	$	277
Foreign exchange contracts		2,613		-		2,612		1
Equity contracts		349		-		333		16
Credit default swaps		2		-		2		-
Total derivative assets	$	8,935	$	-	$	8,641	$	294
Derivative liabilities
Interest rate contracts	$	11,731	$	-	$	8,243	$	3,488
Foreign exchange contracts		2,694		-		2,690		4
Equity contracts		391		-		350		41
Total derivative liabilities	$	14,816	$	-	$	11,283	$	3,533
As at December 31, 2021	Fair value		Level 1		Level 2		Level 3
Derivative assets
Interest rate contracts	$	14,971	$	-	$	12,510	$	2,461
Foreign exchange contracts		854		-		854		-
Equity contracts		1,677		-		1,616		61
Credit default swaps		1		-		1		-
Total derivative assets	$	17,503	$	-	$	14,981	$	2,522
Derivative liabilities
Interest rate contracts	$	7,829	$	-	$	7,419	$	410
Foreign exchange contracts		2,182		-		2,181		1
Equity contracts		27		-		17		10
Total derivative liabilities	$	10,038	$	-	$	9,617	$	421

Level 3 roll forward information for net derivative contracts measured using significant unobservable inputs is disclosed in note 3(c).

Note 5	Insurance and Investment Contract Liabilities
(a)	Insurance and investment contracts
---	---

Manulife Financial Corporation – Third Quarter 2022

2022 Review of Actuarial Methods and Assumptions

The completion of the 2022 annual review of actuarial methods and assumptions resulted in a decrease in insurance contract liabilities, net of reinsurance, of $80, and a net gain to net income attributed to shareholders of $36 post-tax.

	Change in insurance contract liabilities, net of<br><br> <br>reinsurance
For the three and nine months ended September 30, 2022	Total			Attributed to<br><br> <br>participating<br><br> <br>policyholders’<br><br> <br>account^(1)^			Attributed to<br><br> <br>shareholders’<br><br> <br>account			Change in net<br><br> <br>income<br><br> <br>attributed to<br><br> <br>shareholders<br><br> <br>(post-tax)
Long-term care triennial review	$	19		$	-		$	19		$	(15	)
Mortality and morbidity updates		157			(5	)		162			(126	)
Lapses and policyholder behaviour updates		317			74			243			(192	)
Investment related updates		(210	)		(1	)		(209	)		157
Other updates		(363	)		(145	)		(218	)		212
Net impact	$	(80	)	$	(77	)	$	(3	)	$	36
^(1)^	The change in insurance contract liabilities, net of reinsurance, attributable to the participating policyholders’ account was primarily driven by an increase in expected long-term<br> interest rates within the valuation models to reflect the higher interest rate environment, partially offset by the lapse assumption update in Canada.
---	---

Long-term care triennial review

U.S. Insurance completed a comprehensive long-term care (“LTC”) experience study. The review included all aspects of claim assumptions, as well as the progress on future premium rate increases. The impact of the LTC review resulted in a net $15 post-tax charge to net income attributed to shareholders.

The experience study showed that claim costs established in the last triennial review remain appropriate in aggregate for the older blocks of business^1^ supported by robust claims data on this mature block. Insurance contract liabilities were strengthened for claim costs on the newer block of business^2^. This was driven by lower active life mortality^3^ supported by Company experience and a recent industry study, as well as higher utilization of benefits, which included the impact of reflecting higher inflation in the cost-of-care up to the current year. The Company also reviewed and updated incidence and claim termination assumptions which, on a net basis, provided a partial offset to the increase in insurance contract liabilities on active life mortality and utilization. In addition, some policyholders are electing to reduce their benefits in lieu of paying increased premiums which resulted in a reduction in insurance contract liabilities. The overall claims experience review led to a post-tax charge to net income attributed to shareholders of approximately $2.3 billion (US$1.7 billion).

Experience continues to support the assumptions of both future morbidity and mortality improvement, resulting in no changes to these assumptions.

As of September 30, 2022, the Company has received actual premium increase approvals of $2.5 billion pre-tax (US$1.9 billion pre-tax) on a present value basis since the last triennial review in 2019. This aligns with the full amount assumed in the Company’s insurance contract liabilities at that time and demonstrates the Company’s continued strong track record of progress in securing premium rate increases.^4^ In 2022, the review of future premium increases assumed in insurance contract liabilities resulted in a post-tax gain to net income attributed to shareholders of approximately $2.1 billion (US$1.6 billion). This reflects expected future premium increases that are due to the Company’s 2022 review of morbidity, mortality, and lapse assumptions, as well as outstanding amounts from prior state filings. Premium increases averaging approximately 30% will be sought on about one-half of the business, excluding the carryover of 2019 amounts requested. The Company’s assumptions reflect the estimated timing and amount of state approved premium increases.

Other refinements to LTC valuation resulted in a post-tax gain of approximately $0.2 billion (US$0.2 billion) to net income attributed to shareholders.

^1^	First generation policies issued prior to 2002.
^2^	Second generation policies with an average issue date of 2007 and Group policies with an average issue date of 2003.
---	---
^3^	The mortality rate of LTC policyholders who are currently not on claim.
---	---
^4^	Actual experience obtaining premium increases could be materially different than what the Company has assumed, resulting in further increases or decreases in insurance contract<br> liabilities, which could be material.
---	---

Manulife Financial Corporation – Third Quarter 2022

Mortality and morbidity updates

Mortality and morbidity updates resulted in a $126 post-tax charge to net income attributed to shareholders, driven by a detailed review of the mortality and morbidity assumptions for the Company’s Canada insurance business, and by updates to morbidity assumptions in Vietnam to align with experience.

Lapses and policyholder behaviour updates

Updates to lapses and policyholder behaviour assumptions resulted in a $192 post-tax charge to net income attributed to shareholders.

The Company completed a detailed review of lapse assumptions for Singapore, and increased lapse rates to align with experience on index-linked products, which reduced projected future fee income to be received on these products.

The Company also increased lapse rates on Canada’s term insurance products for policies approaching their renewal date, reflecting emerging experience in the Company’s study.

Investment-related updates

Updates to investment return assumptions resulted in a $157 post-tax gain to net income attributed to shareholders, primarily driven by annual updates to the Company’s valuation models to reflect market movements during the year. No changes were made to the Company’s long-term assumed returns.

Other updates

Other updates resulted in a $212 post-tax gain to net income attributed to shareholders, which included refinements to the projection of the Company’s tax and liability cash flows, as well as various other modelling updates.

2021 Review of Actuarial Methods and Assumptions

The 2021 annual review of actuarial methods and assumptions resulted in an increase in insurance contract liabilities of $287, net of reinsurance, and a decrease in net income attributed to shareholders of $41 post-tax.

	Change in insurance contract liabilities, net of reinsurance
For the three and nine months ended September 30, 2021	Total			Attributed to<br><br> <br>participating<br><br> <br>policyholders’<br><br> <br>account^(1)^			Attributed to<br><br> <br>shareholders’<br><br> <br>account			Change in net<br><br> <br>income<br><br> <br>attributed to<br><br> <br>shareholders<br><br> <br>(post-tax)
U.S. variable annuity product review	$	51		$	-		$	51		$	(40	)
Mortality and morbidity updates		350			-			350			(257	)
Lapses and policyholder behaviour updates		686			18			668			(534	)
Expense updates		(653	)		(25	)		(628	)		503
Investment related updates		(257	)		(2	)		(255	)		168
Other updates		110			231			(121	)		119
Net impact	$	287		$	222		$	65		$	(41	)
^(1)^	The change in insurance contract liabilities, net of reinsurance, attributable to the participating policyholders’ account was primarily driven by a reduction in the expected<br> long-term interest rates within the valuation models to reflect the low interest rate environment.
---	---
(b)	Investment contracts – Fair value measurement
---	---

As at September 30, 2022, the fair value of investment contract liabilities measured at fair value was $788 (December 31, 2021 – $802). The carrying value and fair value of investment contract liabilities measured at amortized cost were $2,471 and $2,466, respectively (December 31, 2021 – $2,315 and $2,618, respectively). The carrying value and fair value of investment contract liabilities net of reinsurance assets were $2,428 and $2,426, respectively (December 31, 2021 – $2,267 and $2,566, respectively).

Manulife Financial Corporation – Third Quarter 2022

(c)	Gross claims and benefits

The following table presents a breakdown of gross claims and benefits for the three and nine months ended September 30, 2022 and 2021.

	three months ended<br><br> <br>September 30,						nine months ended<br><br> <br>September 30,
For the	2022			2021			2022			2021
Death, disability and other claims	$	4,786		$	4,660		$	14,456		$	13,816
Maturity and surrender benefits		2,593			2,070			7,647			6,410
Annuity payments		791			828			2,414			2,457
Policyholder dividends and experience rating refunds		380			386			1,009			902
Net transfers from segregated funds		(270	)		(159	)		(840	)		(520	)
Total	$	8,280		$	7,785		$	24,686		$	23,065
(d)	Reinsurance transaction
---	---

On November 15, 2021, the Company, through its subsidiary John Hancock Life Insurance Company (U.S.A.) (“JHUSA”), entered into a reinsurance agreement with Venerable Holdings, Inc. to reinsure a block of legacy U.S. variable annuity (“VA”) policies. Under the terms of the transaction, the Company will retain responsibility for the maintenance of the policies with no intended impact to VA policyholders. The transaction was structured as coinsurance for the general fund liabilities and modified coinsurance for the segregated fund liabilities.

The transaction closed on February 1, 2022 resulting in a cumulative after-tax gain of $771, comprising a cumulative after-tax gain of $811 recognized in 2022, and a one-time after-tax loss of $40 recognized in the fourth quarter 2021.

Note 6	Risk Management

The Company’s policies and procedures for managing risk related to financial instruments and insurance contracts can be found in note 8 of the Company’s 2021 Annual Consolidated Financial Statements as well as the denoted text and tables in the “Risk Management and Risk Factors” section of the Company’s MD&A in the 2021 Annual Report.

(a)	Risk disclosures included in the Third Quarter MD&A

Market risk sensitivities related to variable annuity and segregated fund guarantees, publicly traded equity performance risk, interest rate and spread risk and alternative long-duration asset performance risk are disclosed in denoted text and tables in the “Risk Management and Risk Factors Update” section of the Third Quarter 2022 MD&A. These disclosures are in accordance with IFRS 7 “Financial Instruments: Disclosures” and IAS 34 “Interim Financial Reporting” and are an integral part of these Interim Consolidated Financial Statements.

(b)	Credit risk
(I)	Credit quality
---	---

The credit quality of commercial mortgages and private placements is assessed at least annually by using an internal rating based on regular monitoring of credit related exposures, considering both qualitative and quantitative factors.

Manulife Financial Corporation – Third Quarter 2022

The following table presents the credit quality and carrying value of the commercial mortgages and private placements.

As at September 30, 2022	AAA		AA			A	BBB		BB		B and lower		Total
Commercial mortgages
Retail	$	115	$	1,601	$	4,923	$	2,097	$	197	$	2	$	8,935
Office		103		1,437		5,929		1,450		124		34		9,077
Multi-family residential		500		2,532		3,767		903		11		-		7,713
Industrial		60		910		3,203		416		-		-		4,589
Other		190		744		833		778		-		-		2,545
Total commercial mortgages		968		7,224		18,655		5,644		332		36		32,859
Agricultural mortgages		-		-		123		247		-		-		370
Private placements		976		7,272		16,450		17,202		1,045		3,727		46,672
Total	$	1,944	$	14,496	$	35,228	$	23,093	$	1,377	$	3,763	$	79,901
As at December 31, 2021	AAA		AA			A	BBB		BB		B and lower		Total
Commercial mortgages
Retail	$	113	$	1,340	$	5,179	$	1,936	$	228	$	2	$	8,798
Office		56		1,256		6,004		1,291		87		40		8,734
Multi-family residential		557		1,869		3,771		767		32		-		6,996
Industrial		47		376		2,808		328		-		-		3,559
Other		212		1,010		787		956		47		-		3,012
Total commercial mortgages		985		5,851		18,549		5,278		394		42		31,099
Agricultural mortgages		-		-		119		242		-		-		361
Private placements		976		5,721		16,147		16,220		1,161		2,618		42,843
Total	$	1,961	$	11,572	$	34,815	$	21,740	$	1,555	$	2,660	$	74,303

The Company assesses credit quality of residential mortgages and loans to Bank clients at least annually with the loan status as performing or non-performing being the key credit quality indicator.

The following table presents the carrying value of residential mortgages and loans to Bank clients.

	September 30, 2022						December 31, 2021
As at	Insured		Uninsured		Total		Insured		Uninsured		Total
Residential mortgages
Performing	$	7,204	$	14,220	$	21,424	$	7,264	$	13,272	$	20,536
Non-performing^(1)^		2		30		32		6		12		18
Loans to Bank clients
Performing		n/a		2,795		2,795		n/a		2,506		2,506
Non-performing^(1)^		n/a		4		4		n/a		-		-
Total	$	7,206	$	17,049	$	24,255	$	7,270	$	15,790	$	23,060
^(1)^	Non-performing refers to payments that are 90 days or more past due.
---	---

Manulife Financial Corporation – Third Quarter 2022

(II)	Past due or credit impaired financial assets

The following table presents the carrying value of financial assets with some or all of their contractual payments past due but which are not impaired and impaired financial assets and the allowance for credit losses.

	Past due but not impaired
As at September 30, 2022	Less than 90<br><br> <br>days		90 days and<br><br> <br>greater		Total		Total<br><br> <br>impaired		Allowance<br><br> <br>for credit<br><br> <br>losses
Debt securities^(1),(2)^
FVTPL	$	661	$	751	$	1,412	$	4	$	-
AFS		316		-		316		-		-
Private placements^(1)^		1,045		-		1,045		233		29
Mortgages and loans to Bank clients		81		-		81		65		23
Other financial assets		26		44		70		1		-
Total	$	2,129	$	795	$	2,924	$	303	$	52
	Past due but not impaired
As at December 31, 2021	Less than 90<br><br> <br>days		90 days and<br><br> <br>greater		Total		Total<br><br> <br>impaired		Allowance<br><br> <br>for credit<br><br> <br>losses
Debt securities
FVTPL	$	20	$	-	$	20	$	2	$	-
AFS		-		-		-		-		-
Private placements		63		-		63		175		22
Mortgages and loans to Bank clients		61		-		61		51		22
Other financial assets		261		47		308		-		-
Total	$	405	$	47	$	452	$	228	$	44
^(1)^	Payments of $35 on $2,022 (December 31, 2021 – $nil and $20, respectively) of financial assets past due less than 90 days are delayed.
---	---
^(2)^	Payments of $13 on $751 (December 31, 2021 – $nil and $nil, respectively) of financial assets past due greater than 90 days are delayed.
---	---
(c)	Securities lending, repurchase and reverse repurchase transactions
---	---

As at September 30, 2022, the Company had loaned securities (which are included in invested assets), with a market value of $702 (December 31, 2021 – $564). The Company holds collateral with a current market value that exceeds the value of securities lent in all cases.

As at September 30, 2022, the Company had engaged in reverse repurchase transactions of $642 (December 31, 2021 – $1,490) which are recorded as receivables. In addition, the Company had engaged in repurchase transactions of $978 as at September 30, 2022 (December 31, 2021 – $536) which are recorded as payables.

(d)	Credit default swaps

The Company replicates exposure to specific issuers by selling credit protection via credit default swaps (“CDS”) to complement its cash debt securities investing. The Company does not write CDS protection in excess of its government bond holdings.

Manulife Financial Corporation – Third Quarter 2022

The following table presents details of the CDS protection sold by type of contract and external agency rating for the underlying reference security.

As at September 30, 2022	Notional<br><br> <br>amount^(1)^		Fair value		Weighted<br><br> <br>average<br><br> <br>maturity<br><br> <br>(in years)^(2)^
Single name CDS^(3),(4)^– Corporate debt
A	$	114	$	2		5
BBB		24		-		1
Total single name CDS	$	138	$	2		4
Total CDS protection sold	$	138	$	2		4
As at December 31, 2021	Notional<br><br> <br>amount^(1)^		Fair value		Weighted<br><br> <br>average <br><br> maturity<br><br> <br>(in years)^(2)^
Single name CDS^(3),(4)^– Corporate debt
A	$	16	$	-		1
BBB		28		1		2
Total single name CDS	$	44	$	1		2
Total CDS protection sold	$	44	$	1		2
^(1)^	Notional amounts represent the maximum future payments the Company would have to pay its CDS counterparties assuming a default of the underlying credit and zero<br> recovery on the underlying issuer obligations.
---	---
^(2)^	The weighted average maturity of the CDS is weighted based on notional amounts.
---	---
^(3)^	Ratings are based on S&P where available followed by Moody’s, DBRS, and Fitch. If no rating is available from a rating agency, an internally developed<br> rating is used.
---	---
^(4)^	The Company held no purchased credit protection.
---	---
(e)	Derivatives
---	---

The Company’s point-in-time exposure to losses related to credit risk of a derivative counterparty is limited to the amount of any net gains that may have accrued with the particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in a loss position and the impact of collateral on hand. The Company limits the risk of credit losses from derivative counterparties by using investment grade counterparties, entering into master netting arrangements which permit the offsetting of contracts in a loss position in the case of a counterparty default, and entering into Credit Support Annex agreements whereby collateral must be provided when the exposure exceeds a certain threshold.

All contracts are held with or guaranteed by investment grade counterparties, the majority of whom are rated A- or higher. As at September 30, 2022, the percentage of the Company’s derivative exposure with counterparties rated AA- or higher was 36 per cent (December 31, 2021 – 17 per cent). As at September 30, 2022, the largest single counterparty exposure, without taking into consideration the impact of master netting agreements or the benefit of collateral held, was $1,530 (December 31, 2021 – $2,132). The net exposure to this counterparty, after taking into consideration master netting agreements and the fair value of collateral held, was $nil (December 31, 2021 – $nil).

(f)	Offsetting financial assets and financial liabilities

Certain derivatives, securities lent and repurchase agreements have conditional offset rights. The Company does not offset these financial instruments in the Consolidated Statements of Financial Position, as the rights of offset are conditional. In the case of derivatives, collateral is collected from and pledged to counterparties and clearing houses to manage credit risk exposure in accordance with Credit Support Annexes to swap agreements and clearing agreements. Under master netting agreements, the Company has a right of offset in the event of default, insolvency, bankruptcy or other early termination.

In the case of reverse repurchase and repurchase transactions, additional collateral may be collected from or pledged to counterparties to manage credit exposure according to bilateral reverse repurchase or repurchase agreements. In the event of default by a reverse purchase transaction counterparty, the Company is entitled to liquidate the collateral held to offset against the same counterparty’s obligation.

Manulife Financial Corporation – Third Quarter 2022

The following table presents the effect of conditional master netting and similar arrangements. Similar arrangements may include global master repurchase agreements, global master securities lending agreements, and any related rights to financial collateral pledged or received.

				Related amounts not set off in the<br><br> <br>Consolidated Statements of Financial<br><br> <br>Position
As at September 30, 2022	Gross amounts of<br><br> <br>financial<br><br> <br>instruments^(1)^			Amounts subject to<br><br> <br>an enforceable<br><br> <br>master netting<br><br> <br>arrangement or<br><br> <br>similar agreements			Financial and<br><br> <br>cash collateral<br><br> <br>pledged<br><br> <br>(received)^(2)^			Net amount<br><br> <br>including<br><br> <br>financing<br><br> <br>entity^(3)^			Net amounts<br><br> <br>excluding<br><br> <br>financing entity
Financial assets
Derivative assets	$	9,408		$	(7,650	)	$	(1,643	)	$	115		$	115
Securities lending		702			-			(702	)		-			-
Reverse repurchase agreements		642			(616	)		(26	)		-			-
Total financial assets	$	10,752		$	(8,266	)	$	(2,371	)	$	115		$	115
Financial liabilities
Derivative liabilities	$	(15,631	)	$	7,650		$	7,834		$	(147	)	$	(93	)
Repurchase agreements		(978	)		616			362			-			-
Total financial liabilities	$	(16,609	)	$	8,266		$	8,196		$	(147	)	$	(93	)
				Related amounts not set off in the<br><br> <br>Consolidated Statements of Financial<br><br> <br>Position
As at December 31, 2021	Gross amounts of<br><br> <br>financial<br><br> <br>instruments^(1)^			Amounts subject to<br><br> <br>an enforceable<br><br> <br>master netting<br><br> <br>arrangement or<br><br> <br>similar agreements			Financial and<br><br> <br>cash collateral<br><br> <br>pledged<br><br> <br>(received)^(2)^			Net amount<br><br> <br>including<br><br> <br>financing<br><br> <br>entity^(3)^			Net amounts<br><br> <br>excluding<br><br> <br>financing entity
Financial assets
Derivative assets	$	18,226		$	(8,410	)	$	(9,522	)	$	294		$	294
Securities lending		564			-			(564	)		-			-
Reverse repurchase agreements		1,490			(183	)		(1,307	)		-			-
Total financial assets	$	20,280		$	(8,593	)	$	(11,393	)	$	294		$	294
Financial liabilities
Derivative liabilities	$	(10,940	)	$	8,410		$	2,250		$	(280	)	$	(79	)
Repurchase agreements		(536	)		183			353			-			-
Total financial liabilities	$	(11,476	)	$	8,593		$	2,603		$	(280	)	$	(79	)
^(1)^	Financial assets and liabilities include accrued interest of $479 and $815, respectively (December 31, 2021 – $725 and $902, respectively).
---	---
^(2)^	Financial and cash collateral exclude over-collateralization. As at September 30, 2022, the Company was over-collateralized on OTC derivative assets, OTC derivative liabilities,<br> securities lending and reverse repurchase agreements and repurchase agreements in the amounts of $768, $1,350, $59 and $nil, respectively (December 31, 2021 – $599, $875, $36 and $2, respectively). As at September 30, 2022, collateral<br> pledged (received) does not include collateral-in-transit on OTC instruments or include initial margin on exchange traded contracts or cleared contracts.
---	---
^(3)^	Includes derivative contracts entered between the Company and its unconsolidated financing entity (refer to note 12). The Company does not exchange collateral on derivative<br> contracts entered with this entity.
---	---

Manulife Financial Corporation – Third Quarter 2022

The Company also has certain credit linked note assets and variable surplus note liabilities which have unconditional offsetting rights. Under the netting agreements, the Company has rights of offset including in the event of the Company’s default, insolvency, or bankruptcy. These financial instruments are offset in the Company’s Consolidated Statements of Financial Position.

A credit linked note is a fixed income instrument the term of which, in this case, is linked to a variable surplus note. A surplus note is a subordinated debt obligation that often qualifies as surplus (the U.S. statutory equivalent of equity) by some U.S. state insurance regulators. Interest payments on surplus notes are made after all other contractual payments are made. The following table presents the effect of unconditional netting.

As at September 30, 2022	Gross amounts of<br><br> <br>financial<br><br> <br>instruments			Amounts subject to<br><br> <br>an enforceable<br><br> <br>netting<br><br> <br>arrangement			Net amounts of<br><br> <br>financial<br><br> <br>instruments
Credit linked note	$	1,250		$	(1,250	)	$	-
Variable surplus note		(1,250	)		1,250			-
As at December 31, 2021	Gross amounts of<br><br> <br>financial<br><br> <br>instruments			Amounts subject to<br><br> <br>an enforceable<br><br> <br>netting<br><br> <br>arrangement			Net amounts of<br><br> <br>financial<br><br> <br>instruments
Credit linked note	$	1,054		$	(1,054	)	$	-
Variable surplus note		(1,054	)		1,054			-
Note 7	Long-Term Debt
---	---
(a)	Carrying value of long-term debt instruments
---	---
As at	Issue date	Maturity date	Par value		December 31,<br><br> <br>2021
---	---	---	---	---	---	---
3.050% Senior notes^(1)^	August 27, 2020	August 27, 2060	US1,155	1,580	$	1,455
5.375% Senior notes^(1)^	March 4, 2016	March 4, 2046	US750	1,018		939
3.703% Senior notes^(1),(2)^	March 16, 2022	March 16, 2032	US750	1,024		-
2.396% Senior notes^(1)^	June 1, 2020	June 1, 2027	US200	274		253
2.484% Senior notes^(1)^	May 19, 2020	May 19, 2027	US500	684		630
3.527% Senior notes^(1)^	December 2, 2016	December 2, 2026	US270	370		342
4.150% Senior notes^(1)^	March 4, 2016	March 4, 2026	US1,000	1,370		1,263
Total				6,320	$	4,882

All values are in US Dollars.

^(1)^	These U.S. dollar senior notes have been designated as hedges of the Company’s net investment in its U.S. operations which reduces the earnings volatility that would otherwise<br> arise from the re-measurement of these senior notes into Canadian dollars.
^(2)^	Issued by MFC during the first quarter, interest is payable semi-annually. The Company may redeem the senior notes in whole or in part, at any time, at a redemption price equal to<br> the greater of par and a price based on the yield of a corresponding U.S. Treasury bond, from redemption date to December 16, 2031, plus 25 bps, together with accrued and unpaid interest.
---	---
(b)	Fair value measurement
---	---

Fair value of long-term debt instruments is determined using the following hierarchy:

Level 1 – Fair value is determined using quoted market prices where available.

Level 2 – When quoted market prices are not available, fair value is determined with reference to quoted prices of similar debt instruments or estimated using discounted cash flows based on observable market rates.

The Company measures long-term debt at amortized cost in the Consolidated Statements of Financial Position. As at September 30, 2022, the fair value of long-term debt was $5,624 (December 31, 2021 – $5,439). Fair value of long-term debt was determined using Level 2 valuation techniques (December 31, 2021 – Level 2).

Manulife Financial Corporation – Third Quarter 2022

Note 8	Capital Instruments
(a)	Carrying value of capital instruments
---	---
As at	Issue date	Earliest par<br><br> <br>redemption date	Maturity date	Par value		December 31, 2021
---	---	---	---	---	---	---	---
JHFC Subordinated notes^(1)^	December 14, 2006	n/a	December 15, 2036	650	647	$	647
2.818% MFC Subordinated debentures^(1)^	May 12, 2020	May 13, 2030	May 13, 2035	1,000	996		995
4.061% MFC Subordinated notes^(1),(2)^	February 24, 2017	February 24, 2027	February 24, 2032	US750	1,027		947
2.237% MFC Subordinated debentures^(1)^	May 12, 2020	May 12, 2025	May 12, 2030	1,000	997		997
3.00% MFC Subordinated notes^(1)^	November 21, 2017	November 21, 2024	November 21, 2029	S500	478		469
3.049% MFC Subordinated debentures^(1)^	August 18, 2017	August 20, 2024	August 20, 2029	750	749		748
3.317% MFC Subordinated debentures^(1)^	May 9, 2018	May 9, 2023	May 9, 2028	600	600		599
3.181% MLI Subordinated debentures^(1),(3)^	November 20, 2015	November 22, 2022	November 22, 2027	1,000	1,000		999
7.375% JHUSA Surplus notes	February 25, 1994	n/a	February 15, 2024	US450	624		579
Total					7,118	$	6,980

All values are in US Dollars.

^(1)^	The Company is monitoring regulatory and market developments globally with respect to the interest rate benchmark reform. As reference interest rates for these capital instruments<br> could potentially be discontinued in the future, the Company will take appropriate actions in due course to accomplish the necessary transitions or replacements. As at September 30, 2022, capital instruments of $647 (December 31, 2021 –<br> $647) have interest rate referencing CDOR. In addition, capital instruments of $4,341, $1,027, and $478 (December 31, 2021 – $4,338, $947, and $469, respectively) have interest rate reset in the future referencing CDOR, the USD Mid-Swap<br> rate, and the SGD swap rate, respectively.
^(2)^	Designated as a hedge of the Company’s net investment in its U.S. operations which reduces the earnings volatility that would otherwise arise from the re-measurement of the<br> subordinated notes into Canadian dollars.
---	---
^(3)^	On October 12, 2022, MLI announced its intention to redeem in full the 3.181% MLI subordinated debentures at par, on November 22, 2022, the earliest par redemption date.
---	---
(b)	Fair value measurement
---	---

Fair value of capital instruments is determined using the following hierarchy:

Level 1 – Fair value is determined using quoted market prices where available.

The Company measures capital instruments at amortized cost in the Consolidated Statements of Financial Position. As at September 30, 2022, the fair value of capital instruments was $6,741 (December 31, 2021 – $7,213). Fair value of capital instruments was determined using Level 2 valuation techniques (December 31, 2021 – Level 2).

Manulife Financial Corporation – Third Quarter 2022

Note 9	Equity Capital and Earnings Per Share
(a)	Preferred shares and other equity instruments
---	---

The following table presents information about the outstanding preferred shares and other equity instruments as at September 30, 2022 and December 31, 2021.

											Net amount^(4)^
As at	Issue date	Annual<br><br> <br>dividend/<br><br> <br>distribution<br><br> <br>rate^(1)^			Earliest<br><br> <br>redemption<br><br> <br>date^(2),(3)^		Number of<br><br> <br>shares<br><br> <br>(in millions)		Face<br><br> <br>amount		September 30,<br><br> <br>2022		December 31,<br><br> <br>2021
Preferred shares
Class A preferred shares
Series 2	February 18, 2005		4.65	%		n/a		14	$	350	$	344	$	344
Series 3	January 3, 2006		4.50	%		n/a		12		300		294		294
Class 1 preferred shares
Series 3^(5),(6)^	March 11, 2011		2.348	%	June 19, 2026			7		163		160		160
Series 4^(7)^	June 20, 2016	floating			June 19, 2026			1		37		36		36
Series 7^(8)^	February 22, 2012		4.312	%	March 19, 2022			10		250		-		244
Series 9^(5),(6),(13)^	May 24, 2012		5.978	%	September 19, 2027			10		250		244		244
Series 11^(5),(6)^	December 4, 2012		4.731	%	March 19, 2023			8		200		196		196
Series 13^(5),(6)^	June 21, 2013		4.414	%	September 19, 2023			8		200		196		196
Series 15^(5),(6)^	February 25, 2014		3.786	%	June 19, 2024			8		200		195		195
Series 17^(5),(6)^	August 15, 2014		3.80	%	December 19, 2024			14		350		343		343
Series 19^(5),(6)^	December 3, 2014		3.675	%	March 19, 2025			10		250		246		246
Series 23^(8)^	November 22, 2016		4.85	%	March 19, 2022			19		475		-		467
Series 25^(5),(6)^	February 20, 2018		4.70	%	June 19, 2023			10		250		245		245
Other equity instruments
Limited recourse capital notes
Series 1^(9),(12)^	February 19, 2021		3.375	%	May 19, 2026			n/a		2,000		1,982		1,982
Series 2^(10),(12)^	November 12, 2021		4.100	%	February 19, 2027			n/a		1,200		1,189		1,189
Series 3^(11),(12)^	June 16, 2022		7.117	%	June 19, 2027			n/a		1,000		990		-
Total								131	$	7,475	$	6,660	$	6,381
^(1)^	Holders of Class A and Class 1 preferred shares are entitled to receive non-cumulative preferential cash dividends on a quarterly basis, as and when declared<br> by the Board of Directors. Non-deferrable distributions are payable to all LRCN holders semi-annually at the Company’s discretion.
---	---
^(2)^	Redemption of all preferred shares is subject to regulatory approval. MFC may redeem each series, in whole or in part, at par, on the earliest redemption date<br> or every five years thereafter, except for Class A Series 2, Class A Series 3 and Class 1 Series 4 preferred shares. Class A Series 2 and Series 3 preferred shares are past their respective earliest redemption date and MFC may redeem these<br> shares, in whole or in part, at par at any time, subject to regulatory approval, as noted. MFC may redeem the Class 1 Series 4, in whole or in part, at any time, at $25.00 per share if redeemed on June 19, 2026 (the earliest redemption<br> date) and on June 19 every five years thereafter, or at $25.50 per share if redeemed on any other date after June 19, 2021, subject to regulatory approval, as noted.
---	---
^(3)^	Redemption of all LRCN series is subject to regulatory approval. MFC may at its option redeem each series in whole or in part, at a redemption price equal to<br> par, together with accrued and unpaid interest. The redemption period for Series 1 is every five years during the period from May 19 to and including June 19, commencing in 2026. The redemption period for Series 2 is every five years during<br> the period from February 19 to and including March 19, commencing in 2027. After the first redemption date, the redemption period for Series 3 is every five years during the period from May 19 to and including June 19, commencing in 2032.
---	---
^(4)^	Net of after-tax issuance costs.
---	---
^(5)^	On the earliest redemption date and every five years thereafter, the annual dividend rate will be reset to the five-year Government of Canada bond yield plus a yield specified for<br> each series. The specified yield for Class 1 preferred shares is: Series 3 – 1.41%, Series 9 – 2.86%, Series 11 – 2.61%, Series 13 – 2.22%, Series 15 – 2.16%, Series 17 – 2.36%, Series 19 – 2.30%, and Series 25 – 2.55%.
---	---
^(6)^	On the earliest redemption date and every five years thereafter, Class 1 preferred shares are convertible at the option of the holder into a new series that is one number higher<br> than their existing series, and the holders are entitled to non-cumulative preferential cash dividends, payable quarterly if and when declared by the Board of Directors, at a rate equal to the three-month Government of Canada Treasury bill<br> yield plus the rate specified in footnote 5 above.
---	---
^(7)^	The floating dividend rate for the Class 1 Series 4 shares equals the three-month Government of Canada Treasury bill yield plus 1.41%.
---	---
^(8)^	MFC redeemed in full the Class 1 Series 7 and Class 1 Series 23 preferred shares at par, on March 19, 2022, the earliest par redemption date.
---	---
^(9)^	The LRCN – Series 1 distribute at a fixed rate of 3.375% payable semi-annually, until June 18, 2026. On June 19, 2026 and every five years thereafter until<br> June 19, 2076, the rate on the LRCN – Series 1 will be reset at a rate equal to the five-year Government of Canada yield as defined in the prospectus, plus 2.839%. Non-deferrable distributions are payable semi-annually on the LRCN – Series<br> 1 at the Company’s discretion. Non-payment of distributions or principal when due will result in a recourse event, with the noteholders’ sole remedy being receipt of their proportionate share of Class 1 Series 27 preferred shares held in a<br> consolidated trust (the Limited Recourse Trust).
---	---
^(10)^	The LRCN – Series 2 distribute at a fixed rate of 4.10% payable semi-annually, until March 18, 2027. On March 19, 2027 and every five years thereafter until<br> March 19, 2077, the rate on the LRCN – Series 2 will be reset at a rate equal to the five-year Government of Canada yield as defined in the prospectus, plus 2.704%. Non-deferrable distributions are payable semi-annually on the LRCN – Series<br> 2 at the Company’s discretion. Non-payment of distributions or principal when due will result in a recourse event, with the noteholders’ sole remedy being receipt of their proportionate share of Class 1 Series 28 preferred shares held in<br> the Limited Recourse Trust.
---	---
^(11)^	The LRCN – Series 3 distribute at a fixed rate of 7.117% payable semi-annually, until June 18, 2027. On June 19, 2027 and every five years thereafter until<br> June 19, 2077, the rate on the LRCN – Series 3 will be reset at a rate equal to the five-year Government of Canada yield as defined in the prospectus, plus 3.95%. Non-deferrable distributions are payable semi-annually on the LRCN – Series 3<br> at the Company’s discretion. Non-payment of distributions or principal when due will result in a recourse event, with the noteholders’ sole remedy being receipt of their proportionate share of Class 1 Series 29 preferred shares held in the<br> Limited Recourse Trust.
---	---
^(12)^	All claims of the holders of LRCN series against MFC will be extinguished upon receipt of the corresponding trust assets. The Class 1 Series 27, Class 1 Series<br> 28, and Class 1 Series 29 preferred shares are eliminated on the Company’s Consolidated Statements of Financial Position while being held in the Limited
---	---

Manulife Financial Corporation – Third Quarter 2022

Recourse Trust.
^(13)^	MFC did not exercise its right to redeem all or any of the outstanding Class 1 Shares Series 9 on September 19, 2022, the earliest redemption date. The dividend rate was reset as specified in footnote 5<br> above to an annual fixed rate of 5.978%, for a five-year period commencing on September 20, 2022.
---	---
(b)	Common shares
---	---

As at September 30, 2022, there were 21 million outstanding stock options and deferred share units that entitle the holder to receive common shares or payment in cash or common shares, at the option of the holder (December 31, 2021 – 22 million).

For the	nine months ended<br><br> <br>September 30, 2022	year ended<br><br> <br>December 31, 2021
Number of common shares (in millions)
Balance, beginning of period	1,943	1,940
Purchased for cancellation	(56)	-
Issued on exercise of stock options and deferred share units	1	3
Balance, end of period	1,888	1,943

Normal Course Issuer Bid

On February 1, 2022, the Company announced that the Toronto Stock Exchange (“TSX”) approved a normal course issuer bid (“NCIB”) permitting the purchase for cancellation of up to 97 million common shares. Purchases under the NCIB commenced on February 3, 2022 and will continue until February 2, 2023, when the NCIB expires, or such earlier date as the Company completes its purchases. During the nine months ended September 30, 2022, the Company purchased approximately 56 million shares for $1,332. Of this, $659 was recorded in common shares and $673 was recorded in retained earnings in the Consolidated Statements of Changes in Equity.

(c)	Earnings per share

The following is a reconciliation of the denominators (number of shares) in the calculation of basic and diluted earnings per common share.

For the	three months ended<br><br> <br>September 30,				nine months ended<br><br> <br>September 30,
(in millions)	2022		2021		2022		2021
Weighted average number of common shares		1,902		1,942		1,920		1,942
Dilutive stock-based awards^(1)^		2		4		3		4
Weighted average number of diluted common shares		1,904		1,946		1,923		1,946
^(1)^	The dilutive effect of stock-based awards was calculated using the treasury stock method. This method calculates the number of incremental shares by assuming the outstanding<br> stock-based awards are (i) exercised and (ii) then reduced by the number of shares assumed to be repurchased from the issuance proceeds, using the average market price of MFC common shares for the period.
---	---
Note 10	Revenue from Service Contracts
---	---

The Company provides investment management services, transaction processing and administrative services and distribution and related services to proprietary and third-party investment funds, retirement plans, group benefit plans, institutional investors and other arrangements. The Company also provides real estate management services to tenants of the Company’s investment properties.

The Company’s service contracts generally impose single performance obligations, each consisting of a series of similar related services for each customer.

The Company’s performance obligations within service arrangements are generally satisfied over time as the customer simultaneously receives and consumes the benefits of the services rendered, measured using an output method. Fees typically include variable consideration and the related revenue is recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty is subsequently resolved.

Asset based fees vary with asset values of accounts under management, subject to market conditions and investor behaviors beyond the Company’s control. Transaction processing and administrative fees vary with activity volume, also beyond the Company’s control. Some fees, including distribution fees, are based on account balances and transaction volumes. Fees related to account balances and transaction volumes are measured daily.

Manulife Financial Corporation – Third Quarter 2022

Real estate management service fees include fixed portions plus recovery of variable costs of services rendered to tenants. Fees related to services provided are generally recognized as services are rendered, which is when it becomes highly probable that no significant reversal of cumulative revenue recognized will occur. The Company has determined that its service contracts have no significant financing components because fees are collected monthly. The Company has no significant contract assets or contract liabilities.

The following tables present revenue from service contracts by service lines and reporting segments as disclosed in note 13.

For the three months ended September 30, 2022	Asia		Canada		U.S.		Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Investment management and other related fees	$	57	$	59	$	110	$	766		$	(62	)	$	930
Transaction processing, administration, and service fees		72		212		3		595			(1	)		881
Distribution fees and other		35		12		21		189			(3	)		254
Total included in other revenue		164		283		134		1,550			(66	)		2,065
Revenue from non-service lines		213		37		143		(4	)		(77	)		312
Total other revenue	$	377	$	320	$	277	$	1,546		$	(143	)	$	2,377
Real estate management services included in net<br><br> <br>investment income	$	8	$	39	$	33	$	-		$	2		$	82
For the three months ended September 30, 2021	Asia		Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---
Investment management and other related fees	$	16	$	58	$	126	$	820	$	(64	)	$	956
Transaction processing, administration, and service fees		205		237		4		649		(1	)		1,094
Distribution fees and other		72		7		17		203		(15	)		284
Total included in other revenue		293		302		147		1,672		(80	)		2,334
Revenue from non-service lines		181		24		445		2		8			660
Total other revenue	$	474	$	326	$	592	$	1,674	$	(72	)	$	2,994
Real estate management services included in net<br><br> <br>investment income	$	9	$	36	$	32	$	-	$	2		$	79
For the nine months ended September 30, 2022	Asia		Canada		U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
Investment management and other related fees	$	174	$	181	$	331		$	2,328		$	(184	)	$	2,830
Transaction processing, administration, and service fees		217		657		9			1,812			(4	)		2,691
Distribution fees and other		114		24		62			580			(32	)		748
Total included in other revenue		505		862		402			4,720			(220	)		6,269
Revenue from non-service lines		444		159		(176	)		(9	)		(262	)		156
Total other revenue	$	949	$	1,021	$	226		$	4,711		$	(482	)	$	6,425
Real estate management services included in net<br><br> <br>investment income	$	27	$	108	$	98		$	-		$	6		$	239
For the nine months ended September 30, 2021	Asia		Canada		U.S.		Global<br><br> <br>WAM		Corporate<br><br> <br>and Other			Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---
Investment management and other related fees	$	99	$	170	$	371	$	2,339	$	(181	)	$	2,798
Transaction processing, administration, and service fees		346		675		10		1,864		(8	)		2,887
Distribution fees and other		220		15		51		590		(43	)		833
Total included in other revenue		665		860		432		4,793		(232	)		6,518
Revenue from non-service lines		729		139		939		-		66			1,873
Total other revenue	$	1,394	$	999	$	1,371	$	4,793	$	(166	)	$	8,391
Real estate management services included in net<br><br> <br>investment income	$	28	$	101	$	96	$	-	$	5		$	230

Manulife Financial Corporation – Third Quarter 2022

Note 11	Employee Future Benefits

The Company maintains a number of pension plans, both defined benefit and defined contribution, and retiree welfare plans for eligible employees and agents. Information about the financial impacts of the Company’s material pension and retiree welfare plans in the U.S. and Canada is as follows.

	Pension plans						Retiree welfare plans^(1)^
For the three months ended September 30,	2022			2021			2022			2021
Defined benefit current service cost	$	12		$	10		$	-		$	-
Defined benefit administrative expenses		3			2			-			-
Service cost		15			12			-			-
Interest on net defined benefit (asset) liability		-			1			-			1
Defined benefit cost		15			13			-			1
Defined contribution cost		20			20			-			-
Net benefit cost reported in earnings	$	35		$	33		$	-		$	1
Actuarial (gain) loss on economic assumption changes	$	(15	)	$	(28	)	$	(10	)	$	(3	)
Investment (gain) loss (excluding interest income)		88			41			9			1
Change in effect of asset limit		(16	)		-			-			-
Remeasurement (gain) loss recorded in AOCI, net of tax	$	57		$	13		$	(1	)	$	(2	)
For the nine months ended September 30,	Pension plans						Retiree welfare plans^(1)^
		2022			2021			2022			2021
Defined benefit current service cost	$	34		$	32		$	-		$	-
Defined benefit administrative expenses		8			7			1			1
Service cost		42			39			1			1
Interest on net defined benefit (asset) liability		1			4			-			1
Defined benefit cost		43			43			1			2
Defined contribution cost		66			65			-			-
Net benefit cost reported in earnings	$	109		$	108		$	1		$	2
Actuarial (gain) loss on economic assumption changes	$	(636	)	$	(179	)	$	(95	)	$	(21	)
Investment (gain) loss (excluding interest income)		661			30			67			1
Change in effect of asset limit		(4	)		-			-			-
Remeasurement (gain) loss recorded in AOCI, net of tax	$	21		$	(149	)	$	(28	)	$	(20	)
^(1)^	There are no significant current service costs for the retiree welfare plans as they are closed and mostly frozen. The remeasurement gain or loss on these plans is due to the volatility of discount rates and investment returns.
---	---
Note 12	Commitments and Contingencies
---	---
(a)	Legal proceedings
---	---

The Company is regularly involved in legal actions, both as a defendant and as a plaintiff. The legal actions where the Company is a party ordinarily relate to its activities as a provider of insurance protection or wealth management products, reinsurance, or in its capacity as an investment adviser, employer, or taxpayer. Other life insurers and asset managers, operating in the jurisdictions in which the Company does business, have been subject to a wide variety of other types of actions, some of which resulted in substantial judgments or settlements against the defendants; it is possible that the Company may become involved in similar actions in the future. In addition, government and regulatory bodies in Canada, the United States, Asia and other jurisdictions where the Company conducts business regularly make inquiries and, from time to time, require the production of information or conduct examinations concerning the Company's compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers.

In June 2018, a class action was initiated against John Hancock Life Insurance Company (U.S.A.) (“JHUSA”) and John Hancock Life Insurance Company of New York (“JHNY”) in the U.S. District Court for the Southern District of New York on behalf of owners of approximately 1,500 Performance Universal Life (“PerfUL”) policies issued between 2003 and 2010 whose policies were subject to a Cost of Insurance (“COI”) increase announced in 2018. On May 17, 2022, at a Fairness Hearing, the Court approved the class Settlement Agreement that it had preliminary approved on January 5, 2022. The settlement has been implemented. In the Class Notice process, an institutional investor which owns approximately 150 of the policies that met the class definition “opted out” of the settlement. No subsequent action has thus far been taken with respect to those opt out policies.

Manulife Financial Corporation – Third Quarter 2022

In addition to the class action, eleven individual lawsuits opposing the Performance UL COI increases were also filed. Each of the lawsuits, except two, is brought by plaintiffs owning multiple policies and/or by entities managing them for investment purposes. Two of the pending federal cases have now been settled and these involved a combined 45 PerfUL policies. On September 8, 2022, two new individual lawsuits were filed in New York and California federal courts, with respect to the 16 policies owned by Skellig Capital. There are now five lawsuits pending in federal courts in New York and California and three in New York state court. In the aggregate, approximately 135 PerfUL policies are involved in these cases. There are also approximately 140 policies that have been ‘opted out’ of the class settlement, and although no litigation is pending with respect to those policies, future litigation is probable. Of the remaining non-class/individual lawsuits, discovery has commenced. With respect to the non-class/individual lawsuits pending in the New York federal district court (not including the recently filed Skellig lawsuits), the court has approved a briefing schedule and set the final pre-trial hearing for February 23, 2023. The Company continues to defend the individual lawsuits. In 2021, the Company recorded an accrual in relation to the class and individual lawsuits. In Q3 2022, the accrual was increased.

(b)	Guarantees
(I)	Guarantees regarding Manulife Finance (Delaware), L.P. (“MFLP”)
---	---

MFC has guaranteed the payment of amounts on the $650 subordinated debentures due on December 15, 2041 issued by MFLP, a wholly owned unconsolidated financing entity.

(II)	Guarantees regarding The Manufacturers Life Insurance Company

MFC has provided a subordinated guarantee for the $1,000 subordinated debentures issued by MLI on November 20, 2015.

The following table presents certain condensed consolidated financial information for MFC and MFLP.

Condensed Consolidated Statements of Income Information

For the three months ended September 30, 2022	MFC<br><br> <br>(Guarantor)		MLI<br><br> <br>consolidated		Other<br><br> <br>subsidiaries<br><br> <br>of MFC on<br><br> <br>a combined<br><br> <br>basis			Consolidation<br><br> <br>adjustments			Total<br><br> <br>consolidated<br><br> <br>amounts		MFLP
Total revenue	$	196	$	7,793	$	198		$	(410	)	$	7,777	$	26
Net income (loss) attributed to shareholders		1,347		1,431		(194	)		(1,237	)		1,347		13
For the three months ended September 30, 2021	MFC<br><br> <br>(Guarantor)		MLI<br><br> <br>consolidated		Other<br><br> <br>subsidiaries<br><br> <br>of MFC on<br><br> <br>a combined<br><br> <br>basis			Consolidation<br><br> <br>adjustments			Total<br><br> <br>consolidated<br><br> <br>amounts		MFLP
Total revenue	$	171	$	15,991	$	186		$	(365	)	$	15,983	$	16
Net income (loss) attributed to shareholders		1,592		1,660		(173	)		(1,487	)		1,592		6
For the nine months ended September 30, 2022	MFC<br><br> <br>(Guarantor)		MLI consolidated		Other<br><br> <br>subsidiaries<br><br> <br>of MFC on<br><br> <br>a combined<br><br> <br>basis			Consolidation<br><br> <br>adjustments			Total<br><br> <br>consolidated<br><br> <br>amounts		MFLP
Total revenue	$	345	$	1,775	$	352		$	(726	)	$	1,746	$	55
Net income (loss) attributed to shareholders		5,403		5,625		(345	)		(5,280	)		5,403		22
For the nine months ended September 30, 2021	MFC<br><br> <br>(Guarantor)		MLI<br><br> <br>consolidated		Other<br><br> <br>subsidiaries<br><br> <br>of MFC on<br><br> <br>a combined<br><br> <br>basis			Consolidation<br><br> <br>adjustments			Total<br><br> <br>consolidated<br><br> <br>amounts		MFLP
Total revenue	$	327	$	40,246	$	369		$	(732	)	$	40,210	$	32
Net income (loss) attributed to shareholders		5,021		5,259		(344	)		(4,915	)		5,021		6

Manulife Financial Corporation – Third Quarter 2022

Condensed Consolidated Statements of Financial Position Information

As at September 30, 2022	MFC<br><br> <br>(Guarantor)		MLI<br><br> <br>consolidated		Other<br><br> <br>subsidiaries<br><br> <br>of MFC on<br><br> <br>a combined<br><br> <br>basis		Consolidation<br><br> <br>adjustments			Total<br><br> <br>consolidated<br><br> <br>amounts		MFLP
Invested assets	$	70	$	411,211	$	11	$	-		$	411,292	$	2
Total other assets		91,040		93,062		41,755		(137,671	)		88,186		971
Segregated funds net assets		-		335,245		-		-			335,245		-
Insurance contract liabilities		-		369,671		-		-			369,671		-
Investment contract liabilities		-		3,259		-		-			3,259		-
Segregated funds net liabilities		-		335,245		-		-			335,245		-
Total other liabilities		35,032		59,125		37,897		(61,813	)		70,241		713
As at December 31, 2021	MFC<br><br> <br>(Guarantor)		MLI<br><br> <br>consolidated		Other<br><br> <br>subsidiaries<br><br> <br>of MFC on<br><br> <br>a combined<br><br> <br>basis		Consolidation<br><br> <br>adjustments			Total<br><br> <br>consolidated<br><br> <br>amounts		MFLP
Invested assets	$	78	$	427,010	$	10	$	-		$	427,098	$	3
Total other assets		68,866		91,412		3,203		(72,724	)		90,757		1,088
Segregated funds net assets		-		399,788		-		-			399,788		-
Insurance contract liabilities		-		392,275		-		-			392,275		-
Investment contract liabilities		-		3,117		-		-			3,117		-
Segregated funds net liabilities		-		399,788		-		-			399,788		-
Total other liabilities		10,536		53,962		-		(904	)		63,594		852
(III)	Guarantees regarding John Hancock Life Insurance Company (U.S.A.) (“JHUSA”)
---	---

Details of guarantees regarding certain securities issued or to be issued by JHUSA are outlined in note 15.

Note 13	Segment and Geographic Reporting

The Company’s reporting segments are Asia, Canada, U.S., Global WAM and Corporate and Other. Each reporting segment is responsible for managing its operating results, developing products, defining strategies for services and distribution based on the profile and needs of its business and market. The Company’s significant product and service offerings by the reporting segments are mentioned below.

Wealth and asset management businesses (Global WAM) – include mutual funds and exchange traded funds, group retirement and savings products, and institutional asset management services across all major asset classes. These products and services are distributed through multiple distribution channels, including agents and brokers affiliated with the Company, independent securities brokerage firms and financial advisors pension plan consultants and banks.

Insurance and annuity products (Asia, Canada and U.S.) – include a variety of individual life insurance, individual and group long-term care insurance and guaranteed and partially guaranteed annuity products. Products are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners and direct marketing. Manulife Bank of Canada offers a variety of deposit and credit products to Canadian customers.

Corporate and Other Segment – comprised of investment performance of assets backing capital, net of amounts allocated to operating segments; costs incurred by the corporate office related to shareholder activities (not allocated to the operating segments); financing costs; Property and Casualty Reinsurance Business; and run-off reinsurance operations including variable annuities and accident and health.

Manulife Financial Corporation – Third Quarter 2022

The following tables present results by reporting segments and by geographical location.

(a)	By Segment
For the three months ended<br><br> <br>September 30, 2022	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
Revenue
Life and health insurance	$	4,481		$	2,496		$	1,693		$	-		$	40		$	8,710
Annuities and pensions		679			116			(33	)		-			-			762
Net premium income		5,160			2,612			1,660			-			40			9,472
Net investment income (loss)		(1,694	)		1,410			(3,504	)		(4	)		(280	)		(4,072	)
Other revenue		377			320			277			1,546			(143	)		2,377
Total revenue		3,843			4,342			(1,567	)		1,542			(383	)		7,777
Contract benefits and expenses
Life and health insurance		1,089			2,405			(2,932	)		-			271			833
Annuities and pensions		964			72			(119	)		10			-			927
Net benefits and claims		2,053			2,477			(3,051	)		10			271			1,760
Interest expense		58			187			4			2			122			373
Other expenses		1,254			859			714			1,135			45			4,007
Total contract benefits and expenses		3,365			3,523			(2,333	)		1,147			438			6,140
Income (loss) before income taxes		478			819			766			395			(821	)		1,637
Income tax recovery (expense)		(60	)		(191	)		(114	)		(50	)		83			(332	)
Net income (loss)		418			628			652			345			(738	)		1,305
Less net income (loss) attributed to:
Non-controlling interests		(18	)		-			-			-			-			(18	)
Participating policyholders		(85	)		50			11			-			-			(24	)
Net income (loss) attributed to shareholders	$	521		$	578		$	641		$	345		$	(738	)	$	1,347
For the three months ended<br><br> <br>September 30, 2021	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
Revenue
Life and health insurance	$	5,293		$	2,348		$	1,598		$	-		$	30		$	9,269
Annuities and pensions		637			70			7			-			-			714
Net premium income		5,930			2,418			1,605			-			30			9,983
Net investment income (loss)		254			167			2,453			6			126			3,006
Other revenue		474			326			592			1,674			(72	)		2,994
Total revenue		6,658			2,911			4,650			1,680			84			15,983
Contract benefits and expenses
Life and health insurance		4,261			2,573			3,794			-			167			10,795
Annuities and pensions		418			(491	)		(604	)		29			-			(648	)
Net benefits and claims		4,679			2,082			3,190			29			167			10,147
Interest expense		57			84			13			(1	)		109			262
Other expenses		1,271			846			648			1,234			95			4,094
Total contract benefits and expenses		6,007			3,012			3,851			1,262			371			14,503
Income (loss) before income taxes		651			(101	)		799			418			(287	)		1,480
Income tax recovery (expense)		(84	)		44			(94	)		(67	)		35			(166	)
Net income (loss)		567			(57	)		705			351			(252	)		1,314
Less net income (loss) attributed to:
Non-controlling interests		48			-			-			-			-			48
Participating policyholders		(303	)		(31	)		8			-			-			(326	)
Net income (loss) attributed to shareholders	$	822		$	(26	)	$	697		$	351		$	(252	)	$	1,592

Manulife Financial Corporation – Third Quarter 2022

As at and for the nine months ended<br><br> <br>September 30, 2022	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
Revenue
Life and health insurance	$	14,513		$	7,476		$	4,906		$	-		$	119		$	27,014
Annuities and pensions		2,112			305			(830	)		-			-			1,587
Net premium income		16,625			7,781			4,076			-			119			28,601
Net investment income (loss)		(8,220	)		(8,479	)		(15,542	)		(62	)		(977	)		(33,280	)
Other revenue		949			1,021			226			4,711			(482	)		6,425
Total revenue		9,354			323			(11,240	)		4,649			(1,340	)		1,746
Contract benefits and expenses
Life and health insurance		1,287			3,599			(14,826	)		-			347			(9,593	)
Annuities and pensions		2,830			(8,175	)		(2,848	)		16			-			(8,177	)
Net benefits and claims		4,117			(4,576	)		(17,674	)		16			347			(17,770	)
Interest expense		171			369			46			2			346			934
Other expenses		3,692			2,607			2,035			3,488			155			11,977
Total contract benefits and expenses		7,980			(1,600	)		(15,593	)		3,506			848			(4,859	)
Income (loss) before income taxes		1,374			1,923			4,353			1,143			(2,188	)		6,605
Income tax recovery (expense)		(174	)		(471	)		(798	)		(168	)		212			(1,399	)
Net income (loss)		1,200			1,452			3,555			975			(1,976	)		5,206
Less net income (loss) attributed to:
Non-controlling interests		(9	)		-			-			1			-			(8	)
Participating policyholders		(446	)		242			15			-			-			(189	)
Net income (loss) attributed to shareholders	$	1,655		$	1,210		$	3,540		$	974		$	(1,976	)	$	5,403
Total assets	$	151,882		$	153,615		$	268,111		$	220,956		$	40,159		$	834,723
As at and for the nine months ended<br><br> <br>September 30, 2021	Asia			Canada			U.S.			Global<br><br> <br>WAM			Corporate<br><br> <br>and Other			Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
Revenue
Life and health insurance	$	15,579		$	6,766		$	4,534		$	-		$	92		$	26,971
Annuities and pensions		1,750			256			28			-			-			2,034
Net premium income		17,329			7,022			4,562			-			92			29,005
Net investment income (loss)		2,897			(1,755	)		1,607			21			44			2,814
Other revenue		1,394			999			1,371			4,793			(166	)		8,391
Total revenue		21,620			6,266			7,540			4,814			(30	)		40,210
Contract benefits and expenses
Life and health insurance		13,218			7,213			5,005			-			151			25,587
Annuities and pensions		1,743			(4,638	)		(1,521	)		80			-			(4,336	)
Net benefits and claims		14,961			2,575			3,484			80			151			21,251
Interest expense		178			204			34			-			355			771
Other expenses		3,976			2,502			2,153			3,531			382			12,544
Total contract benefits and expenses		19,115			5,281			5,671			3,611			888			34,566
Income (loss) before income taxes		2,505			985			1,869			1,203			(918	)		5,644
Income tax recovery (expense)		(362	)		(158	)		(264	)		(183	)		184			(783	)
Net income (loss)		2,143			827			1,605			1,020			(734	)		4,861
Less net income (loss) attributed to:
Non-controlling interests		222			-			-			1			-			223
Participating policyholders		(491	)		89			19			-			-			(383	)
Net income (loss) attributed to shareholders	$	2,412		$	738		$	1,586		$	1,019		$	(734	)	$	5,021
Total assets	$	157,766		$	165,685		$	287,933		$	251,237		$	35,669		$	898,290

Manulife Financial Corporation – Third Quarter 2022

(b)	By Geographic Location
For the three months ended<br><br> <br>September 30, 2022	Asia			Canada		U.S.			Other		Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---
Revenue
Life and health insurance	$	4,505		$	2,420	$	1,693		$	92	$	8,710
Annuities and pensions		679			116		(33	)		-		762
Net premium income		5,184			2,536		1,660			92		9,472
Net investment income (loss)		(1,949	)		1,390		(3,588	)		75		(4,072	)
Other revenue		657			779		939			2		2,377
Total revenue	$	3,892		$	4,705	$	(989	)	$	169	$	7,777
For the three months ended<br><br> <br>September 30, 2021	Asia		Canada		U.S.		Other		Total
---	---	---	---	---	---	---	---	---	---	---
Revenue
Life and health insurance	$	5,314	$	2,269	$	1,598	$	88	$	9,269
Annuities and pensions		637		70		7		-		714
Net premium income		5,951		2,339		1,605		88		9,983
Net investment income (loss)		414		133		2,371		88		3,006
Other revenue		782		847		1,365		-		2,994
Total revenue	$	7,147	$	3,319	$	5,341	$	176	$	15,983
For the nine months ended<br><br> <br>September 30, 2022	Asia			Canada			U.S.			Other		Total
---	---	---	---	---	---	---	---	---	---	---	---	---	---	---
Revenue
Life and health insurance	$	14,581		$	7,244		$	4,907		$	282	$	27,014
Annuities and pensions		2,112			305			(830	)		-		1,587
Net premium income		16,693			7,549			4,077			282		28,601
Net investment income (loss)		(8,688	)		(9,001	)		(15,889	)		298		(33,280	)
Other revenue		1,761			2,404			2,219			41		6,425
Total revenue	$	9,766		$	952		$	(9,593	)	$	621	$	1,746
For the nine months ended<br><br> <br>September 30, 2021	Asia		Canada			U.S.		Other		Total
---	---	---	---	---	---	---	---	---	---	---	---
Revenue
Life and health insurance	$	15,645	$	6,523		$	4,535	$	268	$	26,971
Annuities and pensions		1,750		256			28		-		2,034
Net premium income		17,395		6,779			4,563		268		29,005
Net investment income (loss)		3,209		(2,107	)		1,515		197		2,814
Other revenue		2,244		2,496			3,649		2		8,391
Total revenue	$	22,848	$	7,168		$	9,727	$	467	$	40,210

Manulife Financial Corporation – Third Quarter 2022

100

Note 14	Segregated Funds

The Company manages a number of segregated funds on behalf of policyholders. Policyholders are provided with the opportunity to invest in different categories of segregated funds that respectively hold a range of underlying investments. The underlying investments of the segregated funds consist of both individual securities and mutual funds. The carrying value and change in segregated funds net assets are as follows.

Segregated funds net assets

As at	September 30, 2022			December 31, 2021
Investments at market value
Cash and short-term securities	$	4,499		$	3,955
Debt securities		15,105			18,651
Equities		14,197			16,844
Mutual funds		297,389			354,882
Other investments		4,712			4,613
Accrued investment income		395			2,340
Other assets and liabilities, net		(710	)		(1,089	)
Total segregated funds net assets	$	335,587		$	400,196
Composition of segregated funds net assets
Held by policyholders	$	335,245		$	399,788
Held by the Company		342			408
Total segregated funds net assets	$	335,587		$	400,196

Changes in segregated funds net assets

	three months ended<br><br> <br>September 30,						nine months ended<br><br> <br>September 30,
For the	2022			2021			2022			2021
Net policyholder cash flows
Deposits from policyholders	$	9,841		$	10,929		$	32,263		$	33,628
Net transfers to general fund		(270	)		(159	)		(840	)		(520	)
Payments to policyholders		(10,010	)		(12,826	)		(34,217	)		(38,775	)
		(439	)		(2,056	)		(2,794	)		(5,667	)
Investment related
Interest and dividends		1,175			1,011			4,304			4,046
Net realized and unrealized investment gains (losses)		(12,674	)		(1,153	)		(79,489	)		24,822
		(11,499	)		(142	)		(75,185	)		28,868
Other
Management and administration fees		(901	)		(1,014	)		(2,914	)		(3,085	)
Impact of changes in foreign exchange rates		13,179			7,169			16,284			276
		12,278			6,155			13,370			(2,809	)
Net additions (deductions)		340			3,957			(64,609	)		20,392
Segregated funds net assets, beginning of period		335,247			384,244			400,196			367,809
Segregated funds net assets, end of period	$	335,587		$	388,201		$	335,587		$	388,201

Segregated funds assets may be exposed to a variety of financial and other risks. These risks are primarily mitigated by investment guidelines that are actively monitored by professional and experienced portfolio advisors. The Company is not exposed to these risks beyond the liabilities related to the guarantees associated with certain variable life and annuity products included in segregated funds. Accordingly, the Company’s exposure to loss from segregated fund products is limited to the value of these guarantees.

These guarantees are recorded within the Company’s insurance contract liabilities. Assets supporting these guarantees are recognized in the Company’s invested assets according to their investment type. The “Risk Management and Risk Factors Update” section of the Third Quarter 2022 MD&A provides information regarding market risk sensitivities associated with variable annuity and segregated fund guarantees.

Manulife Financial Corporation – Third Quarter 2022

101

Note 15	Information Provided in Connection with Investments in Deferred Annuity Contracts and SignatureNotes Issued or Assumed by John Hancock Life Insurance Company<br> (U.S.A.)

The following condensed consolidated financial information, presented in accordance with IFRS, and the related disclosure have been included in these Interim Consolidated Financial Statements with respect to JHUSA in compliance with Regulation S-X and Rule 12h-5 of the United States Securities and Exchange Commission (the “Commission”). These financial statements are (i) incorporated by reference in the registration statements of MFC and JHUSA that relate to MFC’s guarantee of certain securities to be issued by JHUSA and (ii) are provided in reliance on an exemption from continuous disclosure obligations of JHUSA. For information about JHUSA, the MFC guarantees and restrictions on the ability of MFC to obtain funds from its subsidiaries by dividend or loan, refer to note 23 to the Company’s 2021 Annual Consolidated Financial Statements.

Condensed Consolidated Statement of Financial Position

As at September 30, 2022	MFC<br><br> <br>(Guarantor)		JHUSA<br><br> <br>(Issuer)		Other<br><br> <br>subsidiaries			Consolidation adjustments			Consolidated<br><br> <br>MFC
Assets
Invested assets	$	70	$	116,472	$	295,242		$	(492	)	$	411,292
Investments in unconsolidated subsidiaries		71,742		9,210		40,525			(121,477	)		-
Reinsurance assets		-		62,573		12,217			(25,861	)		48,929
Other assets		19,298		9,431		72,050			(61,522	)		39,257
Segregated funds net assets		-		167,739		169,762			(2,256	)		335,245
Total assets	$	91,110	$	365,425	$	589,796		$	(211,608	)	$	834,723
Liabilities and equity
Insurance contract liabilities	$	-	$	158,252	$	237,977		$	(26,558	)	$	369,671
Investment contract liabilities		-		1,420		1,839			-			3,259
Other liabilities		23,865		19,665		74,540			(61,267	)		56,803
Long-term debt		6,320		-		-			-			6,320
Capital instruments		4,847		624		20,247			(18,600	)		7,118
Segregated funds net liabilities		-		167,739		169,762			(2,256	)		335,245
Shareholders' and other equity holders' equity		56,078		17,725		85,202			(102,927	)		56,078
Participating policyholders' equity		-		-		(1,426	)		-			(1,426	)
Non-controlling interests		-		-		1,655			-			1,655
Total liabilities and equity	$	91,110	$	365,425	$	589,796		$	(211,608	)	$	834,723

Manulife Financial Corporation – Third Quarter 2022

102

Condensed Consolidated Statement of Financial Position

As at December 31, 2021	MFC<br><br> <br>(Guarantor)		JHUSA<br><br> <br>(Issuer)		Other<br><br> <br>subsidiaries			Consolidation adjustments			Consolidated<br><br> <br>MFC
Assets
Invested assets	$	78	$	116,705	$	310,679		$	(364	)	$	427,098
Investments in unconsolidated subsidiaries		68,655		9,107		20,788			(98,550	)		-
Reinsurance assets		-		63,838		11,309			(30,568	)		44,579
Other assets		211		18,085		49,956			(22,074	)		46,178
Segregated funds net assets		-		204,493		197,220			(1,925	)		399,788
Total assets	$	68,944	$	412,228	$	589,952		$	(153,481	)	$	917,643
Liabilities and equity
Insurance contract liabilities	$	-	$	166,535	$	257,044		$	(31,304	)	$	392,275
Investment contract liabilities		-		1,227		1,890			-			3,117
Other liabilities		899		21,806		50,836			(21,809	)		51,732
Long-term debt		4,882		-		-			-			4,882
Capital instruments		4,755		579		1,646			-			6,980
Segregated funds net liabilities		-		204,493		197,220			(1,925	)		399,788
Shareholders' and other equity holders' equity		58,408		17,588		80,855			(98,443	)		58,408
Participating policyholders' equity		-		-		(1,233	)		-			(1,233	)
Non-controlling interests		-		-		1,694			-			1,694
Total liabilities and equity	$	68,944	$	412,228	$	589,952		$	(153,481	)	$	917,643

Condensed Consolidated Statement of Income

For the three months ended<br><br> <br>September 30, 2022	MFC<br><br> <br>(Guarantor)			JHUSA<br><br> <br>(Issuer)			Other<br><br> <br>subsidiaries			Consolidation adjustments			Consolidated<br><br> <br>MFC
Revenue
Net premium income	$	-		$	1,152		$	8,266		$	54		$	9,472
Net investment income (loss)		214			(2,601	)		(1,248	)		(437	)		(4,072	)
Other revenue		(18	)		302			1,680			413			2,377
Total revenue		196			(1,147	)		8,698			30			7,777
Contract benefits and expenses
Net benefits and claims		-			(2,291	)		3,346			705			1,760
Commissions, investment and general expenses		9			752			3,347			(221	)		3,887
Other expenses		121			59			767			(454	)		493
Total contract benefits and expenses		130			(1,480	)		7,460			30			6,140
Income (loss) before income taxes		66			333			1,238			-			1,637
Income tax (expense) recovery		(12	)		(20	)		(300	)		-			(332	)
Income (loss) after income taxes		54			313			938			-			1,305
Equity in net income (loss) of unconsolidated subsidiaries		1,293			277			590			(2,160	)		-
Net income (loss)	$	1,347		$	590		$	1,528		$	(2,160	)	$	1,305
Net income (loss) attributed to:
Non-controlling interests	$	-		$	-		$	(18	)	$	-		$	(18	)
Participating policyholders		-			(2	)		(22	)		-			(24	)
Shareholders and other equity holders		1,347			592			1,568			(2,160	)		1,347
	$	1,347		$	590		$	1,528		$	(2,160	)	$	1,305

Manulife Financial Corporation – Third Quarter 2022

103

Condensed Consolidated Statement of Income

For the three months ended<br><br> <br>September 30, 2021	MFC<br><br> <br>(Guarantor)			JHUSA<br><br> <br>(Issuer)			Other<br><br> <br>subsidiaries			Consolidation adjustments			Consolidated<br><br> <br>MFC
Revenue
Net premium income	$	-		$	1,122		$	8,858		$	3		$	9,983
Net investment income (loss)		180			2,118			1,093			(385	)		3,006
Other revenue		(9	)		572			3,108			(677	)		2,994
Total revenue		171			3,812			13,059			(1,059	)		15,983
Contract benefits and expenses
Net benefits and claims		-			3,019			7,443			(315	)		10,147
Commissions, investment and general expenses		4			749			3,592			(358	)		3,987
Other expenses		89			60			606			(386	)		369
Total contract benefits and expenses		93			3,828			11,641			(1,059	)		14,503
Income (loss) before income taxes		78			(16	)		1,418			-			1,480
Income tax (expense) recovery		(21	)		53			(198	)		-			(166	)
Income (loss) after income taxes		57			37			1,220			-			1,314
Equity in net income (loss) of unconsolidated subsidiaries		1,535			460			497			(2,492	)		-
Net income (loss)	$	1,592		$	497		$	1,717		$	(2,492	)	$	1,314
Net income (loss) attributed to:
Non-controlling interests	$	-		$	-		$	48		$	-		$	48
Participating policyholders		-			(2	)		(326	)		2			(326	)
Shareholders and other equity holders		1,592			499			1,995			(2,494	)		1,592
	$	1,592		$	497		$	1,717		$	(2,492	)	$	1,314

Condensed Consolidated Statement of Income

For the nine months ended<br><br> <br>September 30, 2022	MFC<br><br> <br>(Guarantor)			JHUSA<br><br> <br>(Issuer)			Other<br><br> <br>subsidiaries			Consolidation adjustments			Consolidated<br><br> <br>MFC
Revenue
Net premium income	$	-		$	4,203		$	24,344		$	54		$	28,601
Net investment income (loss)		355			(11,632	)		(21,134	)		(869	)		(33,280	)
Other revenue		(10	)		(223	)		4,854			1,804			6,425
Total revenue		345			(7,652	)		8,064			989			1,746
Contract benefits and expenses
Net benefits and claims		-			(10,822	)		(8,209	)		1,261			(17,770	)
Commissions, investment and general expenses		24			2,227			10,203			(808	)		11,646
Other expenses		315			187			227			536			1,265
Total contract benefits and expenses		339			(8,408	)		2,221			989			(4,859	)
Income (loss) before income taxes		6			756			5,843			-			6,605
Income tax (expense) recovery		18			(99	)		(1,318	)		-			(1,399	)
Income (loss) after income taxes		24			657			4,525			-			5,206
Equity in net income (loss) of unconsolidated subsidiaries		5,379			946			1,603			(7,928	)		-
Net income (loss)	$	5,403		$	1,603		$	6,128		$	(7,928	)	$	5,206
Net income (loss) attributed to:
Non-controlling interests	$	-		$	-		$	(8	)	$	-		$	(8	)
Participating policyholders		-			(240	)		51			-			(189	)
Shareholders and other equity holders		5,403			1,843			6,085			(7,928	)		5,403
	$	5,403		$	1,603		$	6,128		$	(7,928	)	$	5,206

Manulife Financial Corporation – Third Quarter 2022

104

Condensed Consolidated Statement of Income

For the nine months ended<br><br> <br>September 30, 2021	MFC<br><br> <br>(Guarantor)		JHUSA<br><br> <br>(Issuer)			Other<br><br> <br>subsidiaries			Consolidation adjustments			Consolidated<br><br> <br>MFC
Revenue
Net premium income	$	-	$	3,297		$	25,705		$	3		$	29,005
Net investment income (loss)		295		860			2,443			(784	)		2,814
Other revenue		32		1,477			6,818			64			8,391
Total revenue		327		5,634			34,966			(717	)		40,210
Contract benefits and expenses
Net benefits and claims		-		3,178			16,938			1,135			21,251
Commissions, investment and general expenses		15		2,563			10,714			(1,062	)		12,230
Other expenses		303		163			1,409			(790	)		1,085
Total contract benefits and expenses		318		5,904			29,061			(717	)		34,566
Income (loss) before income taxes		9		(270	)		5,905			-			5,644
Income tax (expense) recovery		3		159			(945	)		-			(783	)
Income (loss) after income taxes		12		(111	)		4,960			-			4,861
Equity in net income (loss) of unconsolidated subsidiaries		5,009		1,177			1,066			(7,252	)		-
Net income (loss)	$	5,021	$	1,066		$	6,026		$	(7,252	)	$	4,861
Net income (loss) attributed to:
Non-controlling interests	$	-	$	-		$	223		$	-		$	223
Participating policyholders		-		(3	)		(383	)		3			(383	)
Shareholders and other equity holders		5,021		1,069			6,186			(7,255	)		5,021
	$	5,021	$	1,066		$	6,026		$	(7,252	)	$	4,861

Manulife Financial Corporation – Third Quarter 2022

105

Consolidated Statement of Cash Flows

For the nine months ended September 30, 2022	MFC<br><br> <br>(Guarantor)			JHUSA<br><br> <br>(Issuer)			Other<br><br> <br>subsidiaries			Consolidation<br><br> <br>adjustments			Consolidated<br><br> <br>MFC
Operating activities
Net income (loss)	$	5,403		$	1,603		$	6,128		$	(7,928	)	$	5,206
Adjustments:
Equity in net income of unconsolidated subsidiaries		(5,379	)		(946	)		(1,603	)		7,928			-
Increase (decrease) in insurance contract liabilities		-			(20,244	)		(13,793	)		-			(34,037	)
Increase (decrease) in investment contract liabilities		-			32			(22	)		-			10
(Increase) decrease in reinsurance assets		-			6,658			(7,537	)		-			(879	)
Amortization of (premium) discount on invested assets		-			35			(14	)		-			21
Other amortization		6			92			302			-			400
Net realized and unrealized (gains) losses and impairment on<br><br> <br>assets		(7	)		15,580			32,636			-			48,209
Gain on U.S. variable annuity reinsurance transaction (pre-tax)		-			(1,026	)		-			-			(1,026	)
Deferred income tax expense (recovery)		(18	)		329			566			-			877
Stock option expense		-			(2	)		5			-			3
Cash provided by (used in) operating activities before undernoted<br><br> <br>items		5			2,111			16,668			-			18,784
Dividends from unconsolidated subsidiary		-			289			734			(1,023	)		-
Cash decrease due to U.S. variable annuity reinsurance<br><br> <br>transaction		-			(1,263	)		-			-			(1,263	)
Changes in policy related and operating receivables and payables		(351	)		2,639			(7,061	)		-			(4,773	)
Cash provided by (used in) operating activities		(346	)		3,776			10,341			(1,023	)		12,748
Investing activities
Purchases and mortgage advances		-			(24,068	)		(63,748	)		-			(87,816	)
Disposals and repayments		1			19,690			54,535			-			74,226
Changes in investment broker net receivables and payables		-			24			(242	)		-			(218	)
Investment in common shares of subsidiaries		(1,962	)		-			-			1,962			-
Capital contribution to unconsolidated subsidiaries		-			19			-			(19	)		-
Notes receivable from parent		-			-			(23,052	)		23,052			-
Notes receivable from subsidiaries		(18,597	)		(7	)		-			18,604			-
Cash provided by (used in) investing activities		(20,558	)		(4,342	)		(32,507	)		43,599			(13,808	)
Financing activities
Issue of long-term debt, net		946			-			-			-			946
Secured borrowings		-			-			735			-			735
Change in repurchase agreements and securities sold but not yet<br><br> <br>purchased		-			-			(457	)		-			(457	)
Changes in deposits from Bank clients, net		-			-			885			-			885
Lease payments		-			(4	)		(86	)		-			(90	)
Shareholders' dividends and other equity distributions		(2,070	)		-			-			-			(2,070	)
Common shares repurchased		(1,332	)		-			-			-			(1,332	)
Common shares issued, net		19			-			1,962			(1,962	)		19
Preferred shares and other equity issued, net		990			-			-			-			990
Preferred shares redeemed, net		(711	)		-			-			-			(711	)
Contributions from (distributions to) non-controlling interests, net		-			-			(22	)		-			(22	)
Dividends paid to parent		-			(734	)		(289	)		1,023			-
Capital contributions by parent		-			-			(19	)		19			-
Notes payable to parent		-			-			18,604			(18,604	)		-
Notes payable to subsidiaries		23,052			-			-			(23,052	)		-
Cash provided by (used in) financing activities		20,894			(738	)		21,313			(42,576	)		(1,107	)
Cash and short-term securities
Increase (decrease) during the period		(10	)		(1,304	)		(853	)		-			(2,167	)
Effect of foreign exchange rate changes on cash and short-term<br><br> <br>securities		2			57			536			-			595
Balance, beginning of period		78			3,565			18,287			-			21,930
Balance, end of period		70			2,318			17,970			-			20,358
Cash and short-term securities
Beginning of period
Gross cash and short-term securities		78			4,087			18,429			-			22,594
Net payments in transit, included in other liabilities		-			(522	)		(142	)		-			(664	)
Net cash and short-term securities, beginning of period		78			3,565			18,287			-			21,930
End of period
Gross cash and short-term securities		70			2,545			18,336			-			20,951
Net payments in transit, included in other liabilities		-			(227	)		(366	)		-			(593	)
Net cash and short-term securities, end of period	$	70		$	2,318		$	17,970		$	-		$	20,358
Supplemental disclosures on cash flow information:
Interest received	$	355		$	2,829		$	6,142		$	(801	)	$	8,525
Interest paid		346			71			1,220			(801	)		836
Income taxes paid (refund)		-			125			1,115			-			1,240

Manulife Financial Corporation – Third Quarter 2022

106

Consolidated Statement of Cash Flows

For the nine months ended September 30, 2021	MFC<br><br> <br>(Guarantor)			JHUSA<br><br> <br>(Issuer)			Other<br><br> <br>subsidiaries			Consolidation<br><br> <br>adjustments			Consolidated<br><br> <br>MFC
Operating activities
Net income (loss)	$	5,021		$	1,066		$	6,026		$	(7,252	)	$	4,861
Adjustments:
Equity in net income of unconsolidated subsidiaries		(5,009	)		(1,177	)		(1,066	)		7,252			-
Increase (decrease) in insurance contract liabilities		-			(1,994	)		4,606			-			2,612
Increase (decrease) in investment contract liabilities		-			35			(10	)		-			25
(Increase) decrease in reinsurance assets		-			1,593			(1,012	)		-			581
Amortization of (premium) discount on invested assets		-			37			83			-			120
Other amortization		14			92			293			-			399
Net realized and unrealized (gains) losses and impairment on<br><br> <br>assets		63			2,948			6,175			-			9,186
Deferred income tax expense (recovery)		2			266			(31	)		-			237
Stock option expense		-			(2	)		9			-			7
Cash provided by (used in) operating activities before undernoted<br><br> <br>items		91			2,864			15,073			-			18,028
Dividends from unconsolidated subsidiary		-			301			-			(301	)		-
Changes in policy related and operating receivables and payables		(386	)		(1,120	)		(104	)		-			(1,610	)
Cash provided by (used in) operating activities		(295	)		2,045			14,969			(301	)		16,418
Investing activities
Purchases and mortgage advances		-			(23,962	)		(65,242	)		-			(89,204	)
Disposals and repayments		-			21,209			48,729			-			69,938
Changes in investment broker net receivables and payables		-			(102	)		690			-			588
Investment in common shares of subsidiaries		(2,000	)		-			-			2,000			-
Net cash flows from acquisition and disposal of subsidiaries and<br><br> <br>businesses		-			-			(4	)		-			(4	)
Capital contribution to unconsolidated subsidiaries		-			(1	)		-			1			-
Return of capital from unconsolidated subsidiaries		-			1			-			(1	)		-
Notes receivable from parent		-			-			(53,438	)		53,438			-
Notes receivable from subsidiaries		(49,238	)		-			-			49,238			-
Cash provided by (used in) investing activities		(51,238	)		(2,855	)		(69,265	)		104,676			(18,682	)
Financing activities
Redemption of long-term debt		(1,250	)		-			-			-			(1,250	)
Redemption of capital instruments		(468	)		-			(350	)		-			(818	)
Secured borrowings		-			-			17			-			17
Change in repurchase agreements and securities sold but not yet<br><br> <br>purchased		-			-			258			-			258
Changes in deposits from Bank clients, net		-			-			266			-			266
Lease payments		-			(5	)		(91	)		-			(96	)
Shareholders' dividends and other equity distributions		(1,783	)		-			-			-			(1,783	)
Common shares issued, net		45			-			2,000			(2,000	)		45
Other equity issued, net		1,983			-			-			-			1,983
Preferred shares redeemed, net		(418	)		-			-			-			(418	)
Contributions from (distributions to) non-controlling interests, net		-			-			(15	)		-			(15	)
Dividends paid to parent		-			-			(301	)		301			-
Capital contributions by parent		-			-			1			(1	)		-
Return of capital to parent		-			-			(1	)		1			-
Notes payable to parent		-			-			49,238			(49,238	)		-
Notes payable to subsidiaries		53,438			-			-			(53,438	)		-
Cash provided by (used in) financing activities		51,547			(5	)		51,022			(104,375	)		(1,811	)
Cash and short-term securities
Increase (decrease) during the period		14			(815	)		(3,274	)		-			(4,075	)
Effect of foreign exchange rate changes on cash and short-term<br><br> <br>securities		-			3			(233	)		-			(230	)
Balance, beginning of period		47			4,907			20,629			-			25,583
Balance, end of period		61			4,095			17,122			-			21,278
Cash and short-term securities
Beginning of period
Gross cash and short-term securities		47			5,213			20,907			-			26,167
Net payments in transit, included in other liabilities		-			(306	)		(278	)		-			(584	)
Net cash and short-term securities, beginning of period		47			4,907			20,629			-			25,583
End of period
Gross cash and short-term securities		61			4,570			17,483			-			22,114
Net payments in transit, included in other liabilities		-			(475	)		(361	)		-			(836	)
Net cash and short-term securities, end of period	$	61		$	4,095		$	17,122		$	-		$	21,278
Supplemental disclosures on cash flow information:
Interest received	$	356		$	3,091		$	5,700		$	(780	)	$	8,367
Interest paid		343			46			1,113			(780	)		722
Income taxes paid (refund)		-			(118	)		465			-			347
Note 16	Comparatives
---	---

Certain comparative amounts have been reclassified to conform to the current period's presentation.

Manulife Financial Corporation – Third Quarter 2022

107

SHAREHOLDER INFORMATION

MANULIFE FINANCIAL CORPORATION<br><br> <br>HEAD OFFICE<br><br> <br>200 Bloor Street East<br><br> <br>Toronto, ON Canada M4W 1E5<br><br> <br>Telephone: 416 926-3000<br><br> <br>Online: www.manulife.com<br><br> <br><br><br> <br>INVESTOR RELATIONS<br><br> <br>Financial analysts, portfolio managers and<br><br> <br>other investors requiring financial information<br><br> <br>may contact our Investor Relations Department<br><br> <br>or access our website at www.manulife.com<br><br> <br>Email: InvestRel@manulife.com<br><br> <br><br><br> <br>SHAREHOLDER SERVICES<br><br> <br>For information or assistance regarding<br><br> <br>your share account, including dividends,<br><br> <br>changes of address or ownership, lost<br><br> <br>certificates, to eliminate duplicate mailings<br><br> <br>or to receive shareholder material<br><br> <br>electronically, please contact our Transfer<br><br> <br>Agents in Canada, the United States, Hong Kong<br><br> <br>or the Philippines. If you live outside one<br><br> <br>of these countries, please contact our Canadian<br><br> <br>Transfer Agent.	TRANSFER AGENTS<br><br> <br>Canada<br><br> <br>TSX Trust Company<br><br> <br>P.O. Box 700, Station B<br><br> <br>Montreal, QC Canada H3B 3K3<br><br> <br>Toll Free: 1 800 783-9495<br><br> <br>Collect: 416 682-3864<br><br> <br>Email: manulifeinquiries@tmx.com<br><br> <br>Online: www.tsxtrust.com<br><br> <br>TSX Trust Company offices are also<br><br> <br>located in Toronto, Calgary, Montreal<br><br> <br>and Vancouver.<br><br> <br><br><br> <br>United States<br><br> <br>American Stock Transfer & Trust Company, LLC<br><br> <br>P.O. Box 199036<br><br> <br>Brooklyn, NY 11219<br><br> <br>United States<br><br> <br>Toll Free: 1 800 249-7702<br><br> <br>Collect: 416 682-3864<br><br> <br>Email: manulifeinquiries@tmx.com<br><br> <br>Online: www.tsxtrust.com<br><br> <br><br><br> <br>Hong Kong<br><br> <br>Tricor Investor Services Limited<br><br> <br>17/F, Far East Finance Centre<br><br> <br>16 Harcourt Road<br><br> <br>Hong Kong<br><br> <br>Telephone: 852 2980-1333<br><br> Email: is-enquiries@hk.tricorglobal.com<br><br> <br>Online: www.tricoris.com	Philippines<br><br> <br>Rizal Commercial Banking Corporation<br><br> <br>Ground Floor, West Wing<br><br> <br>GPL (Grepalife) Building<br><br> <br>221 Senator Gil Puyat Avenue<br><br> <br>Makati City, Metro Manila, Philippines<br><br> <br>Telephone: 632 5318-8567<br><br> <br>Email: rcbcstocktransfer@rcbc.com<br><br> <br>Online: www.rcbc.com/stocktransfer<br><br> <br><br><br> <br>AUDITORS<br><br> <br>Ernst & Young LLP<br><br> <br>Chartered Professional Accountants<br><br> <br>Licensed Public Accountants<br><br> <br>Toronto, Canada
		The following Manulife<br> documents are available online at www.manulife.com<br><br> <br><br> <br> <br>· Annual Report and Proxy Circular<br><br> <br>· Notice of Annual Meeting<br><br> <br>· Shareholders Reports<br><br> <br>· Public Accountability Statement<br><br> <br>· 2021 Environmental, Social and<br><br> <br>Governance Report
Rating
---
Financial strength is a key factor in generating new business, maintaining and expanding<br> distribution relations and providing a base for expansion, acquisitions and growth. As at September 30, 2022, Manulife had total capital of C63.4 billion, including C56.1 billion of total shareholders’ and<br> other equity. The Manufacturers Life Insurance Company’s financial strength ratings are among the strongest in the insurance industry.
---	---	---
	MLI Rating	Rank
	AA-	(4th of 21 ratings)
	A1	(5th of 21 ratings)
	AA-	(4th of 21 ratings)
	AA	(3rd of 22 ratings)
	A+ (Superior)	(2nd of 13 ratings)

All values are in US Dollars.

Rating agencies include AM Best Company (“AM Best”), DBRS Limited and affiliated entities (“DBRS Morningstar”), Fitch Ratings Inc. (“Fitch”), Moody’s Investors Service Inc. (“Moody’s”), and S&P Global Ratings (“S&P”).

Common Stock Trading Data
The following values are the high, low and close prices, including the average daily trading<br> volume for Manulife Financial Corporation’s common stock on the Canadian exchanges, the U.S. exchanges, The Stock Exchange of Hong Kong and the Philippine Stock Exchange for the third quarter. The common stock<br> symbol is MFC on all exchanges except Hong Kong where it is 945.	As at September 30, 2022, there were 1,888 million<br> common shares outstanding.
---	---	---	---	---	---	---
		July 1 –<br><br> <br>September 30,<br><br> <br>2022	Canada<br><br> <br>Canadian $	U.S.<br><br> <br>United States $	Hong Kong<br><br> <br>Hong Kong $	Philippines<br><br> <br>Philippine<br><br> <br>Pesos
		High	$24.48	$19.12	$146.70	P 1,020
		Low	$21.48	$15.64	$122.80	P 851
		Close	$21.68	$15.67	$124.10	P 991
		Average Daily<br><br> <br>Volume (000)	10,297	3,021	22	0.2

Manulife Financial Corporation - Third Quarter 2022

108

Consent to receive documents electronically

Electronic documents available from Manulife. Manulife is pleased to offer Electronic Documents. Access the information when you want, no more waiting for the mail. The Manulife documents available electronically are: · Annual Report and Proxy Circular · Notice of Annual Meeting · Shareholder Reports

These documents will be available to you on our website www.manulife.com at the same time as they are mailed to other shareholders. Documents relating to the annual meeting, including annual reports, will be available on the website at least until the next version is available. We will notify you when documents will be available on the website and confirm the instructions for accessing the documents at the same time. In the event that the documents are not available on our website, paper copies will be mailed to you. This information is also available for viewing or downloading under quarterly reports from the Investor Relations section of our website at www.manulife.com

---

…………………………………….………………….………Detach

                            Here ..…………………………..……………………………………………………

To receive documents electronically when they are available through Manulife’s electronic delivery service, complete this form and return it as indicated. I have read and understand the statement on the reverse and consent to receive electronically the Manulife documents listed in the manner described. I acknowledge that I have the computer requirements to access the documents that are made available on Manulife’s website. I understand that I am not required to consent to electronic delivery and that I may revoke my consent at any time. Please note: We will contact you by phone only if there is a problem with your email address. The information provided is confidential and will not be used for any purpose other than that described.

Please Print: _________________________________________________________ Shareholder Name _________________________________________________________ Contact Phone Number _________________________________________________________ Shareholder Email Address _________________________________________________________ Shareholder Signature _________________________________________________________ Date

Manulife Financial Corporation - Third Quarter 2022

109

Form 52-109F2

Certification of Interim Filings

Full Certificate

I, Roy Gori, President and Chief Executive Officer of Manulife Financial Corporation, certify the following:

1.	Review: I have reviewed the interim financial report and interim MD&A<br> (together, the “interim filings”) of Manulife Financial Corporation (the “issuer”) for the interim period ended September 30, 2022.
2.	No misrepresentations: Based on my knowledge, having exercised reasonable<br> diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it<br> was made, with respect to the period covered by the interim filings.
---	---
3.	Fair presentation: Based on my knowledge, having exercised reasonable<br> diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of<br> the date of and for the periods presented in the interim filings.
---	---
4.	Responsibility: The issuer’s other certifying officer(s) and I are<br> responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim Filings, for the issuer.
---	---
5.	Design: Subject to the limitations, if any, described in paragraphs 5.2<br> and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings
---	---
(a)	designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
---	---
(i)	material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
---	---
(ii)	information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded,<br> processed, summarized and reported within the time periods specified in securities legislation; and
---	---
(b)	designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of<br> financial statements for external purposes in accordance with the issuer’s GAAP.
---	---
5.1	Control framework: The control framework the issuer’s other certifying<br> officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
---	---
5.2	N/A
---	---
5.3	N/A
---	---
6.	Reporting changes in ICFR: The issuer has disclosed in its interim<br> MD&A any change in the issuer’s ICFR that occurred during the period beginning on July 1, 2022 and ended on September 30, 2022 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.
---	---

Date: November 9, 2022

/s/ Roy Gori

Roy Gori

President and Chief Executive Officer

Form 52-109F2

Certification of Interim Filings

Full Certificate

I, Philip J. Witherington, Chief Financial Officer of Manulife Financial Corporation, certify the following:

1.	Review: I have reviewed the interim financial report and interim MD&A<br> (together, the “interim filings”) of Manulife Financial Corporation (the “issuer”) for the interim period ended September 30, 2022.
2.	No misrepresentations: Based on my knowledge, having exercised reasonable<br> diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it<br> was made, with respect to the period covered by the interim filings.
---	---
3.	Fair presentation: Based on my knowledge, having exercised reasonable<br> diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of<br> the date of and for the periods presented in the interim filings.
---	---
4.	Responsibility: The issuer’s other certifying officer(s) and I are<br> responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim Filings, for the issuer.
---	---
5.	Design: Subject to the limitations, if any, described in paragraphs 5.2<br> and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings
---	---
(a)	designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
---	---
(i)	material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
---	---
(ii)	information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded,<br> processed, summarized and reported within the time periods specified in securities legislation; and
---	---
(b)	designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of<br> financial statements for external purposes in accordance with the issuer’s GAAP.
---	---
5.1	Control framework: The control framework the issuer’s other certifying<br> officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
---	---
5.2	N/A
---	---
5.3	N/A
---	---
6.	Reporting changes in ICFR: The issuer has disclosed in its interim<br> MD&A any change in the issuer’s ICFR that occurred during the period beginning on July 1, 2022 and ended on September 30, 2022 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.
---	---

Date: November 9, 2022

/s/ Philip J. Witherington

Philip J. Witherington

Chief Financial Officer